\begin{thebibliography}{565}
\providecommand{\natexlab}[1]{#1}
\providecommand{\url}[1]{\texttt{#1}}
\expandafter\ifx\csname urlstyle\endcsname\relax
  \providecommand{\doi}[1]{doi: #1}\else
  \providecommand{\doi}{doi: \begingroup \urlstyle{rm}\Url}\fi

\bibitem[bib(2000)]{bib3221}
Myocardial infarction redefined a consensus document of the joint european
  society of cardiology/american college of cardiology committee for the
  redefinition of myocardial infarction. j am coll cardiol.
\newblock 2000.

\bibitem[bib(2001)]{bib368}
American heart association task force on practice guidelines. evaluation and
  management of chronic heart failure in the adult.acc/aha practice guidelines.
\newblock 2001.

\bibitem[bib(2002)]{bib3222}
Acc/aha 2002 guideline update for the management of patients with unstable
  angina and non-st-segment elevation myocardial infarction. a report of the
  american college of cardiology/american heart association task force on
  practice guidelines (committee on the management of patients with unstable
  angina).
\newblock 2002.

\bibitem[bib(2003)]{bib370}
Clinical guideline 5. chronic heart failure. management of chronic heart
  failure in adults in primary and secondary care.
\newblock 2003.

\bibitem[108(205)]{108}
\emph{author = {Kiefer and Wiedemann year =}, 2004, title = {Neuroendocrine
  pathways of addictive behaviour.}, journal = {Addict Biol}, 9}, 12, 205.

\bibitem[Ahluwalia and AJ(2005)]{267}
Ahluwalia and Hobbs AJ.
\newblock Endothelium-derived c-type natriuretic peptide more than just a
  hyperpolarized factor.
\newblock \emph{Trends Pharmacol Sci}, 26:\penalty0 162--167, 2005.

\bibitem[Ahluwalia et~al.(2004{\natexlab{a}})Ahluwalia, MacAllister, and
  AJ]{168}
Ahluwalia, MacAllister, and Hobbs AJ.
\newblock Vascular actions of natriuretic peptides. cyclic gmp-dependent and
  -independent mechanisms.
\newblock \emph{Basic Res Cardiol}, 99:\penalty0 83--89, 2004{\natexlab{a}}.

\bibitem[Ahluwalia et~al.(2004{\natexlab{b}})Ahluwalia, RJ, and AJ]{bib355}
Ahluwalia, MacAllister RJ, and Hobbs AJ.
\newblock Vascular actions of natriuretic peptides. cyclic gmp-dependent and
  -independent mechanisms.
\newblock \emph{Basic Res Cardiol}, 99:\penalty0 83--89, 2004{\natexlab{b}}.

\bibitem[Allgren et~al.(1997)Allgren, Marbury, Rahman, Weisberg, Fenves,
  Lafayette, Sweet, Genter, Kurnik, Conger, and Sayegh]{Allgren1997}
RL~Allgren, TC~Marbury, SN~Rahman, LS~Weisberg, AZ~Fenves, RA~Lafayette,
  RM~Sweet, FC~Genter, BR~Kurnik, JD~Conger, and MH~Sayegh.
\newblock Anaritide in acute tubular necrosis; auriculin anaritide acute renal
  failure study group.
\newblock \emph{N Engl J Med}, 336:\penalty0 828--834, 1997.

\bibitem[Almeida et~al.(1986)Almeida, Suzuki, and Maack]{Almeida1986}
FA~Almeida, M~Suzuki, and T~Maack.
\newblock Atrial natriuretic factor increases hematocrit and decreases plasma
  volume in nephrectomized rats.
\newblock \emph{Life Sci}, 39:\penalty0 1193--1199, 1986.

\bibitem[Ammarguellat et~al.(2001)Ammarguellat, Larouche, and
  Schiffrin]{Ammarguellat2001}
F~Ammarguellat, I~Larouche, and EL~Schiffrin.
\newblock Myocardial fibrosis in doca-salt hypertensive rats: effect of
  endothelin et(a) receptor antagonism.
\newblock \emph{Circulation}, 103:\penalty0 319--324, 2001.

\bibitem[Anand et~al.(2003)Anand, LD, and et~al]{bib3191}
Anand, Fisher LD, and Chiang~YT et~al.
\newblock Val-heft investigators. changes in brain natriuretic peptide and
  norepinephrine over time and mortality and morbidity in the valsartan heart
  failure trial (val-heft).
\newblock \emph{Circulation}, 107:\penalty0 1278--1283, 2003.

\bibitem[Anand-Srivastava and GJ(1993)]{164}
Anand-Srivastava and Trachte GJ.
\newblock Atrial natriuretic factor receptors and signal transduction
  mechanisms.
\newblock \emph{Pharmacol Rev}, 45:\penalty0 455--497, 1993.

\bibitem[Anand-Srivastava et~al.(1988)Anand-Srivastava, MR, and M]{bib357}
Anand-Srivastava, Sairam MR, and Cantin M.
\newblock Ring-deleted analogs of atrial natriuretic factor inhibit adenylate
  cyclase/camp system. possible coupling of clearance atrial natriuretic factor
  receptors to adenylate cyclase/camp signal transduction system.
\newblock \emph{J Biol Chem}, 265:\penalty0 8566--8572, 1988.

\bibitem[andAndreasson K and et~al(2002)]{bib3288}
Persson andAndreasson K and Kahan~T et~al.
\newblock Neurohormonal activation in heart failure after acute myocardial
  infarction treated with beta-receptor antagonists.
\newblock \emph{Eur J Heart Fail}, 4:\penalty0 73--82, 2002.

\bibitem[Ando et~al.(1996)Ando, Ogawa, and Yamaki]{125}
Ando, Ogawa, and Yamaki.
\newblock Plasma concentrations of atrial, brain, and c-type natriuretic
  peptides and endothelin-1 in patients with chronic respiratory diseases.
\newblock \emph{Chest}, 110:\penalty0 462--468, 1996.

\bibitem[Andreassi et~al.(2001)Andreassi, S, and et~al]{bib343}
Andreassi, Del~Ry S, and Palmieri~C et~al.
\newblock Up-regulation of ‘clearance’ receptors in patients with chronic
  heart failure: a possible explanation for the resistance to biological
  effects of cardiac natriuretic hormones.
\newblock \emph{Eur J Heart Fail}, 3:\penalty0 407--414, 2001.

\bibitem[andVasan RS(2003)]{bib3248}
Freitag andVasan RS.
\newblock Screening for left ventricular systolic dysfunction: the use of btype
  natriuretic peptide.
\newblock \emph{Heart Fail Monit}, 4:\penalty0 38--44, 2003.

\bibitem[andYoshikawa T and et~al(2004)]{bib3292}
Yoshizawa andYoshikawa T and Nakamura~I et~al.
\newblock Brain natriuretic peptide response is heterogeneous during
  beta-blocker therapy for congestive heart failure.
\newblock \emph{J Card Fail}, 10:\penalty0 310--315, 2004.

\bibitem[andYoshimura M and et~al(1994)]{bib3118}
Yasue andYoshimura M and Sumida~H et~al.
\newblock Localization and mechanism of secretion of btype natriuretic peptide
  in comparison with those of a-type natriuretic peptide in normal subjects and
  patients with heart failure.
\newblock \emph{Circulation}, 90:\penalty0 195--203, 1994.

\bibitem[andYu CM andYip G~et al(2003)]{bib3289}
Fung andYu CM andYip G~et al.
\newblock Effect of beta blockade (carvedilol or metoprolol) on activation of
  the renin-angiotensin-aldosterone system and natriuretic peptides in chronic
  heart failure.
\newblock \emph{Am J Cardiol}, 92:\penalty0 406--410, 2003.

\bibitem[Antos and Potter(2007)]{Antos2007}
LK~Antos and LR~Potter.
\newblock Adenine nucleotides decrease the apparent km of endogenous
  natriuretic peptide receptors for gtp.
\newblock \emph{Am J Physiol Endocrinol Metab}, 293:\penalty0 E1756--1763,
  2007.

\bibitem[Antos et~al.(2005)Antos, Abbey-Hosch, Flora, and Potter]{Antos2005}
LK~Antos, SE~Abbey-Hosch, DR~Flora, and LR~Potter.
\newblock Atp-independent activation of natriuretic peptide receptors.
\newblock \emph{J Biol Chem}, 280:\penalty0 26928--26932, 2005.

\bibitem[Apple et~al.(2003)Apple, E, and et~al]{bib3114}
Apple, Trinity E, and Steen~J et~al.
\newblock Bnp test utilization for chf in community hospital practice.
\newblock \emph{Clin Chim Acta}, 328:\penalty0 191--193, 2003.

\bibitem[Apple et~al.(2005)Apple, M, and et~al]{bib3131}
Apple, Panteghini M, and Ravkilde~J et~al.
\newblock Quality specifications for b-type natriuretic peptide assays.
\newblock \emph{Clin Chem}, 51:\penalty0 486--493, 2005.

\bibitem[Arakawa et~al.(1994)Arakawa, M, H, and K]{bib3136}
Arakawa, Nakamura M, Aoki H, and Hiramori K.
\newblock Relationship between plasma level of brain natriuretic peptide and
  myocardial infarct size.
\newblock \emph{Cardiology}, 85:\penalty0 334--340, 1994.

\bibitem[Arakawa et~al.(1996)Arakawa, M, H, and K]{bib3224}
Arakawa, Nakamura M, Aoki H, and Hiramori K.
\newblock Plasma brain natriuretic peptide concentrations predict survival
  after acute myocardial infarction.
\newblock \emph{J Am Coll Cardiol}, 27:\penalty0 1656--1661, 1996.

\bibitem[Arden et~al.(1995)Arden, Viars, and Weiss]{7}
Arden, Viars, and Weiss.
\newblock \emph{Genomics}, 26:\penalty0 385--389, 1995.

\bibitem[Barabasi and ZN(2004)]{287}
Barabasi and Oltvai ZN.
\newblock Network biology understanding the cell’s functional organization.
\newblock \emph{Nat Rev Genet}, 5:\penalty0 101--113, 2004.

\bibitem[Bartels et~al.(2004)Bartels, Bukulmez, Padayatti, Rhee, van
  Ravenswaaij-Arts, Pauli, Mundlos, Chitayat, Shih, Al-Gazali, Kant, Cole,
  Morton, Cormier-Daire, Faivre, Lees, Kirk, Mortier, Leroy, Zabel, Kim, Crow,
  Braverman, van-den Akker, and Warman]{Bartels2004}
CF~Bartels, H~Bukulmez, P~Padayatti, DK~Rhee, C~van Ravenswaaij-Arts, RM~Pauli,
  S~Mundlos, D~Chitayat, LY~Shih, LI~Al-Gazali, S~Kant, T~Cole, J~Morton,
  V~Cormier-Daire, L~Faivre, M~Lees, J~Kirk, GR~Mortier, J~Leroy, B~Zabel,
  CA~Kim, Y~Crow, NE~Braverman, F~van-den Akker, and MLA Warman.
\newblock Mutations in the transmembrane natriuretic peptide receptor npr-b
  impair skeletal growth and cause acromesomelic dysplasia, type maroteaux.
\newblock \emph{Am J Hum Genet}, 75:\penalty0 27--34, 2004.

\bibitem[Baruch et~al.(2004)Baruch, RD, and et~al]{bib3193}
Baruch, Glazer RD, and Aknay~N et~al.
\newblock Morbidity, mortality, physiologic and functional parameters in
  elderly and non-elderly patients in the valsartan heart failure trial
  (valheft).
\newblock \emph{Am Heart J}, 148:\penalty0 951--957, 2004.

\bibitem[Bay et~al.(2003)Bay, V, and et~al]{bib3115}
Bay, Kirk V, and Parner~J et~al.
\newblock Nt-probnp: a new diagnostic screening tool to differentiate between
  patients with normal and reduced left ventricular systolic function.
\newblock \emph{Heart}, 89:\penalty0 150--154, 2003.

\bibitem[Belenky et~al.(2004{\natexlab{a}})Belenky, A, and et~al]{bib336}
Belenky, Smith A, and Zhang~B et~al.
\newblock The effect of class-specific protease inhibitors on the stabilization
  of b-type natriuretic peptide in human plasma.
\newblock \emph{Clin Chim Acta}, 340:\penalty0 163--172, 2004{\natexlab{a}}.

\bibitem[Belenky et~al.(2004{\natexlab{b}})Belenky, Smith, and Zhang]{15}
Belenky, Smith, and Zhang.
\newblock The effect of class-specific protease inhibitors on the stabilization
  of b-type natriuretic peptide in human plasma.
\newblock \emph{Clin Chim Acta}, 340:\penalty0 163--172, 2004{\natexlab{b}}.

\bibitem[Benedict(1994)]{bib359}
Benedict.
\newblock Neurohormonal aspects of congestive heart failure.
\newblock \emph{(Review) Cardiol Clin}, 12:\penalty0 9--23, 1994.

\bibitem[Benedict et~al.(1996)Benedict, B, and et~al]{bib3187}
Benedict, Shelton B, and Johnstone~DE et~al.
\newblock Prognostic significance of plasma norepinephrine in patients with
  asymptomatic left ventricular dysfunction. solvd investigators.
\newblock \emph{Circulation}, 94:\penalty0 690--697, 1996.

\bibitem[Bennett et~al.(1991)Bennett, Bennett, Vitangcol, Jewett, Burnier,
  Henzel, and Lowe]{Bennett1991}
BD~Bennett, GL~Bennett, RV~Vitangcol, JR~Jewett, J~Burnier, W~Henzel, and
  DG~Lowe.
\newblock Extracellular domain-igg fusion proteins for three human natriuretic
  peptide receptors; hormone pharmacology and application to solid phase
  screening of synthetic peptide antisera.
\newblock \emph{J Biol Chem}, 266:\penalty0 23060--23067, 1991.

\bibitem[Bentzen et~al.(2003)Bentzen, Pedersen, and HB]{197}
Bentzen, Pedersen, and Pedersen HB.
\newblock Abnormal rhythmic oscillations of atrial natriuretic peptide and
  brain natriuretic peptide in heart failure.
\newblock \emph{Clin Sci}, 104:\penalty0 303--312, 2003.

\bibitem[Berger et~al.(2005)Berger, M, and et~al]{bib3206}
Berger, Huelsmann M, and Strecker~K et~al.
\newblock Neurohormonal risk stratification for sudden death and death owing to
  progressive heart failure in chronic heart failure.
\newblock \emph{Eur J Clin Invest}, 35:\penalty0 24--31, 2005.

\bibitem[Berger et~al.(2002)Berger, Huelsman, Strecker, Bojic, Moser, Stanek,
  and Pacher]{Berger2002}
R~Berger, M~Huelsman, K~Strecker, A~Bojic, P~Moser, B~Stanek, and R~Pacher.
\newblock B-type natriuretic peptide predicts sudden death in patients with
  chronic heart failure.
\newblock \emph{Circulation}, 105:\penalty0 2392--7, 2002.

\bibitem[Bernstein et~al.(1997)Bernstein, Midtbo, and Urdal]{131}
Bernstein, Midtbo, and Urdal.
\newblock Serum n-terminal pro-atrial natriuretic factor 1-98 before and during
  thyroxine replacement therapy in severe hypothyroidism.
\newblock \emph{Thyroid}, 7:\penalty0 415--419, 1997.

\bibitem[Bettencourt(2004)]{bib364}
Bettencourt.
\newblock Nt-probnp and bnp: biomarkers for heart failure management.
\newblock \emph{(Review) Eur J Heart Fail}, 6:\penalty0 359--363, 2004.

\bibitem[Bettencourt et~al.(2000)Bettencourt, A, and et~al]{bib3140}
Bettencourt, Ferreira A, and Pardal-Oliveira~N et~al.
\newblock Clinical significance of brain natriuretic peptide in patients with
  postmyocardial infarction.
\newblock \emph{Clin Cardiol}, 23:\penalty0 921--927, 2000.

\bibitem[Bex and Corbin(1985)]{109}
Bex and Corbin.
\newblock Atrial natriuretic factor stimulates testosterone production by mouse
  interstitial cells.
\newblock \emph{Eur J Pharmacol}, 115:\penalty0 125--126, 1985.

\bibitem[Bhalla et~al.(2004{\natexlab{a}})Bhalla, A, and et~al]{bib389}
Bhalla, Chiang A, and Epshteyn~VA et~al.
\newblock Prognostic role of b-type natriuretic peptide levels in patients with
  type 2 diabetes mellitus.
\newblock \emph{J Am Coll Cardiol}, 44:\penalty0 1047--1052,
  2004{\natexlab{a}}.

\bibitem[Bhalla et~al.(2004{\natexlab{b}})Bhalla, Chiang, and VA]{141}
Bhalla, Chiang, and Epshteyn VA.
\newblock \emph{title = { Prognostic role of B-type natriuretic peptide levels
  in patients with type}, 2 diabetes mellitus.}, 44:\penalty0 1047--1052,
  2004{\natexlab{b}}.

\bibitem[Bilder et~al.(1986)Bilder, Schofield, and Blaine]{Bilder1986}
GE~Bilder, TL~Schofield, and EH~Blaine.
\newblock Release of atrial natriuretic factor; effects of repetitive stretch
  and temperature.
\newblock \emph{Am J Physiol}, 251:\penalty0 F817--F821, 1986.

\bibitem[Bold et~al.(1996)Bold, BG, and de~Bold~ML]{bib312}
De~Bold, Bruneau BG, and Kuroski de~Bold~ML.
\newblock Mechanical and neuroendocrine regulation of the endocrine heart.
\newblock \emph{(Review) Cardiovasc Res}, 31:\penalty0 7--18, 1996.

\bibitem[Bold et~al.(2001)Bold, KKY, and et~al]{bib31}
De~Bold, Ma~KKY, and Zhang~Y et~al.
\newblock The physiological and pathophysiological modulation of the endocrine
  function of the heart.
\newblock \emph{(Review) Can J Physiol Pharmacol}, 79:\penalty0 705--714, 2001.

\bibitem[Bonow and JE(1992)]{bib3121}
Bonow and Udelson JE.
\newblock Left ventricular diastolic dysfunction as a cause of congestive heart
  failure.
\newblock \emph{Ann Intern Med}, 117:\penalty0 502--510, 1992.

\bibitem[Boomsma and van~den Meiracker(2001)]{Boomsma2001}
F~Boomsma and AH~van~den Meiracker.
\newblock Plasma aand b-type natriuretic peptides: physiology, methodology and
  clinical use.
\newblock \emph{Cardiovasc Res}, 51:\penalty0 442--9, 2001.

\bibitem[Booz(2005)]{120}
Booz.
\newblock Putting the brakes on cardiac hypertrophy exploiting the no-cgmp
  counter-regulatory system.
\newblock \emph{Hypertension}, 45:\penalty0 341--346, 2005.

\bibitem[Bosc et~al.(2000)Bosc, Majowicz, and NA]{285}
Gonzalez Bosc, Majowicz, and Vidal NA.
\newblock Effects of atrial natriuretic peptide in the gut.
\newblock \emph{Peptides}, 21:\penalty0 875--887, 2000.

\bibitem[Bossuyt(2003)]{bib371}
Bossuyt.
\newblock Study design and quality of evidence. in: Price cp, christenson rh
  (eds) evidence-based laboratory medicine. from principles to outcome.
\newblock \emph{AACC Press, Washington DC, pp 75-92}, 2003.

\bibitem[Bouissou et~al.(1989)Bouissou, FX, and et~al]{bib3278}
Bouissou, Galen FX, and Richalet~JP et~al.
\newblock Effects of propranolol and pindolol on plasma anp levels in humans at
  rest and during exercise.
\newblock \emph{Am J Physiol}, 257:\penalty0 R259--264, 1989.

\bibitem[Brown et~al.(1997)Brown, Chen, and Hong]{Brown1997}
J~Brown, Q~Chen, and G~Hong.
\newblock An autocrine system for c-type natriuretic peptide within rat carotid
  neointima during arterial repair.
\newblock \emph{Am J Physiol}, 272:\penalty0 H2919--H2931, 1997.

\bibitem[Bruins et~al.(2004{\natexlab{a}})Bruins, MR, and et~al]{bib3101}
Bruins, Fokkema MR, and Romer~JW et~al.
\newblock High intraindividual variation of b-type natriuretic peptide (bnp)
  and amino-terminal probnp in patients with stable chronic heart failure.
\newblock \emph{Clin Chem}, 50:\penalty0 2052--2058, 2004{\natexlab{a}}.

\bibitem[Bruins et~al.(2004{\natexlab{b}})Bruins, Fokkema, Romer, Dejongste,
  van~der Dijs, van~den Ouweland, and Muskiet]{Bruins2004}
S~Bruins, MR~Fokkema, JW~Romer, MJ~Dejongste, FP~van~der Dijs, JM~van~den
  Ouweland, and FA~Muskiet.
\newblock High intraindividual variation of b-type natriuretic peptide (bnp)
  and amino-terminal probnp in patients with stable chronic heart failure.
\newblock \emph{Clin Chem}, 50:\penalty0 2052--8, 2004{\natexlab{b}}.

\bibitem[Bryan and LR(2002)]{bib349}
Bryan and Potter LR.
\newblock The atrial natriuretic peptide receptor (npr-a/gc-a) is
  dephosphorylated by distinct microcystin-sensitive and magnesium-dependent
  protein phosphatases.
\newblock \emph{J Biol Chem}, 277:\penalty0 16041--16047, 2002.

\bibitem[Bryan et~al.(2006)Bryan, Smirnov, Smolenski, Feil, Feil, Hofmann,
  Lohmann, and Potter]{Bryan2006}
PM~Bryan, D~Smirnov, A~Smolenski, S~Feil, R~Feil, F~Hofmann, S~Lohmann, and
  LR~Potter.
\newblock A sensitive method for determining the phosphorylation status of
  natriuretic peptide receptors: cgk-ialpha does not regulate npr-a.
\newblock \emph{Biochemistry}, 45:\penalty0 1295--1303, 2006.

\bibitem[Buckley et~al.(1999)Buckley, Marcus, and Yacoub]{Buckley1999}
MG~Buckley, NJ~Marcus, and MH~Yacoub.
\newblock Cardiac peptide stability, aprotinin and room temperature: importance
  for assessing cardiac function in clinical practice.
\newblock \emph{Clin Sci (Lond)}, 97:\penalty0 689--95, 1999.

\bibitem[Burczynska et~al.(2007)Burczynska, Duda, and Sharma]{Burczynska2007}
B~Burczynska, T~Duda, and RK~Sharma.
\newblock Atp signaling site in the arm domain of atrial natriuretic factor
  receptor guanylate cyclase.
\newblock \emph{Mol Cell Biochem}, 301:\penalty0 93--107, 2007.

\bibitem[Burnett et~al.(1986)Burnett, Kao, Hu, Heser, Heublein, Granger,
  Opgenorth, and Reeder]{Burnett1986}
JC~Burnett, PC~Kao, DC~Hu, DW~Heser, D~Heublein, JP~Granger, TJ~Opgenorth, and
  GS~Reeder.
\newblock Atrial natriuretic peptide elevation in congestive heart failure in
  the human.
\newblock \emph{Science}, 231:\penalty0 11451147, 1986.

\bibitem[Cappuccio et~al.(1989)Cappuccio, Markandu, and MG]{139}
Cappuccio, Markandu, and Buckley MG.
\newblock Raised plasma levels of atrial natriuretic peptides in addison’s
  disease.
\newblock \emph{J Endocrinol Invest}, 12:\penalty0 205--207, 1989.

\bibitem[Cardarelli and TG(2003)]{bib3168}
Cardarelli and Lumicao TG.
\newblock B-type natriuretic peptide: a review of its diagnostic, prognostic,
  and therapeutic monitoring value in heart failure for primary care
  physicians.
\newblock \emph{(Review) J Am Board Fam Pract}, 16:\penalty0 327--333, 2003.

\bibitem[Casco et~al.(2002)Casco, Veinot, and de~Bold~ML]{272}
Casco, Veinot, and Kuroski de~Bold~ML.
\newblock Natriuretic peptide system gene expression in human coronary
  arteries.
\newblock \emph{J Histochem Cytochem}, 50:\penalty0 799--809, 2002.

\bibitem[Castillo et~al.(2004{\natexlab{a}})Castillo, A, R, and CH]{bib386}
Castillo, Zagler A, Carrillo-Jimenez R, and Hennekens CH.
\newblock Brain natriuretic peptide: a potential marker for mortality in septic
  shock.
\newblock \emph{Int J Infect Dis}, 8:\penalty0 271--274, 2004{\natexlab{a}}.

\bibitem[Castillo et~al.(2004{\natexlab{b}})Castillo, Zagler, Carrillo-Jimenez,
  and CH]{146}
Castillo, Zagler, Carrillo-Jimenez, and Hennekens CH.
\newblock Brain natriuretic peptide a potential marker for mortality in septic
  shock.
\newblock \emph{Int J Infect Dis}, 8:\penalty0 271--274, 2004{\natexlab{b}}.

\bibitem[Chang et~al.(1989)Chang, Lowe, Lewis, Hellmiss, Chen, and
  Goeddel]{Chang1989}
MS~Chang, DG~Lowe, M~Lewis, R~Hellmiss, E~Chen, and DV~Goeddel.
\newblock Differential activation by atrial and brain natriuretic peptides of
  two different receptor guanylate cyclases.
\newblock \emph{Nature}, 341:\penalty0 68--72, 1989.

\bibitem[Charles et~al.(2006)Charles, Prickett, Espiner, Rademaker, Richards,
  and Yandle]{Charles2006}
CJ~Charles, TC~Prickett, EA~Espiner, MT~Rademaker, AM~Richards, and TG~Yandle.
\newblock Regional sampling and the effects of experimental heart failure in
  sheep: differential responses in a, b and c-type natriuretic peptides.
\newblock \emph{Peptides}, 27:\penalty0 62--68, 2006.

\bibitem[Charloux et~al.(2003)Charloux, F, and et~al]{bib325}
Charloux, Piquard F, and Doutreleau~S et~al.
\newblock Mechanisms of renal hyporesponsiveness to anp in heart failure.
\newblock \emph{(Review) Eur J Clin Invest}, 33:\penalty0 769--778, 2003.

\bibitem[Chatterjee et~al.(1999)Chatterjee, Hawksworthy, and JS]{116}
Chatterjee, Hawksworthy, and McLay JS.
\newblock Cytokine-stimulated nitric oxide production in the human renal
  proximal tubule and its modulation by natriuretic peptides a novel
  immunomodulatory mechanism?
\newblock \emph{Exp Nephrol}, 7:\penalty0 438--448, 1999.

\bibitem[Chen and Burnett()]{84}
Chen and Burnett.

\bibitem[Chen et~al.(2006)Chen, Schirger, Cataliotti, and Burnett]{Chen2006}
HH~Chen, JA~Schirger, A~Cataliotti, and JC~Burnett.
\newblock Intact acute cardiorenal and humoral responsiveness following chronic
  subcutaneous administration of the cardiac peptide bnp in experimental heart
  failure.
\newblock \emph{Eur J Heart Fail}, 8:\penalty0 681--686, 2006.

\bibitem[Cheung et~al.(1999)Cheung, Leung, and Shiu]{261}
Cheung, Leung, and Shiu.
\newblock Hpaii polymorphism in the atrial natriuretic peptide gene and
  hypertension.
\newblock \emph{Am J Hypertens}, 12:\penalty0 524--527, 1999.

\bibitem[Chikuda et~al.(2004)Chikuda, Kugimiya, Hoshi, Ikeda, Ogasawara,
  Shimoaka, Kawano, Kamekura, Tsuchida, Yokoi, Nakamura, Komeda, Chung, and
  Kawaguchi]{Chikuda2004}
H~Chikuda, F~Kugimiya, K~Hoshi, T~Ikeda, T~Ogasawara, T~Shimoaka, H~Kawano,
  S~Kamekura, A~Tsuchida, N~Yokoi, K~Nakamura, K~Komeda, UI~Chung, and
  H~Kawaguchi.
\newblock Cyclic gmp-dependent protein kinase ii is a molecular switch from
  proliferation to hypertrophic differentiation of chondrocytes.
\newblock \emph{Genes Dev}, 18:\penalty0 2418--2429, 2004.

\bibitem[Chinkers and EM(1992)]{173}
Chinkers and Wilson EM.
\newblock Ligand-independent oligomerization of natriuretic peptide receptors.
  identification of heteromeric receptors and a dominant negative mutant.
\newblock \emph{J Biol Chem}, 267:\penalty0 18589--18597, 1992.

\bibitem[Choy et~al.(1994)Choy, D, and et~al]{bib3177}
Choy, Darbar D, and Lang~CC et~al.
\newblock Detection of left ventricular dysfunction after acute myocardial
  infarction: comparison of clinical, echocardiographic, and neurohormonal
  methods.
\newblock \emph{Br Heart J}, 72:\penalty0 16--22, 1994.

\bibitem[Chun et~al.(1997)Chun, Itoh, Ogawa, Tamura, Takaya, Igaki, Yamashita,
  Doi, Inoue, Masatsugu, Korenaga, Ando, and Nakao]{Chun1997}
TH~Chun, H~Itoh, Y~Ogawa, N~Tamura, K~Takaya, T~Igaki, J~Yamashita, K~Doi,
  M~Inoue, K~Masatsugu, R~Korenaga, J~Ando, and K~Nakao.
\newblock Shear stress augments expression of c-type natriuretic peptide and
  adrenomedullin.
\newblock \emph{Hypertension}, 29:\penalty0 1296--1302, 1997.

\bibitem[Chusho et~al.(2001)Chusho, Tamura, Ogawa, Yasoda, Suda, Miyazawa,
  Nakamura, Nakao, Kurihara, Komatsu, Itoh, Tanaka, Saito, and
  Katsuki]{Chusho2001}
H~Chusho, N~Tamura, Y~Ogawa, A~Yasoda, M~Suda, T~Miyazawa, K~Nakamura, K~Nakao,
  T~Kurihara, Y~Komatsu, H~Itoh, K~Tanaka, Y~Saito, and M~Katsuki.
\newblock Dwarfism and early death in mice lacking ctype natriuretic peptide.
\newblock \emph{Proc Natl Acad Sci U S A}, 98:\penalty0 4016--4021, 2001.

\bibitem[Clavell et~al.(1993)Clavell, Stingo, Wei, Heublein, and
  Burnett]{Clavell1993}
AL~Clavell, AJ~Stingo, CM~Wei, DM~Heublein, and JC~Burnett.
\newblock C-type natriuretic peptide: a selective cardiovascular peptide.
\newblock \emph{Am J Physiol}, 264:\penalty0 R290--295, 1993.

\bibitem[Cleland et~al.(2007)Cleland, Coletta, and Clark]{Cleland2007}
JG~Cleland, AP~Coletta, and AL~Clark.
\newblock Clinical trials update from the american college of cardiology 2007:
  Alpha, everest, fusion ii, validd, parr-2, remodel, spice, courage, coach,
  remadhe, pro-bnp for the evaluation of dyspnoea and this-diet.
\newblock \emph{Eur J Heart Fail}, 9:\penalty0 740--745, 2007.

\bibitem[Clerico(2002{\natexlab{a}})]{30}
Clerico.
\newblock Pathophysiological and clinical relevance of circulating levels of
  cardiac natriuretic hormones is their assay merely a marker of cardiac
  disease?
\newblock \emph{Clin Chem Lab Med}, 40:\penalty0 752--760, 2002{\natexlab{a}}.

\bibitem[Clerico(2002{\natexlab{b}})]{bib32}
Clerico.
\newblock Pathophysiological and clinical relevance of circulating levels of
  cardiac natriuretic hormones: is their assay merely a marker of cardiac
  disease?
\newblock \emph{(Opinion Article) Clin Chem Lab Med}, 40:\penalty0 752--760,
  2002{\natexlab{b}}.

\bibitem[Clerico(2003)]{252}
Clerico.
\newblock Increasing impact of laboratory medicine in clinical cardiology.
\newblock \emph{Clin Chem Lab Med}, 41:\penalty0 871--883, 2003.

\bibitem[Clerico and Emdin(2004{\natexlab{a}})]{28}
Clerico and Emdin.
\newblock Diagnostic accuracy and prognostic relevance of the measurement of
  the cardiac natriuretic a review.
\newblock \emph{Clin Chem}, 50:\penalty0 33--50, 2004{\natexlab{a}}.

\bibitem[Clerico and Emdin(2004{\natexlab{b}})]{bib35}
Clerico and Emdin.
\newblock Diagnostic accuracy and prognostic relevance of the measurement of
  the cardiac natriuretic peptides: a review.
\newblock \emph{(Review) Clin Chem}, 50:\penalty0 33--50, 2004{\natexlab{b}}.

\bibitem[Clerico and Iervasi(1995{\natexlab{a}})]{200}
Clerico and Iervasi.
\newblock Alterations in metabolic clearance of atrial natriuretic peptides in
  heart failure how do they relate to the resistance to atrial natriuretic
  peptides?
\newblock \emph{J Card Fail}, 1:\penalty0 323--328, 1995{\natexlab{a}}.

\bibitem[Clerico and Iervasi(1995{\natexlab{b}})]{bib327}
Clerico and Iervasi.
\newblock Alterations in metabolic clearance of atrial natriuretic peptides in
  heart failure: how do they relate to the resistance to atrial natriuretic
  peptides?
\newblock \emph{J Card Fail}, 1:\penalty0 323--328, 1995{\natexlab{b}}.

\bibitem[Clerico et~al.(2000{\natexlab{a}})Clerico, G, and A]{bib333}
Clerico, Iervasi G, and Pilo A.
\newblock Turnover studies on cardiac natriuretic peptides: methodological,
  pathophysiological and therapeutical considerations.
\newblock \emph{Curr Drug Metab}, 1:\penalty0 85--105, 2000{\natexlab{a}}.

\bibitem[Clerico et~al.(2000{\natexlab{b}})Clerico, S, and D]{bib318}
Clerico, Del~Ry S, and Giannessi D.
\newblock Measurement of natriuretic cardiac hormones (anp, bnp, and related
  peptides) in clinical practice: the need for a new generation of immunoassay
  methods.
\newblock \emph{(Review) Clin Chem}, 46:\penalty0 1529--1534,
  2000{\natexlab{b}}.

\bibitem[Clerico et~al.(2001)Clerico, R, S, and D]{bib322}
Clerico, Caprioli R, Del~Ry S, and Giannessi D.
\newblock Clinical relevance of cardiac natriuretic peptides measured by means
  of competitive and non-competitive immunoassay methods in patients with renal
  failure on chronic hemodialysis.
\newblock \emph{J Endocrinol Invest}, 24:\penalty0 24--30, 2001.

\bibitem[Clerico et~al.(2002)Clerico, S, and et~al]{bib37}
Clerico, Del~Ry S, and Maffei~S et~al.
\newblock Circulating levels of cardiac natriuretic hormones in healthy adult
  subjects: effects of aging and sex.
\newblock \emph{Clin Chem Lab Med}, 40:\penalty0 371--377, 2002.

\bibitem[Clerico et~al.(2005)Clerico, GC, A, and M]{bib3103}
Clerico, Zucchelli GC, Pilo A, and Emdin M.
\newblock Clinical relevance of biological variation of b-type natriuretic
  peptide.
\newblock \emph{(Letter) Clin Chem}, 51:\penalty0 925--926, 2005.

\bibitem[Clerico et~al.(2006{\natexlab{a}})Clerico, FA, C, and M]{bib3298}
Clerico, Recchia FA, Passino C, and Emdin M.
\newblock Cardiac endocrine function is an essential component of the
  homeostatic regulation network: physiological and clinical implications.
\newblock \emph{Am J Physiol Heart Circ Physiol}, 290:\penalty0 H17--29,
  2006{\natexlab{a}}.

\bibitem[Clerico et~al.(2006{\natexlab{b}})Clerico, Recchia, Passino, and
  Emdin]{288}
Clerico, Recchia, Passino, and Emdin.
\newblock Cardiac endocrine function is an essential component of the
  homeostatic regulation network physiological and clinical implications.
\newblock \emph{Am J Physiol Heart Circ Physiol}, 290:\penalty0 H17--29,
  2006{\natexlab{b}}.

\bibitem[Cody et~al.(1986{\natexlab{a}})Cody, SA, and et~al]{bib328}
Cody, Atlas SA, and Laragh~JH et~al.
\newblock Atrial natriuretic factor in normal subjects and heart failure
  patients: plasma levels and renal, hormonal and hemodynamic responses to
  peptide infusion.
\newblock \emph{J Clin Invest}, 78:\penalty0 1362--1374, 1986{\natexlab{a}}.

\bibitem[Cody et~al.(1986{\natexlab{b}})Cody, Atlas, Laragh, Kubo, Covit,
  Ryman, Shaknovich, Pondolfino, Clark, Camargo, Scarborough, and
  Lewicki]{Cody1986}
RJ~Cody, SA~Atlas, JH~Laragh, SH~Kubo, AB~Covit, KS~Ryman, A~Shaknovich,
  K~Pondolfino, M~Clark, MJ~Camargo, RM~Scarborough, and JA~Lewicki.
\newblock Atrial natriuretic factor in normal subjects and heart failure
  patients; plasma levels and renal, hormonal, and hemodynamic responses to
  peptide infusion.
\newblock \emph{J Clin Invest}, 78:\penalty0 1362--1374, 1986{\natexlab{b}}.

\bibitem[Colantonio et~al.(1991)Colantonio, R, and et~al]{bib3279}
Colantonio, Casale R, and Desiati~P et~al.
\newblock Short-term effects of atenolol and nifedipine on atrial natriuretic
  peptide, plasma renin activity, and plasma aldosterone in patients with
  essential hypertension.
\newblock \emph{J Clin Pharmacol}, 31:\penalty0 238--242, 1991.

\bibitem[Cotter et~al.(2004)Cotter, E, and et~al]{bib3277}
Cotter, Kaluski E, and Stangl~K et~al.
\newblock The hemodynamic and neurohormonal effects of low doses of tezosentan
  (an endothelin a/b receptor antagonist) in patients with acute heart failure.
\newblock \emph{Eur J Heart Fail}, 6:\penalty0 601--609, 2004.

\bibitem[Cowie and GF(2002)]{bib365}
Cowie and Mendez GF.
\newblock Bnp and congestive heart failure.
\newblock \emph{(Review) Prog Cardiovasc Dis}, 44:\penalty0 293--321, 2002.

\bibitem[Cowie et~al.(1997)Cowie, AD, and et~al]{bib3110}
Cowie, Struthers AD, and Wood~DA et~al.
\newblock Value of natriuretic peptides in assessment of patients with possible
  new heart failure in primary care.
\newblock \emph{Lancet}, 350:\penalty0 1349--1353, 1997.

\bibitem[Cowie et~al.(2003)Cowie, Jourdain, Maisel, Dahlstrom, Follath, Isnard,
  Luchner, McDonagh, Mair, Nieminen, and Francis]{Cowie2003}
MR~Cowie, P~Jourdain, A~Maisel, U~Dahlstrom, F~Follath, R~Isnard, A~Luchner,
  T~McDonagh, J~Mair, M~Nieminen, and G~Francis.
\newblock Clinical applications of b-type natriuretic peptide (bnp) testing.
\newblock \emph{Eur Heart J}, 24:\penalty0 1710--8, 2003.

\bibitem[Crilley and M(2001)]{bib3226}
Crilley and Farrer M.
\newblock Left ventricular remodelling and brain natriuretic peptide after
  first myocardial infarction.
\newblock \emph{Heart}, 86:\penalty0 638--642, 2001.

\bibitem[da~Silva et~al.(2005)da~Silva, de~Bold~A, and et~al]{bib3294}
Beck da~Silva, de~Bold~A, and Fraser~M et~al.
\newblock Bnp-guided therapy not better than expert's clinical assessment for
  beta-blocker titration in patients with heart failure.
\newblock \emph{Congest Heart Fail}, 11:\penalty0 248--253, 2005.

\bibitem[Darbar et~al.(1996)Darbar, NC, and et~al]{bib3225}
Darbar, Davidson NC, and Gillespie~N et~al.
\newblock Diagnostic value of b-type natriuretic peptide concentrations in
  patients with acute myocardial infarction.
\newblock \emph{Am J Cardiol}, 78:\penalty0 284--287, 1996.

\bibitem[Das et~al.(2005)Das, Drazner, Dries, Vega, Stanek, Abdullah, Canham,
  Chung, Leonard, Wians, and deLemos]{Das2005}
SR~Das, MH~Drazner, DL~Dries, GL~Vega, HG~Stanek, SM~Abdullah, RM~Canham,
  AK~Chung, D~Leonard, Jr~Fh Wians, and JA~deLemos.
\newblock Impact of body mass and body composition on circulating levels of
  natriuretic peptides: results from the dallas heart study.
\newblock \emph{Circulation}, 112:\penalty0 2163--8, 2005.

\bibitem[Davidson et~al.(1996{\natexlab{a}})Davidson, Barr, and AD]{278}
Davidson, Barr, and Struthers AD.
\newblock C-type natriuretic peptide. an endogenous inhibitor of vascular
  angiotensin-converting enzyme activity.
\newblock \emph{Circulation}, 931:\penalty0 155--159, 1996{\natexlab{a}}.

\bibitem[Davidson et~al.(1996{\natexlab{b}})Davidson, WJ, DJ, and AD]{bib3271}
Davidson, Coutie WJ, Webb DJ, and Struthers AD.
\newblock Hormonal and renal differences between low dose and high dose
  angiotensin converting enzyme inhibitor treatment in patients with chronic
  heart failure.
\newblock \emph{Heart}, 75:\penalty0 576--581, 1996{\natexlab{b}}.

\bibitem[Davis et~al.(1992)Davis, LC, and et~al]{bib3249}
Davis, Fish LC, and Elahi~D et~al.
\newblock Atrial natriuretic peptide levels in the prediction of congestive
  heart failure risk in frail elderly.
\newblock \emph{JAMA}, 267:\penalty0 2625--2629, 1992.

\bibitem[Dawson and AD(2002)]{bib341}
Dawson and Struthers AD.
\newblock Vasopeptidase inhibitors in heart failure.
\newblock \emph{(Review) J Renin Angiotensin Aldosterone Syst}, 3:\penalty0
  156--159, 2002.

\bibitem[de~Bold et~al.(1981)de~Bold, Borenstein, Veress, and
  Sonnenberg]{deBold1981}
AJ~de~Bold, HB~Borenstein, AH~Veress, and H~Sonnenberg.
\newblock A rapid and potent natriuretic response to intravenous injection of
  atrial myocardial extract in rats.
\newblock \emph{Life Sciences}, 28\penalty0 (1):\penalty0 89--94, 1981.

\bibitem[de~Bold(1999)]{bib313}
Kuroski de~Bold.
\newblock Estrogen, natriuretic peptides and the renin-angiotensin system.
\newblock \emph{(Review) Cardiovasc Res}, 41:\penalty0 524--531, 1999.

\bibitem[de~Lemos et~al.(2003)de~Lemos, DK, and MH]{bib34}
de~Lemos, McGuire DK, and Drazner MH.
\newblock B-type natriuretic peptide in cardiovascular disease.
\newblock \emph{(Review) Lancet}, 362:\penalty0 316--322, 2003.

\bibitem[Del-Ry et~al.(2005)Del-Ry, Passino, Maltinti, Emdin, and
  Giannessi]{Del-Ry2005}
S~Del-Ry, C~Passino, M~Maltinti, M~Emdin, and D~Giannessi.
\newblock C-type natriuretic peptide plasma levels increase in patients with
  chronic heart failure as a function of clinical severity.
\newblock \emph{Eur J Heart Fail}, 7:\penalty0 1145--1148, 2005.

\bibitem[deLemos et~al.(2003)deLemos, McGuire, and MH]{77}
deLemos, McGuire, and Drazner MH.
\newblock B-type natriuretic peptide in cardiovascular disease.
\newblock \emph{Lancet}, 362:\penalty0 316--322, 2003.

\bibitem[deLemos et~al.(2001)deLemos, Morrow, Bentley, Omland, Sabatine,
  McCabe, Hall, Cannon, and Braunwald]{deLemos2001}
JA~deLemos, DA~Morrow, JH~Bentley, T~Omland, MS~Sabatine, CH~McCabe, C~Hall,
  CP~Cannon, and E~Braunwald.
\newblock The prognostic value of b-type natriuretic peptide in patients with
  acute coronary syndromes.
\newblock \emph{N Engl J Med}, 345:\penalty0 1014--21, 2001.

\bibitem[deLissovoy et~al.(2003)deLissovoy, Stier, Ciesla, Munger, and
  Burger]{deLissovoy2003}
G~deLissovoy, DM~Stier, G~Ciesla, M~Munger, and AJ~Burger.
\newblock Economic implications of nesiritide versus dobutamine in the
  treatment of patients with acutely decompensated congestive heart failure.
\newblock \emph{Am J Cardiol}, 92:\penalty0 631--633, 2003.

\bibitem[Dessi-Fulgheri et~al.(1998)Dessi-Fulgheri, R, and A]{bib351}
Dessi-Fulgheri, Sarzani R, and Rappelli A.
\newblock The natriuretic peptide system in obesity-related hypertension: new
  pathophysiological aspects.
\newblock \emph{J Nephrol}, 11:\penalty0 296--299, 1998.

\bibitem[Dickey et~al.(2007)Dickey, Flora, Bryan, Xu, Chen, and
  Potter]{Dickey2007}
DM~Dickey, DR~Flora, PM~Bryan, X~Xu, Y~Chen, and LR~Potter.
\newblock Differential regulation of membrane guanylyl cyclases in congestive
  heart failure: natriuretic peptide receptor (npr)-b, not npr-a, is the
  predominant natriuretic peptide receptor in the failing heart.
\newblock \emph{Endocrinology}, 148:\penalty0 35183522, 2007.

\bibitem[Dokainish et~al.(2004)Dokainish, WA, and et~al]{bib3178}
Dokainish, Zoghbi WA, and Lakkis~NM et~al.
\newblock Comparative accuracy of b-type natriuretic peptide and tissue doppler
  echocardiography in the diagnosis of congestive heart failure.
\newblock \emph{Am J Cardiol}, 93:\penalty0 1130--1151, 2004.

\bibitem[Doust et~al.(2004)Doust, PP, E, and AJ]{bib372}
Doust, Glasziou PP, Pietrzak E, and Dobson AJ.
\newblock A systematic review of the diagnostic accuracy of natriuretic
  peptides for heart failure.
\newblock \emph{(Review) Arch Intern Med}, 164:\penalty0 1978--1984, 2004.

\bibitem[Doust et~al.(2005)Doust, E, A, and P]{bib3186}
Doust, Pietrzak E, Dobson A, and Glasziou P.
\newblock How well does b-type natriuretic peptide predict death and cardiac
  events in patients with heart failure: systematic review.
\newblock \emph{(Review) BMJ}, 330:\penalty0 625--633, 2005.

\bibitem[Drewett et~al.(1990)Drewett, RJ, and GJ]{bib356}
Drewett, Ziegler RJ, and Trachte GJ.
\newblock Neuromodulatory effects of atrial natriuretic factor are independent
  of guanylate cyclase in adrenergic neuronal pheochromocytoma cells.
\newblock \emph{J Pharmacol Exp Ther}, 255:\penalty0 497--503, 1990.

\bibitem[Drewett et~al.(1992)Drewett, Ziegler, and GJ]{191}
Drewett, Ziegler, and Trachte GJ.
\newblock Neuromodulatory effects of atrial natriuretic peptides correlate with
  an inhibition of adenylate cyclase but not an activation of guanylate
  cyclase.
\newblock \emph{J Pharmacol Exp Ther}, 260:\penalty0 689--696, 1992.

\bibitem[Duda and RK(1990)]{178}
Duda and Sharma RK.
\newblock Regulation of guanylate cyclase activity by atrial natriuretic factor
  and protein kinase c.
\newblock \emph{Mol Cell Biochem}, 93:\penalty0 179--184, 1990.

\bibitem[Dyrbye and MM(2003)]{bib3247}
Dyrbye and Redfield MM.
\newblock The role of brain natriuretic peptide in population screening.
\newblock \emph{Heart Fail Rev}, 8:\penalty0 349--354, 2003.

\bibitem[d’Eril et~al.(2003)d’Eril, T, and et~al]{bib398}
Melzi d’Eril, Tagnochetti T, and Nauti~A et~al.
\newblock Biological variation of n-terminal probrain natriuretic peptide in
  healthy individuals.
\newblock \emph{Clin Chem}, 49:\penalty0 1554--1555, 2003.

\bibitem[D’Souza et~al.(2004)D’Souza, Davis, and GF]{192}
D’Souza, Davis, and Baxter GF.
\newblock Autocrine and paracrine actions of natriuretic peptides in the heart.
\newblock \emph{Pharmacol Ther}, 101:\penalty0 113--129, 2004.

\bibitem[Edwards et~al.(1988)Edwards, Zimmerman, Schwab, Heublein, and
  Burnett]{Edwards1988}
BS~Edwards, RS~Zimmerman, TR~Schwab, DM~Heublein, and JC~Burnett.
\newblock Atrial stretch, not pressure, is the principal determinant
  controlling the acute release of atrial natriuretic factor.
\newblock \emph{Circ Res}, 62:\penalty0 191--195, 1988.

\bibitem[Emdin et~al.(2004)Emdin, C, and et~al]{bib360}
Emdin, Passino C, and Prontera~C et~al.
\newblock Cardiac natriuretic hormones, neuro-hormones, thyroid hormones and
  cytokines in normal subjects and patients with heart failure.
\newblock \emph{Clin Chem Lab Med}, 42:\penalty0 627--636, 2004.

\bibitem[Emdin et~al.(2005)Emdin, A, and et~al]{bib3296}
Emdin, Clerico A, and Clemenza~F et~al.
\newblock Recommendations for the clinical use of cardiac natriuretic peptides.
\newblock \emph{Ital Heart J}, 6:\penalty0 430--446, 2005.

\bibitem[Evans et~al.(2002)Evans, Youssef, and TG]{279}
Evans, Youssef, and Yandle TG.
\newblock Effects of endothelin-1 on release of adrenomedullin and c-type
  natriuretic peptide from individual human vascular endothelial cells.
\newblock \emph{J Endocrinol}, 175:\penalty0 225--232, 2002.

\bibitem[Fan et~al.(2004)Fan, PM, and et~al]{bib348}
Fan, Bryan PM, and Antos~LK et~al.
\newblock Downregulation does not mediate natriuretic peptidedependent
  desensitization of npr-a or npr-b: guanylyl cyclase-linked natriuretic
  peptide receptors do not internalize.
\newblock \emph{Mol Pharmacol (printed online Sept 30, 2004)}, 2004.

\bibitem[Fan et~al.(2005{\natexlab{a}})Fan, Bryan, and LK]{172}
Fan, Bryan, and Antos LK.
\newblock Down-regulation does not mediate natriuretic peptide-dependent
  desensitization of natriuretic peptide receptor (npr)-a or npr-b. guanylyl
  cyclase-linked natriuretic peptide receptors do not internalize.
\newblock \emph{Mol Pharmacol}, 67:\penalty0 1--10, 2005{\natexlab{a}}.

\bibitem[Fan et~al.(2005{\natexlab{b}})Fan, Bryan, Antos, Potthast, and
  Potter]{Fan2005}
D~Fan, PM~Bryan, LK~Antos, RJ~Potthast, and LR~Potter.
\newblock Down-regulation does not mediate natriuretic peptide-dependent
  desensitization of natriuretic peptide receptor (npr)-a or npr-b: Guanylyl
  cyclase-linked natriuretic peptide receptors do not internalize.
\newblock \emph{Mol Pharmacol}, 67:\penalty0 174183, 2005{\natexlab{b}}.

\bibitem[Fermepin et~al.(2000)Fermepin, Vatta, and Presas]{93}
Fermepin, Vatta, and Presas.
\newblock B-type and c-type natriuretic peptides modify norepinephrine uptake
  in discrete encephalic nuclei of the rat.
\newblock \emph{Cell Mol Neurobiol}, 20:\penalty0 763--771, 2000.

\bibitem[Fifer et~al.(1990)Fifer, Molina, Quiroz, Giles, Herrmann,
  De-Scheerder, Clement, Kubo, Cody, and Cohn]{Fifer1990}
MA~Fifer, CR~Molina, AC~Quiroz, TD~Giles, HC~Herrmann, IR~De-Scheerder,
  DL~Clement, S~Kubo, RJ~Cody, and JN~Cohn.
\newblock Hemodynamic and renal effects of atrial natriuretic peptide in
  congestive heart failure.
\newblock \emph{Am J Cardiol}, 65:\penalty0 211--216, 1990.

\bibitem[Fisher et~al.(2001)Fisher, K, and et~al]{bib3113}
Fisher, Filzmaier K, and Stiegler~H et~al.
\newblock Evaluation of a new, rapid bedside test for qualitative determination
  of b-type natriuretic peptide.
\newblock \emph{Clin Chem}, 47:\penalty0 591--594, 2001.

\bibitem[Floras(2002)]{bib342}
Floras.
\newblock Vasopeptidase inhibition: a novel approach to cardiovascular therapy.
\newblock \emph{(Review) Can J Cardiol}, 18:\penalty0 177--182, 2002.

\bibitem[Fluckiger et~al.(1986)Fluckiger, Waeber, Matsueda, Delaloye,
  Nussberger, and Brunner]{Fluckiger1986}
JP~Fluckiger, B~Waeber, G~Matsueda, B~Delaloye, J~Nussberger, and HR~Brunner.
\newblock Effect of atriopeptin iii on hematocrit and volemia of nephrectomized
  rats.
\newblock \emph{Am J Physiol}, 251:\penalty0 H880--H883, 1986.

\bibitem[Foote et~al.(2004)Foote, JD, and andYeo KT]{bib3163}
Foote, Pearlman JD, and Siegel~AH andYeo KT.
\newblock Detection of exercise-induced ischemia by changes in b-type
  natriuretic peptide.
\newblock \emph{J Am Coll Cardiol}, 44:\penalty0 1980--1987, 2004.

\bibitem[Forfia et~al.(2005)Forfia, SP, and et~al]{bib3182}
Forfia, Watkins SP, and Rame~JE et~al.
\newblock Relationship between b-type natriuretic peptides and pulmonary
  capillary wedge pressure in the intensive care unit.
\newblock \emph{J Am Coll Cardiol}, 45:\penalty0 1667--1671, 2005.

\bibitem[Forssmann et~al.(1998)Forssmann, Richter, and Meyer]{Forssmann1998}
WG~Forssmann, R~Richter, and M~Meyer.
\newblock The endocrine heart and natriuretic peptides: histochemistry, cell
  biology, and functional aspects of the renal urodilatin system.
\newblock \emph{Histochem Cell Biol}, 110:\penalty0 335--357, 1998.

\bibitem[Foster and DL(1998)]{181}
Foster and Garber DL.
\newblock Dual role for adenine nucleotide in the regulation of the atrial
  natriuretic factor receptor subtypes by angiotensin ii.
\newblock \emph{J Biol Chem}, 273:\penalty0 16311--16318, 1998.

\bibitem[Fox and andWood DA~et al(2001)]{bib3105}
Fox and Cowie~MR andWood DA~et al.
\newblock Coronary artery disease as the cause of incident heart failure in the
  population.
\newblock \emph{Eur Heart J}, 22:\penalty0 228--236, 2001.

\bibitem[Fraser(2004)]{bib395}
Fraser.
\newblock Inherent biological variation and reference values.
\newblock \emph{(Review) Clin Chem Lab Med}, 42:\penalty0 758--764, 2004.

\bibitem[Friesinger(1999)]{bib311}
Friesinger.
\newblock Cardiovascular disease in the elderly.
\newblock \emph{(Review) Cardiol Clin}, 17:\penalty0 35--49, 1999.

\bibitem[Fujimura et~al.(2000)Fujimura, Y, and et~al]{bib3283}
Fujimura, Yasumura Y, and Ishida~Y et~al.
\newblock Improvement in left ventricular function in response to carvedilol is
  accompanied by attenuation of neurohumoral activation in patients with
  dilated cardiomyopathy.
\newblock \emph{J Card Fail}, 6:\penalty0 3--10, 2000.

\bibitem[Fujio et~al.(1989)Fujio, Ohashi, and Nawata]{136}
Fujio, Ohashi, and Nawata.
\newblock Cardiovascular, renal and endocrine effects of a human atrial
  natriuretic peptide in patients with cushing’s syndrome and primary
  aldosteronism.
\newblock \emph{J Hypertens}, 7:\penalty0 653--659, 1989.

\bibitem[Fukui et~al.(2004)Fukui, Katoh, and Tsuzuki]{153}
Fukui, Katoh, and Tsuzuki.
\newblock Focal brain edema and natriuretic peptides in patients with
  subarachnoid hemorrhage.
\newblock \emph{J Clin Neurosci}, 11:\penalty0 507--511, 2004.

\bibitem[Fuller et~al.(1988)Fuller, Porter, Arfsten, Miller, Schilling,
  Scarborough, Lewicki, and Schenk]{Fuller1988}
F~Fuller, JG~Porter, AE~Arfsten, J~Miller, JW~Schilling, RM~Scarborough,
  JA~Lewicki, and DB~Schenk.
\newblock Atrial natriuretic peptide clearance receptor; complete sequence and
  functional expression of cdna clones.
\newblock \emph{J Biol Chem}, 263:\penalty0 9395--9401, 1988.

\bibitem[Furuya et~al.(1991)Furuya, Yoshida, and Hayashi]{284}
Furuya, Yoshida, and Hayashi.
\newblock C-type natriuretic peptide is a growth inhibitor of rat vascular
  smooth muscle cells.
\newblock \emph{Biochem Biophys Res Commun}, 177:\penalty0 927--931, 1991.

\bibitem[Gackowski et~al.(2004)Gackowski, R, and et~al]{bib3179}
Gackowski, Isnard R, and Golmard~JL et~al.
\newblock Comparison of echocardiography and plasma b-type natriuretic peptide
  for monitoring the response to treatment in acute heart failure.
\newblock \emph{Eur Heart J}, 25:\penalty0 1788--1796, 2004.

\bibitem[Gaggin and Januzzi(2014)]{Gaggin2014}
Hanna~K Gaggin and James~L Januzzi.
\newblock Natriuretic peptides in heart failure syndrome.
\newblock \emph{Clin Lab Med}, 34:\penalty0 43--58, 2014.

\bibitem[Galvani et~al.(2004)Galvani, D, and T]{bib376}
Galvani, Ferrini D, and Ottani T.
\newblock Natriuretic peptides for risk stratification of patients with acute
  coronary syndromes.
\newblock \emph{(Review) Eur J Heart Fail}, 6:\penalty0 327--333, 2004.

\bibitem[Gardner et~al.(2003{\natexlab{a}})Gardner, F, and et~al]{bib3192}
Gardner, Ozalp F, and Murday~AJ et~al.
\newblock N-terminal pro-brain natriuretic peptide. a new gold standard in
  predicting mortality in patients with advanced heart failure.
\newblock \emph{Eur Heart J}, 24:\penalty0 1735--1743, 2003{\natexlab{a}}.

\bibitem[Gardner(2003)]{Gardner2003a}
DG~Gardner.
\newblock Natriuretic peptides: markers or modulators of cardiac hypertrophy?
\newblock \emph{Trends Endocrinol Metab}, 14:\penalty0 411--416, 2003.

\bibitem[Gardner et~al.(2003{\natexlab{b}})Gardner, Ozalp, Murday, Robb, and
  McDonagh]{Gardner2003b}
RS~Gardner, F~Ozalp, AJ~Murday, SD~Robb, and TA~McDonagh.
\newblock N-terminal pro-brain natriuretic peptide a new gold standard in
  predicting mortality in patients with advanced heart failure.
\newblock \emph{Eur Heart J}, 24:\penalty0 1735--43, 2003{\natexlab{b}}.

\bibitem[Giannessi et~al.(2001)Giannessi, MG, and et~al]{bib317}
Giannessi, Andreassi MG, and Del Ry~S et~al.
\newblock Possibility of age regulation of the natriuretic peptide c-receptor
  in human platelets.
\newblock \emph{J Endocrinol Invest}, 24:\penalty0 8--16, 2001.

\bibitem[Glembotski et~al.(1993)Glembotski, Irons, and KA]{62}
Glembotski, Irons, and Krown KA.
\newblock Myocardial a-thrombin receptor activation induces hypertrophy and
  increases atrial natriuretic factor gene expression.
\newblock \emph{J Biol Chem}, 268:\penalty0 20646--20652, 1993.

\bibitem[Goetze(2004{\natexlab{a}})]{14}
Goetze.
\newblock Biochemistry of pro-b-type natriuretic peptide-derived peptides the
  endocrine heart revisited.
\newblock \emph{Clin Chem}, 9:\penalty0 1503--1510, 2004{\natexlab{a}}.

\bibitem[Goetze(2004{\natexlab{b}})]{bib36}
Goetze.
\newblock Biochemistry of pro-b-type natriuretic peptide-derived peptides: the
  endocrine heart revisited.
\newblock \emph{(Review) Clin Chem}, 9:\penalty0 1503--1510,
  2004{\natexlab{b}}.

\bibitem[Goetze et~al.(2004{\natexlab{a}})Goetze, A, and et~al]{bib3245}
Goetze, Gore A, and Moller~CH et~al.
\newblock Acute myocardial hypoxia increases bnp gene expression.
\newblock \emph{FASEB J}, 18:\penalty0 1928--1930, 2004{\natexlab{a}}.

\bibitem[Goetze et~al.(2004{\natexlab{b}})Goetze, Videbaek, and Boesgaard]{207}
Goetze, Videbaek, and Boesgaard.
\newblock Pro-brain natriuretic peptide as marker of cardiovascular or
  pulmonary causes of dyspnea in patients with terminal parenchymal lung
  disease.
\newblock \emph{J Heart Lung Transplant}, 23:\penalty0 80--87,
  2004{\natexlab{b}}.

\bibitem[Goetze et~al.(2005)Goetze, Rehfeld, and Videbaek]{206}
Goetze, Rehfeld, and Videbaek.
\newblock B-type natriuretic peptide and its precursor in cardiac venous blood
  from failing hearts.
\newblock \emph{Eur J Heart Fail}, 7:\penalty0 69--74, 2005.

\bibitem[Goff et~al.(2000)Goff, Jr, Pandey, Chan, Ortiz, and
  Nichaman]{Goff2000}
DC~Goff, Jr, DK~Pandey, FA~Chan, C~Ortiz, and MZ~Nichaman.
\newblock Congestive heart failure in the united states: is there more than
  meets the i(cd code)? the corpus christi heart project.
\newblock \emph{Arch Intern Med}, 160:\penalty0 197--202, 2000.

\bibitem[Goy et~al.(2001)Goy, Oliver, Purdy, Knowles, Fox, Mohler, Qian,
  Smithies, and Maeda]{Goy2001}
MF~Goy, PM~Oliver, KE~Purdy, JW~Knowles, JE~Fox, PJ~Mohler, X~Qian, O~Smithies,
  and N~Maeda.
\newblock Evidence for a novel natriuretic peptide receptor that prefers brain
  natriuretic peptide over atrial natriuretic peptide.
\newblock \emph{Biochem J}, 358:\penalty0 379--387, 2001.

\bibitem[Grepin et~al.(1994)Grepin, Dagnino, Robitaille, Haberstroh, Antakly,
  and Nemer]{Grepin1994}
C~Grepin, L~Dagnino, L~Robitaille, L~Haberstroh, T~Antakly, and M~Nemer.
\newblock A hormone-encoding gene identifies a pathway for cardiac but not
  skeletal muscle gene transcription.
\newblock \emph{Mol Cell Biol}, 14:\penalty0 3115--3129, 1994.

\bibitem[Gutkowska et~al.(1993)Gutkowska, Tremblay, and Antakly]{113}
Gutkowska, Tremblay, and Antakly.
\newblock The atrial natriuretic peptide system in rat ovaries.
\newblock \emph{Endocrinology}, 132:\penalty0 693--700, 1993.

\bibitem[Gyurko et~al.(2000)Gyurko, Kuhlencordt, Fishman, and OL]{118}
Gyurko, Kuhlencordt, Fishman, and Huang OL.
\newblock Modulation of mouse cardiac function in vivo by enos and anp.
\newblock \emph{Am J Physiol}, 278:\penalty0 H971--981, 2000.

\bibitem[Haak et~al.(1990)Haak, Jungmann, and Schoffling]{193}
Haak, Jungmann, and Schoffling.
\newblock 24-hour variation in atrial natriuretic peptide.
\newblock \emph{Lancet}, 335:\penalty0 167--168, 1990.

\bibitem[Haak et~al.(1992)Haak, Jungmann, Schoffling, and KH]{194}
Haak, Jungmann, Schoffling, and Usadel KH.
\newblock Evidence for pulsatile secretion of human atrial natriuretic peptide
  in healthy subjects.
\newblock \emph{Exp Clin Endocrinol}, 99:\penalty0 108--109, 1992.

\bibitem[Hall(2005)]{Hall2005}
C~Hall.
\newblock Nt-probnp: the mechanism behind the marker.
\newblock \emph{J Card Fail}, 11:\penalty0 S81--3, 2005.

\bibitem[Hama et~al.(1995)Hama, H, and et~al]{bib3243}
Hama, Itoh H, and Shirakami~G et~al.
\newblock Rapid ventricular induction of brain natriuretic peptide gene
  expression in experimental acute myocardial infarction.
\newblock \emph{Circulation}, 92:\penalty0 1158--1164, 1995.

\bibitem[Hammerer-Lercher et~al.(2001)Hammerer-Lercher, E, and et~al]{bib319}
Hammerer-Lercher, Neubauer E, and Muller~S et~al.
\newblock Head-to-head comparison of n-terminal pro-brain natriuretic peptide,
  brain natriuretic peptide and n-terminal pro-atrial natriuretic peptide in
  diagnosing left ventricular dysfunction.
\newblock \emph{Clin Chim Acta}, 310:\penalty0 193--197, 2001.

\bibitem[Han and Hasin(2003)]{269}
Han and Hasin.
\newblock Cardiovascular effects of natriuretic peptides and their
  interrelation with endothelin-1.
\newblock \emph{Cardiovasc Drugs Ther}, 17:\penalty0 41--52, 2003.

\bibitem[Hara et~al.(2000)Hara, M, and et~al]{bib3284}
Hara, Hamada M, and Shigematsu~Y et~al.
\newblock Effect of beta-blocker on left ventricular function and natriuretic
  peptides in patients with chronic heart failure treated with
  angiotensinconverting enzyme inhibitor.
\newblock \emph{Jpn Circ J}, 64:\penalty0 365--369, 2000.

\bibitem[Hara et~al.(2002)Hara, M, and et~al]{bib3287}
Hara, Hamada M, and Ohtsuka~T et~al.
\newblock Comparison of treatment effects of bevantolol and metoprolol on
  cardiac function and natriuretic peptides in patients with dilated
  cardiomyopathy.
\newblock \emph{Heart Vessels}, 17:\penalty0 53--56, 2002.

\bibitem[Hardt and Sadoshima(2004)]{83}
Hardt and Sadoshima.
\newblock Negative regulators of cardiac hypertrophy.
\newblock \emph{Cardiovasc Res}, 63:\penalty0 500--509, 2004.

\bibitem[Hartmann et~al.(2004)Hartmann, Packer, Coats, Fowler, Krum, Mohacsi,
  Rouleau, Tendera, Castaigne, Anker, Amann-Zalan, Hoersch, and
  Katus]{Hartmann2004}
F~Hartmann, M~Packer, AJ~Coats, MB~Fowler, H~Krum, P~Mohacsi, JL~Rouleau,
  M~Tendera, A~Castaigne, SD~Anker, I~Amann-Zalan, S~Hoersch, and HA~Katus.
\newblock Prognostic impact of plasma n-terminal pro-brain natriuretic peptide
  in severe chronic congestive heart failure: a substudy of the carvedilol
  prospective randomized cumulative survival (copernicus) trial.
\newblock \emph{Circulation}, 110:\penalty0 1780--6, 2004.

\bibitem[Hayakawa et~al.(2001{\natexlab{a}})Hayakawa, Komada, and
  Hirayama]{157}
Hayakawa, Komada, and Hirayama.
\newblock Plasma levels of natriuretic peptides in relation to
  doxorubicin-induced cardiotoxicity and cardiac function in children with
  cancer.
\newblock \emph{Med Pediatr Oncol}, 37:\penalty0 4--9, 2001{\natexlab{a}}.

\bibitem[Hayakawa et~al.(2001{\natexlab{b}})Hayakawa, Y, and et~al]{bib3152}
Hayakawa, Komada Y, and Hirayama~M et~al.
\newblock Plasma levels of natriuretic peptides in relation to
  doxorubicin-induced cardiotoxicity and cardiac function in children with
  cancer.
\newblock \emph{Med Pediatr Oncol}, 37:\penalty0 4--9, 2001{\natexlab{b}}.

\bibitem[Hayashi et~al.(2001)Hayashi, Tsutamoto, and Wada]{81}
Hayashi, Tsutamoto, and Wada.
\newblock Intravenous atrial natriuretic peptide prevents left ventricular
  remodeling in patients with first anterior acute myocardial infarction.
\newblock \emph{J Am Coll Cardiol}, 37:\penalty0 1820--1826, 2001.

\bibitem[Hedberg et~al.(2004)Hedberg, I, and et~al]{bib3172}
Hedberg, Lonnberg I, and Jonason~T et~al.
\newblock Electrocardiogram and b-type natriuretic peptide as screening tools
  for left ventricular systolic dysfunction in a population-based sample of
  75-year-old men and women.
\newblock \emph{Am Heart J}, 148:\penalty0 524--529, 2004.

\bibitem[Heidenreich et~al.(2004)Heidenreich, MA, and et~al]{bib3145}
Heidenreich, Gubens MA, and Fonarow~GC et~al.
\newblock Cost-effectiveness of screening with b-type natriuretic peptide to
  identify patients with reduced left ventricular ejection fraction.
\newblock \emph{J Am Coll Cardiol}, 43:\penalty0 1019--1026, 2004.

\bibitem[Henriksen et~al.(2003)Henriksen, Gotze, and Fuglsang]{144}
Henriksen, Gotze, and Fuglsang.
\newblock Increased circulating pro-brain natriuretic peptide (probnp) and
  brain natriuretic peptide (bnp) in patients with cirrhosis relation to
  cardiovascular dysfunction and severity of disease.
\newblock \emph{Gut}, 52:\penalty0 1511--1517, 2003.

\bibitem[Hirooka et~al.(2001)Hirooka, Y, and et~al]{bib3285}
Hirooka, Yasumura Y, and Ishida~Y et~al.
\newblock Comparative left ventricular functional and neurohumoral effects of
  chronic treatment with carvedilol versus metoprolol in patients with dilated
  cardiomyopathy.
\newblock \emph{Jpn Circ J}, 65:\penalty0 931--936, 2001.

\bibitem[Hobbs(2003)]{bib3260}
Hobbs.
\newblock Using bnp to diagnose, manage, and treat heart failure.
\newblock \emph{(Review) Cleve Clin J Med}, 70:\penalty0 333--336, 2003.

\bibitem[Hobbs et~al.(2002)Hobbs, RC, and et~al]{bib3109}
Hobbs, Davis RC, and Roalfe~AK et~al.
\newblock Reliability of n-terminal pro-brain natriuretic peptide assay in
  diagnosis of heart failure: cohort study in representative and high risk
  community populations.
\newblock \emph{Br Med J}, 324:\penalty0 1498--1500, 2002.

\bibitem[Holtwick et~al.(2002)Holtwick, Gotthardt, Skryabin, Steinmetz,
  Potthast, Zetsche, Hammer, Herz, and Kuhn]{Holtwick2002}
R~Holtwick, M~Gotthardt, B~Skryabin, M~Steinmetz, R~Potthast, B~Zetsche,
  RE~Hammer, J~Herz, and M~Kuhn.
\newblock Smooth muscle-selective deletion of guanylyl cyclase-a prevents the
  acute but not chronic effects of anp on blood pressure.
\newblock \emph{Proc Natl Acad Sci U S A}, 99:\penalty0 7142--7147, 2002.

\bibitem[Holtwick et~al.(2003)Holtwick, Van-Eickels, Skryabin, Baba, Bubikat,
  Begrow, Schneider, Garbers, and Kuhn]{Holtwick2003}
R~Holtwick, M~Van-Eickels, BV~Skryabin, HA~Baba, A~Bubikat, F~Begrow,
  MD~Schneider, DL~Garbers, and M~Kuhn.
\newblock Pressure-independent cardiac hypertrophy in mice with
  cardiomyocyte-restricted inactivation of the atrial natriuretic peptide
  receptor guanylyl cyclase-a.
\newblock \emph{J Clin Invest}, 111:\penalty0 1399--1407, 2003.

\bibitem[Horio et~al.(1993)Horio, K, and et~al]{bib3134}
Horio, Shimada K, and Kohno~M et~al.
\newblock Serial changes in atrial and brain natriuretic peptides in patients
  with acute myocardial infarction treated with early coronary angioplasty.
\newblock \emph{Am Heart J}, 126:\penalty0 293--299, 1993.

\bibitem[Houben et~al.(2005)Houben, van~der Zander, and de~Leeuw~PW]{270}
Houben, van~der Zander, and de~Leeuw~PW.
\newblock Vascular and renal actions of brain natriuretic peptide in man
  physiology and pharmacology.
\newblock \emph{Fundam Clin Pharmacol}, 19:\penalty0 411--419, 2005.

\bibitem[Hulsmann et~al.(2005)Hulsmann, R, and et~al]{bib3197}
Hulsmann, Berger R, and Mortl~D et~al.
\newblock Incidence of normal values of natriuretic peptides in patients with
  chronic heart failure and impact on survival: a direct comparison of
  nterminal atrial natriuretic peptide, n-terminal brain natriuretic peptide
  and brain natriuretic peptide.
\newblock \emph{Eur J Heart Fail}, 7:\penalty0 552--556, 2005.

\bibitem[Hunt et~al.(1997)Hunt, Richards, and MG]{205}
Hunt, Richards, and Nicholls MG.
\newblock Immunoreactive amino-terminal pro-brain natriuretic peptide
  (nt-probnp) a new marker of cardiac impairment.
\newblock \emph{Clin Endocrinol}, 47:\penalty0 287--296, 1997.

\bibitem[Huo et~al.(1999)Huo, Abe, and KS]{174}
Huo, Abe, and Risono KS.
\newblock Ligand binding-dependent limited proteolysis of the atrial
  natriuretic peptide receptor juxtamembrane hinge structure essential for
  transmembrane signal transduction.
\newblock \emph{Biochemistry}, 38:\penalty0 16941--16951, 1999.

\bibitem[Hutcheon et~al.(2002)Hutcheon, ND, AD, and ME]{bib3143}
Hutcheon, Gillespie ND, Struthers AD, and McMurdo ME.
\newblock B-type natriuretic peptide in the diagnosis of elderly day hospital
  patients.
\newblock \emph{Age Ageing}, 31:\penalty0 295--301, 2002.

\bibitem[Iervasi et~al.(1995)Iervasi, A, and et~al]{bib332}
Iervasi, Clerico A, and Berti~S et~al.
\newblock Altered tissue degradation and distribution of atrial natriuretic
  peptide in patients with idiopathic dilated cardiomyopathy and its
  relationship with clinical severity of the disease and sodium handling.
\newblock \emph{Circulation}, 91:\penalty0 2018--2027, 1995.

\bibitem[Iervasi et~al.(1997)Iervasi, Clerico, and Pilo]{201}
Iervasi, Clerico, and Pilo.
\newblock Evidence that anp tissue extraction is not changed by large increases
  of its plasma levels induced by pacing in humans.
\newblock \emph{J Clin Endocrinol Metab}, 82:\penalty0 884--888, 1997.

\bibitem[Iervasi et~al.(1998)Iervasi, Clerico, and Pilo]{199}
Iervasi, Clerico, and Pilo.
\newblock Atrial natriuretic peptide is not degraded from lungs in humans.
\newblock \emph{J Clin Endocrinol Metab}, 83:\penalty0 2898--2906, 1998.

\bibitem[Imura et~al.(1992)Imura, Nakao, and Itoh]{101}
Imura, Nakao, and Itoh.
\newblock The natriuretic peptide system in the brain implications in the
  central control of cardiovascular and neuroendocrine functions.
\newblock \emph{Front Neuroendocrinol}, 13:\penalty0 217--249, 1992.

\bibitem[Ingelsson et~al.(2005)Ingelsson, Arnlov, Sundstrom, and
  Lind]{Ingelsson2005}
E~Ingelsson, J~Arnlov, J~Sundstrom, and L~Lind.
\newblock The validity of a diagnosis of heart failure in a hospital discharge
  register.
\newblock \emph{Eur J Heart Fail}, 7:\penalty0 787--91, 2005.

\bibitem[Inoue et~al.(2002)Inoue, M, and et~al]{bib3229}
Inoue, Sakuma M, and Yaguchi~I et~al.
\newblock Early recanalization and plasma brain natriuretic peptide as an
  indicator of left ventricular function after acute myocardial infarction.
\newblock \emph{Am Heart J}, 143:\penalty0 790--796, 2002.

\bibitem[Ivanova et~al.(2003)Ivanova, Gregoraszczuk, and Augustowska]{115}
Ivanova, Gregoraszczuk, and Augustowska.
\newblock Localization of atrial natriuretic peptide in pig granulosa cells
  isolated from ovarian follicles of various size.
\newblock \emph{Reprod Biol}, 3:\penalty0 173--181, 2003.

\bibitem[Iwanaga et~al.(2006)Iwanaga, Nishi, Furuichi, Noguchi, Sase, and
  Kihara]{Iwanaga2006}
Y~Iwanaga, I~Nishi, S~Furuichi, T~Noguchi, K~Sase, and Y~Kihara.
\newblock B-type natriuretic peptide strongly reflects diastolic wall stress in
  patients with chronic heart failure: comparison between systolic and
  diastolic heart failure.
\newblock \emph{Journal of American College of Cardiology}, 47:\penalty0
  742--8, 2006.

\bibitem[Januzzi et~al.(2006)Januzzi, van, Lainchbury, Bayes-Genis,
  Ordonez-Llanos, Santalo-Bel, Pinto, and Richards]{Januzzi2006}
JL~Januzzi, KR~van, J~Lainchbury, A~Bayes-Genis, J~Ordonez-Llanos,
  M~Santalo-Bel, YM~Pinto, and M~Richards.
\newblock Nt-probnp testing for diagnosis and short-term prognosis in acute
  destabilized heart failure: an international pooled analysis of 1256
  patients: the international collaborative of nt-probnp study.
\newblock \emph{Eur Heart J}, 27:\penalty0 330--7, 2006.

\bibitem[Jensen et~al.(1997)Jensen, Carstens, Ivarsen, and EB]{134}
Jensen, Carstens, Ivarsen, and Pedersen EB.
\newblock A new, fast and reliable radioiimunoassay of brain natriuretic
  peptide in human plasma. reference values in healthy subjects and in patients
  with different diseases.
\newblock \emph{Scand J Clin Lab Invest}, 57:\penalty0 529--540, 1997.

\bibitem[Jernberg et~al.(2002)Jernberg, M, and B]{bib3231}
Jernberg, Stridsberg M, and Lindahl B.
\newblock 2002.

\bibitem[Jernberg et~al.(2004{\natexlab{a}})Jernberg, S, and et~al]{bib3234}
Jernberg, James S, and Lindahl~B et~al.
\newblock Nt-probnp in unstable coronary artery disease experiences from the
  fast, gusto iv and frisc ii trials.
\newblock \emph{Eur J Heart Fail}, 6:\penalty0 319--325, 2004{\natexlab{a}}.

\bibitem[Jernberg et~al.(2004{\natexlab{b}})Jernberg, S, and et~al]{bib377}
Jernberg, James S, and Lindahl~B et~al.
\newblock Natriuretic peptides in unstable coronary artery disease.
\newblock \emph{(Review) Eur Heart J}, 25:\penalty0 1486--1493,
  2004{\natexlab{b}}.

\bibitem[JL et~al.(2005)JL, Camargo, Anwaruddin, Baggish, Chen, Krauser, Tung,
  Cameron, Nagurney, Chae, Lloyd-Jones, Brown, Foran-Melanson, Sluss,
  Lee-Lewandrowski, and Lewandrowski]{Januzzi2005}
Jr~Januzzi JL, CA~Camargo, S~Anwaruddin, AL~Baggish, AA~Chen, DG~Krauser,
  R~Tung, R~Cameron, JT~Nagurney, CU~Chae, DM~Lloyd-Jones, DF~Brown,
  S~Foran-Melanson, PM~Sluss, E~Lee-Lewandrowski, and KB~Lewandrowski.
\newblock The n-terminal pro-bnp investigation of dyspnea in the emergency
  department (pride) study.
\newblock \emph{Am J Cardiol}, 95:\penalty0 948--54, 2005.

\bibitem[John et~al.(1995{\natexlab{a}})John, Krege, and PM]{255}
John, Krege, and Oliver PM.
\newblock Genetic decrease in atrial natriuretic peptide and salt-sensitive
  hypertension.
\newblock \emph{Science}, 267:\penalty0 679--681, 1995{\natexlab{a}}.

\bibitem[John et~al.(1995{\natexlab{b}})John, Krege, Oliver, Hagaman, Hodgin,
  Pang, Flynn, and Smithies]{John1995}
SW~John, JH~Krege, PM~Oliver, JR~Hagaman, JB~Hodgin, SC~Pang, TG~Flynn, and
  O~Smithies.
\newblock Genetic decreases in atrial natriuretic peptide and salt-sensitive
  hypertension [published erratum appears in science 1995 mar
  24;267(5205):1753].
\newblock \emph{Science}, 267:\penalty0 679--681, 1995{\natexlab{b}}.

\bibitem[John et~al.(1996)John, Veress, Honrath, Chong, Peng, Smithies, and
  Sonnenberg]{John1996}
SW~John, AT~Veress, U~Honrath, CK~Chong, L~Peng, O~Smithies, and H~Sonnenberg.
\newblock Blood pressure and fluid-electrolyte balance in mice with reduced or
  absent anp.
\newblock \emph{Am J Physiol}, 271:\penalty0 R109--114, 1996.

\bibitem[Johnson et~al.(1997)Johnson, Damodaran, and Rushin]{156}
Johnson, Damodaran, and Rushin.
\newblock Ectopic production and processing of atrial natriuretic peptide in a
  small cell.
\newblock \emph{Cancer}, 79:\penalty0 35--44, 1997.

\bibitem[Johnson et~al.(2002)Johnson, T, and et~al]{bib3276}
Johnson, Omland T, and Hall~C et~al.
\newblock Neurohormonal activation rapidly decreases after intravenous therapy
  with diuretics and vasodilators for class iv heart failure.
\newblock \emph{J Am Coll Cardiol}, 39:\penalty0 1623--1629, 2002.

\bibitem[Joubert et~al.(2001)Joubert, Labrecque, and Lean]{182}
Joubert, Labrecque, and De~Lean.
\newblock Reduced activity of the npr-a kinase triggers dephosphorylation and
  homologous desensitization of the receptor.
\newblock \emph{Biochemistry}, 40:\penalty0 11096--11105, 2001.

\bibitem[Joubert et~al.(2005)Joubert, Jossart, McNicoll, and
  De-Lean]{Joubert2005}
S~Joubert, C~Jossart, N~McNicoll, and A~De-Lean.
\newblock Atrial natriuretic peptide-dependent photolabeling of a regulatory
  atp-binding site on the natriuretic peptide receptor-a.
\newblock \emph{FEBS J}, 272:\penalty0 5572--5583, 2005.

\bibitem[Kalra et~al.(2003{\natexlab{a}})Kalra, Clague, and AP]{210}
Kalra, Clague, and Bolger AP.
\newblock Myocardial production of c-type natriuretic peptide in chronic heart
  failure.
\newblock \emph{Circulation}, 107:\penalty0 571--573, 2003{\natexlab{a}}.

\bibitem[Kalra et~al.(2003{\natexlab{b}})Kalra, Clague, Bolger, Anker,
  Poole-Wilson, Struthers, and Coats]{Kalra2003}
PR~Kalra, JR~Clague, AP~Bolger, SD~Anker, PA~Poole-Wilson, AD~Struthers, and
  AJ~Coats.
\newblock Myocardial production of c-type natriuretic peptide in chronic heart
  failure.
\newblock \emph{Circulation}, 107:\penalty0 571--573, 2003{\natexlab{b}}.

\bibitem[Kapoun et~al.(2004)Kapoun, Liang, and O’Young]{98}
Kapoun, Liang, and O’Young.
\newblock B-type natriuretic peptide exerts broad functional opposition to
  transforming growth factor-beta in primary human cardiac fibroblasts
  fibrosis, myofibroblasts conversion, proliferation, and inflammation.
\newblock \emph{Circ Res}, 94:\penalty0 453--461, 2004.

\bibitem[Kato et~al.(2000)Kato, Sugiyama, and Morita]{263}
Kato, Sugiyama, and Morita.
\newblock Genetic analysis of the atrial natriuretic peptide gene in essential
  hypertension.
\newblock \emph{Clin Sci}, 98:\penalty0 251--258, 2000.

\bibitem[Kawai et~al.(2001)Kawai, K, and et~al]{bib3286}
Kawai, Hata K, and Takaoka~H et~al.
\newblock Plasma brain natriuretic peptide as a novel therapeutic indicator in
  idiopathic dilated cardiomyopathy during beta-blocker therapy: a potential of
  hormone-guided treatment.
\newblock \emph{Am Heart J}, 141:\penalty0 925--932, 2001.

\bibitem[Kawai et~al.(2004)Kawai, K, and et~al]{bib367}
Kawai, Hata K, and Tanaka~K et~al.
\newblock Attenuation of biological compensatory action of cardiac natriuretic
  peptide system with aging.
\newblock \emph{Am J Cardiol}, 93:\penalty0 719--723, 2004.

\bibitem[Kellett(2004)]{bib3194}
Kellett.
\newblock Prediction of in-hospital mortality by brain natriuretic peptide
  levels and other independent variables in acutely ill patients with suspected
  heart disease.
\newblock \emph{Can J Cardiol}, 20:\penalty0 686--690, 2004.

\bibitem[Kemperman et~al.(2004)Kemperman, van~den Berg~M, H, and
  de~Jonge~N]{bib3267}
Kemperman, van~den Berg~M, Kirkels H, and de~Jonge~N.
\newblock B-type natriuretic peptide (bnp) and n-terminal probnp in patients
  with end-stage heart failure supported by a left ventricular assist device.
\newblock \emph{Clin Chem}, 50:\penalty0 1670--1672, 2004.

\bibitem[Kiemer et~al.(2002{\natexlab{a}})Kiemer, Lehner, Hartung, and AM]{282}
Kiemer, Lehner, Hartung, and Vollmar AM.
\newblock Inhibition of cyclooxygenase-2 by natriuretic peptides.
\newblock \emph{Endocrinology}, 143:\penalty0 846--852, 2002{\natexlab{a}}.

\bibitem[Kiemer et~al.(2002{\natexlab{b}})Kiemer, Weber, and Furst]{96}
Kiemer, Weber, and Furst.
\newblock Inhibition of p38 mapk activation via induction of mkp-1 atrial
  natriuretic peptide reduces tnf-a-induced actin polymerization and
  endothelial permeability.
\newblock \emph{Circ Res}, 90:\penalty0 874--881, 2002{\natexlab{b}}.

\bibitem[Kiemer et~al.(2005)Kiemer, Furst, and AM]{283}
Kiemer, Furst, and Vollmar AM.
\newblock Vasoprotective actions of the atrial natriuretic peptide.
\newblock \emph{Curr Med Chem Cardiovasc Hematol Agents}, 3:\penalty0 11--21,
  2005.

\bibitem[Kikuta et~al.(1996)Kikuta, Yasue, Yoshimura, Morita, Sumida, Kato,
  Kugiyama, Ogawa, Okumura, Ogawa, and Nakao]{Kikuta1996}
K~Kikuta, H~Yasue, M~Yoshimura, E~Morita, H~Sumida, H~Kato, K~Kugiyama,
  H~Ogawa, K~Okumura, Y~Ogawa, and K~Nakao.
\newblock Increased plasma levels of b-type natriuretic peptide in patients
  with unstable angina.
\newblock \emph{Am Heart J}, 132:\penalty0 101--7, 1996.

\bibitem[Kirchhoff et~al.(2004)Kirchhoff, R, and et~al]{bib3266}
Kirchhoff, Gradaus R, and Stypmann~J et~al.
\newblock Vasoactive peptides during long-term follow-up of patients after
  cardiac transplantation.
\newblock \emph{J Heart Lung Transplant}, 23:\penalty0 284--288, 2004.

\bibitem[Kirk et~al.(2004)Kirk, M, and et~al]{bib3195}
Kirk, Bay M, and Parner~J et~al.
\newblock N-terminal probnp and mortality in hospitalised patients with heart
  failure and preserved vs. reduced systolic function: data from the
  prospective copenhagen hospital heart failure study (chhf).
\newblock \emph{Eur J Heart Fail}, 6:\penalty0 335--341, 2004.

\bibitem[Kishimoto et~al.(1996)Kishimoto, Dubois, and Garbers]{Kishimoto1996}
I~Kishimoto, SK~Dubois, and DL~Garbers.
\newblock The heart communicates with the kidney exclusively through the
  guanylyl cyclase-a receptor: acute handling of sodium and water in response
  to volume expansion.
\newblock \emph{Proc Natl Acad Sci U S A}, 93:\penalty0 6215--6219, 1996.

\bibitem[Kishimoto et~al.(2001)Kishimoto, Rossi, and Garbers]{Kishimoto2001}
I~Kishimoto, K~Rossi, and DL~Garbers.
\newblock A genetic model provides evidence that the receptor for atrial
  natriuretic peptide (guanylyl cyclase-a) inhibits cardiac ventricular myocyte
  hypertrophy.
\newblock \emph{Proc Natl Acad Sci U S A}, 98:\penalty0 2703--2706, 2001.

\bibitem[Knight et~al.(1999)Knight, LC, and et~al]{bib3250}
Knight, Fish LC, and Kiely~DK et~al.
\newblock Atrial natriuretic peptide and the development of congestive heart
  failure in the oldest old: a seven-year prospective study.
\newblock \emph{J Am Geriatr Soc}, 47:\penalty0 407--411, 1999.

\bibitem[Knowles et~al.(2001)Knowles, Esposito, Mao, Hagaman, Fox, Smithies,
  Rockman, and Maeda]{Knowles2001}
JW~Knowles, G~Esposito, L~Mao, JR~Hagaman, JE~Fox, O~Smithies, HA~Rockman, and
  N~Maeda.
\newblock Pressure-independent enhancement of cardiac hypertrophy in
  natriuretic peptide receptor adeficient mice.
\newblock \emph{J Clin Invest}, 107:\penalty0 975--984, 2001.

\bibitem[Knudsen et~al.(2005)Knudsen, Omland, Clopton, Westheim, Wu, Duc,
  McCord, Nowak, Hollander, Storrow, Abraham, McCullough, and
  Maisel]{Knudsen2005}
CW~Knudsen, T~Omland, P~Clopton, A~Westheim, AH~Wu, P~Duc, J~McCord, RM~Nowak,
  JE~Hollander, AB~Storrow, WT~Abraham, PA~McCullough, and A~Maisel.
\newblock Impact of atrial fibrillation on the diagnostic performance of b-type
  natriuretic peptide concentration in dyspneic patients: an analysis from the
  breathing not properly multinational study.
\newblock \emph{J Am Coll Cardiol}, 46:\penalty0 838--44, 2005.

\bibitem[Koh et~al.(1992{\natexlab{a}})Koh, Nussenzveig, and Okolicany]{188}
Koh, Nussenzveig, and Okolicany.
\newblock Dynamics of atrial natriuretic factorguanylate cyclase receptor and
  receptor-ligand complexes in cultured glomerular mesangial and renomedullary
  interstitial cells.
\newblock \emph{J Biol Chem}, 267:\penalty0 11987--11994, 1992{\natexlab{a}}.

\bibitem[Koh et~al.(1992{\natexlab{b}})Koh, Nussenzveig, Okolicany, Price, and
  Maack]{Koh1992}
GY~Koh, DR~Nussenzveig, J~Okolicany, DA~Price, and T~Maack.
\newblock Dynamics of atrial natriuretic factorguanylate cyclase receptors and
  receptor-ligand complexes in cultured glomerular mesangial and renomedullary
  interstitial cells.
\newblock \emph{J Biol Chem}, 267:\penalty0 11987--11994, 1992{\natexlab{b}}.

\bibitem[Kohno et~al.(1992)Kohno, Horio, and Yokokawa]{277}
Kohno, Horio, and Yokokawa.
\newblock \emph{title = { C-type natriuretic peptide inhibits thrombinand
  angiotensin II-stimulated endothelin release via cyclic guanosine},
  3’,5’-monophosphate.}, 19:\penalty0 320--325, 1992.

\bibitem[Kohno et~al.(1993)Kohno, Horio, and Yasunari]{130}
Kohno, Horio, and Yasunari.
\newblock Stimulation of brain natriuretic peptide release from heart by
  thyroid hormone.
\newblock \emph{Metabolism}, 42:\penalty0 1059--1064, 1993.

\bibitem[Kokkonen et~al.(2002)Kokkonen, P\"{o}s\"{o}, Hyypp\"{a}, Huttunen, and
  Lepp\"{a}luoto]{Kokkonen2002}
UM~Kokkonen, AR~P\"{o}s\"{o}, S~Hyypp\"{a}, P~Huttunen, and J~Lepp\"{a}luoto.
\newblock Exercise-induced changes in atrial peptides in relation to
  neuroendocrine responses and fluid balance in the horse.
\newblock \emph{Veterinary Medicine. A, Physiology, Pathology, Clinical
  Medicine}, 49\penalty0 (3):\penalty0 144--50, 4 2002.

\bibitem[Koller et~al.(1991)Koller, Lowe, Bennett, Minamino, Kangawa, Matsuo,
  and Goeddel]{Koller1991}
KJ~Koller, DG~Lowe, GL~Bennett, N~Minamino, K~Kangawa, H~Matsuo, and
  DV~Goeddel.
\newblock Selective activation of the b natriuretic peptide receptor by c-type
  natriuretic peptide (cnp).
\newblock \emph{Science}, 252:\penalty0 120--123, 1991.

\bibitem[Komeichi et~al.(1995)Komeichi, R, and et~al]{bib330}
Komeichi, Moreau R, and Cailmail~S et~al.
\newblock Blunted natriuresis and abnormal systemic hemodynamic responses to
  c-type and brain natriuretic peptides in rats with cirrhosis.
\newblock \emph{J Hepatol}, 22:\penalty0 319--325, 1995.

\bibitem[Konishi et~al.(2003)Konishi, S, and et~al]{bib3290}
Konishi, Nishio S, and Tsutamoto~T et~al.
\newblock Serum carvedilol concentration and its relation to change in plasma
  brain natriuretic peptide level in the treatment of heart failure: a
  preliminary study.
\newblock \emph{Int J Clin Pharmacol Ther}, 41:\penalty0 578--586, 2003.

\bibitem[Kragelund et~al.(2005)Kragelund, B, and et~al]{bib3242}
Kragelund, Gronning B, and Kober~L et~al.
\newblock N-terminal pro-b-type natriuretic peptide and long-term mortality in
  stable coronary heart disease.
\newblock \emph{N Engl J Med}, 352:\penalty0 666--675, 2005.

\bibitem[Krauser et~al.(2005)Krauser, Lloyd-Jones, Chae, Cameron, Anwaruddin,
  Baggish, Chen, Tung, and JL]{Krauser2005}
DG~Krauser, DM~Lloyd-Jones, CU~Chae, R~Cameron, S~Anwaruddin, AL~Baggish,
  A~Chen, R~Tung, and Jr~Januzzi JL.
\newblock Effect of body mass index on natriuretic peptide levels in patients
  with acute congestive heart failure: a probnp investigation of dyspnea in the
  emergency department (pride) substudy.
\newblock \emph{Am Heart J}, 149:\penalty0 744--50, 2005.

\bibitem[Kruger et~al.(2004{\natexlab{a}})Kruger, Graf, and MW]{121}
Kruger, Graf, and Merx MW.
\newblock Brain natriuretic peptide predicts right heart failure in patients
  with acute pulmonary embolism.
\newblock \emph{Am Heart J}, 147:\penalty0 60--65, 2004{\natexlab{a}}.

\bibitem[Kruger et~al.(2004{\natexlab{b}})Kruger, J, and et~al]{bib380}
Kruger, Graf J, and Merx~MW et~al.
\newblock Brain natriuretic peptide predicts right heart failure in patients
  with acute pulmonary embolism.
\newblock \emph{Am Heart J}, 147:\penalty0 60--65, 2004{\natexlab{b}}.

\bibitem[Kruger et~al.(2002)Kruger, Graf, Kunz, Stickel, Hanrath, and
  Janssens]{Kruger2002}
S~Kruger, J~Graf, D~Kunz, T~Stickel, P~Hanrath, and U~Janssens.
\newblock brain natriuretic peptide levels predict functional capacity in
  patients with chronic heart failure.
\newblock \emph{J Am Coll Cardiol}, 40:\penalty0 718--722, 2002.

\bibitem[Kucher et~al.(2003{\natexlab{a}})Kucher, G, and SZ]{bib381}
Kucher, Printzen G, and Goldhaber SZ.
\newblock Prognostic role of brain natriuretic peptide in acute pulmonary
  embolism.
\newblock \emph{Circulation}, 107:\penalty0 2545--2547, 2003{\natexlab{a}}.

\bibitem[Kucher et~al.(2003{\natexlab{b}})Kucher, Printzen, and SZ]{123}
Kucher, Printzen, and Goldhaber SZ.
\newblock Prognostic role of brain natriuretic peptide in acute pulmonary
  embolism.
\newblock \emph{Circulation}, 107:\penalty0 2545--2547, 2003{\natexlab{b}}.

\bibitem[Kuhn(2004)]{165}
Kuhn.
\newblock Molecular physiology of natriuretic peptide signalling.
\newblock \emph{Basic Res Cardiol}, 99:\penalty0 76--82, 2004.

\bibitem[Kuhn et~al.(2004)Kuhn, M, and et~al]{bib347}
Kuhn, Voss M, and Mitko~D et~al.
\newblock Left ventricular assist device support reverses altered cardiac
  expression and function of natriuretic peptides and receptors in end-stage
  heart failure.
\newblock \emph{Cardiovasc Res}, 64:\penalty0 308--314, 2004.

\bibitem[Kuhn et~al.(2002)Kuhn, Holtwick, Baba, Perriard, Schmitz, and
  Ehler]{Kuhn2002}
M~Kuhn, R~Holtwick, HA~Baba, JC~Perriard, W~Schmitz, and E~Ehler.
\newblock Progressive cardiac hypertrophy and dysfunction in atrial natriuretic
  peptide receptor (gc-a) deficient mice.
\newblock \emph{Heart}, 87:\penalty0 368--374, 2002.

\bibitem[Kurnik et~al.(1998)Kurnik, Allgren, Genter, Solomon, Bates, and
  Weisberg]{Kurnik1998}
BR~Kurnik, RL~Allgren, FC~Genter, RJ~Solomon, ER~Bates, and LS~Weisberg.
\newblock Prospective study of atrial natriuretic peptide for the prevention of
  radiocontrast-induced nephropathy.
\newblock \emph{Am J Kidney Dis}, 31:\penalty0 674--680, 1998.

\bibitem[Kurokawa et~al.(1996)Kurokawa, Uede, and Ishiguro]{152}
Kurokawa, Uede, and Ishiguro.
\newblock Pathogenesis of hyponatremia following subarachnoid hemorrhage due to
  ruptured cerebral aneurysm.
\newblock \emph{Surg Neurol}, 46:\penalty0 500--507, 1996.

\bibitem[Labrecque et~al.(1999)Labrecque, McNiccol, Marquis, and Lean]{175}
Labrecque, McNiccol, Marquis, and De~Lean.
\newblock A disulfide-bridged mutant of natriuretic peptide receptor-a displays
  constitutive activity. role of receptor dimerization in signal transduction.
\newblock \emph{J Biol Chem}, 274:\penalty0 9752--9759, 1999.

\bibitem[Labrecque et~al.(2001)Labrecque, Deschenes, McNiccol, and Lean]{176}
Labrecque, Deschenes, McNiccol, and De~Lean.
\newblock Agonistic induction of a covalent dimer in a mutant of natriuretic
  peptide receptor-a documents a juxtamembrane interaction that accompanies
  receptor activation.
\newblock \emph{J Biol Chem}, 276:\penalty0 8064--8072, 2001.

\bibitem[Lang et~al.(1985)Lang, Tholken, Ganten, Luft, Ruskoaho, and
  Unger]{Lang1985}
RE~Lang, H~Tholken, D~Ganten, FC~Luft, H~Ruskoaho, and T~Unger.
\newblock Atrial natriuretic factor-a circulating hormone stimulated by volume
  loading.
\newblock \emph{Nature}, 314:\penalty0 264--266, 1985.

\bibitem[Langenickel et~al.(2006)Langenickel, Buttgereit, Pagel-Langenickel,
  Lindner, Monti, Beuerlein, Al-Saadi, Plehm, Popova, Tank, Dietz, Willenbrock,
  and Bader]{Langenickel2006}
TH~Langenickel, J~Buttgereit, I~Pagel-Langenickel, M~Lindner, J~Monti,
  K~Beuerlein, N~Al-Saadi, R~Plehm, E~Popova, J~Tank, R~Dietz, R~Willenbrock,
  and M~Bader.
\newblock Cardiac hypertrophy in transgenic rats expressing a dominant-negative
  mutant of the natriuretic peptide receptor b.
\newblock \emph{Proc Natl Acad Sci U S A}, 103:\penalty0 4735--4740, 2006.

\bibitem[Langub et~al.(1995)Langub, RE, and JP]{102}
Langub, Watson RE, and Herman JP.
\newblock Distribution of natriuretic peptide precursor mrnas in the rat brain.
\newblock \emph{J Comp Neurol}, 356:\penalty0 183--199, 1995.

\bibitem[Lapinski et~al.(1991)Lapinski, Stepniakowski, and Januszewicz]{138}
Lapinski, Stepniakowski, and Januszewicz.
\newblock Plasma atrial natriuretic peptide concentration in patients with
  primary aldosteronism.
\newblock \emph{J Hypertens}, 9 (Suppl. 6):\penalty0 S260--261, 1991.

\bibitem[LaPointe(2005)]{18}
LaPointe.
\newblock Molecular regulation of the brain natriuretic gene.
\newblock \emph{Peptides}, 26:\penalty0 944--956, 2005.

\bibitem[Latini et~al.(2002{\natexlab{a}})Latini, S, N, and I]{bib362}
Latini, Masson S, De~Angelis N, and Anand I.
\newblock Role of brain natriuretic peptide in the diagnosis and management of
  heart failure: current concepts.
\newblock \emph{(Review) J Card Fail}, 8:\penalty0 288--299,
  2002{\natexlab{a}}.

\bibitem[Latini et~al.(2004)Latini, S, and et~al]{bib3204}
Latini, Masson S, and Anand~I et~al.
\newblock The comparative prognostic value of plasma neurohormones at baseline
  in patients with heart failure enrolled in val-heft.
\newblock \emph{Eur Heart J}, 25:\penalty0 292--299, 2004.

\bibitem[Latini et~al.(2002{\natexlab{b}})Latini, Masson, Anand, Judd,
  Maggioni, Chiang, Bevilacqua, Salio, Cardano, Dunselman, Holwerda, Tognoni,
  and Investigators]{Latini2002}
R~Latini, S~Masson, I~Anand, D~Judd, AP~Maggioni, YT~Chiang, M~Bevilacqua,
  M~Salio, P~Cardano, PH~Dunselman, NJ~Holwerda, G~Tognoni, and Cohn JN;
  Valsartan Heart Failure~Trial Investigators.
\newblock Effects of valsartan on circulating brain natriuretic peptide and
  norepinephrine in symptomatic chronic heart failure the valsartan heart
  failure trial (val-heft).
\newblock \emph{Circulation}, 106:\penalty0 2454--8, 2002{\natexlab{b}}.

\bibitem[Leuchte et~al.(2004{\natexlab{a}})Leuchte, Holzapfel, and RA]{129}
Leuchte, Holzapfel, and Baumgartner RA.
\newblock Clinical significance of brain natriuretic peptide in primary
  pulmonary hypertension.
\newblock \emph{J Am Coll Cardiol}, 43:\penalty0 764--770, 2004{\natexlab{a}}.

\bibitem[Leuchte et~al.(2004{\natexlab{b}})Leuchte, Neurohr, and
  Baumgartner]{128}
Leuchte, Neurohr, and Baumgartner.
\newblock Brain natriuretic peptide and exercise capacity in lung fibrosis and
  pulmonary hypertension.
\newblock \emph{Am J Respir Crit Care Med}, 170:\penalty0 360--365,
  2004{\natexlab{b}}.

\bibitem[Lewin et~al.(2005)Lewin, M, and et~al]{bib3295}
Lewin, Ledwidge M, and O'loughlin~C et~al.
\newblock Clinical deterioration in established heart failure: What is the
  value of bnp and weight gain in aiding diagnosis?
\newblock \emph{Eur J Heart Fail}, 7:\penalty0 953--957, 2005.

\bibitem[Lewis et~al.(2000)Lewis, Salem, Chertow, Weisberg, McGrew, Marbury,
  and Allgren]{Lewis2000}
J~Lewis, MM~Salem, GM~Chertow, LS~Weisberg, F~McGrew, TC~Marbury, and
  RL~Allgren.
\newblock Atrial natriuretic factor in oliguric acute renal failure; anaritide
  acute renal failure study group.
\newblock \emph{Am J Kidney Dis}, 36:\penalty0 767--774, 2000.

\bibitem[Liang et~al.(2000)Liang, Atakilit, and Gardner]{Liang2000}
F~Liang, A~Atakilit, and DG~Gardner.
\newblock Integrin dependence of brain natriuretic peptide gene promoter
  activation by mechanical strain.
\newblock \emph{J Biol Chem}, 275:\penalty0 20355--60, 2000.

\bibitem[Logeart et~al.(2002)Logeart, C, and et~al]{bib373}
Logeart, Saudubray C, and Beyne~P et~al.
\newblock Comparative values of doppler echocardiography and b-type natriuretic
  peptide assay in the etiologic diagnosis of acute dyspnea.
\newblock \emph{J Am Col Cardiol}, 40:\penalty0 1794--1800, 2002.

\bibitem[Lohmann et~al.(1997)Lohmann, Vaandrager, and Smolenski]{166}
Lohmann, Vaandrager, and Smolenski.
\newblock Distinct and specific functions of cgmp-dependent protein kinases.
\newblock \emph{Trend Biochem Sci}, 22:\penalty0 307--312, 1997.

\bibitem[Lopez et~al.(1995)Lopez, Wong, Kishimoto, Dubois, Mach, Friesen,
  Garbers, and Beuve]{Lopez1995}
MJ~Lopez, SK~Wong, I~Kishimoto, S~Dubois, V~Mach, J~Friesen, DL~Garbers, and
  A~Beuve.
\newblock Salt-resistant hypertension in mice lacking the guanylyl cyclase-a
  receptor for atrial natriuretic peptide.
\newblock \emph{Nature}, 378:\penalty0 65--68, 1995.

\bibitem[Lopez et~al.(1997)Lopez, Garbers, and Kuhn]{Lopez1997}
MJ~Lopez, DL~Garbers, and M~Kuhn.
\newblock The guanylyl cyclase-deficient mouse defines differential pathways of
  natriuretic peptide signaling.
\newblock \emph{J Biol Chem}, 272:\penalty0 23064--23068, 1997.

\bibitem[los Angeles~Costa et~al.(2004)los Angeles~Costa, Elesgaray, and
  Loria]{274}
De~los Angeles~Costa, Elesgaray, and Loria.
\newblock Atrial natriuretic peptide influence on nitric oxide system in kidney
  and heart.
\newblock \emph{Regul Pept}, 118:\penalty0 151--157, 2004.

\bibitem[Lubien et~al.(2002)Lubien, A, and et~al]{bib3125}
Lubien, DeMaria A, and Krishnaswamy~P et~al.
\newblock Utility of b-natriuretic peptide in detecting diastolic dysfunction:
  comparison with doppler velocity recordings.
\newblock \emph{Circulation}, 105:\penalty0 595--601, 2002.

\bibitem[Lucarelli et~al.(2001)Lucarelli, Iacoviello, and Dessi-Fulgheri]{266}
Lucarelli, Iacoviello, and Dessi-Fulgheri.
\newblock Associazione di una nuova variante genica del recettore a dei peptidi
  natriuretici con la familiarità per ipertensione arteriosa.
\newblock \emph{Ital Heart J 2 (Suppl 6)}, 10, 2001.

\bibitem[Luchner et~al.(1998)Luchner, Jr, and et~al]{bib3282}
Luchner, Burnett~JC Jr, and Jougasaki~M et~al.
\newblock Augmentation of the cardiac natriuretic peptides by beta-receptor
  antagonism: evidence from a population-based study.
\newblock \emph{J Am Coll Cardiol}, 32:\penalty0 1839--1844, 1998.

\bibitem[Luchner et~al.(2005)Luchner, Hengstenberg, Lowel, Riegger, Schunkert,
  and Holmer]{Luchner2005}
A~Luchner, C~Hengstenberg, H~Lowel, GA~Riegger, H~Schunkert, and S~Holmer.
\newblock Effect of compensated renal dysfunction on approved heart failure
  markers: direct comparison of brain natriuretic peptide (bnp) and n-terminal
  pro-bnp.
\newblock \emph{Hypertension}, 46:\penalty0 118--23, 2005.

\bibitem[Ma et~al.(2004)Ma, Ogawa, and de~Bold~AJ]{56}
Ma, Ogawa, and de~Bold~AJ.
\newblock Selective upregulation of cardiac brain natriuretic peptide at the
  transcriptional and translational levels by pro-inflammatory cytokines and by
  conditioned medium derived from mixed lymphocyte reactions via p38 map
  kinase.
\newblock \emph{J Mol Cell Cardiol}, 36:\penalty0 505--513, 2004.

\bibitem[Maeder et~al.(2003)Maeder, Ammann, Rickli, and Diethelm]{126}
Maeder, Ammann, Rickli, and Diethelm.
\newblock Elevation of b-type natriuretic peptide levels in acute respiratory
  distress syndrome.
\newblock \emph{Swiss Med Wkly}, 133:\penalty0 515--518, 2003.

\bibitem[Maffei et~al.(2001)Maffei, S, C, and A]{bib314}
Maffei, Del~Ry S, Prontera C, and Clerico A.
\newblock Increase in circulating levels of cardiac natriuretic peptides after
  hormone replacement therapy in postmenopausal women.
\newblock \emph{Clin Sci}, 101:\penalty0 447--453, 2001.

\bibitem[Magga et~al.(2004)Magga, Puhakka, and Hietakorpi]{82}
Magga, Puhakka, and Hietakorpi.
\newblock Atrial natriuretic peptide, b-type natriuretic peptide, and serum
  collagen markers after acute myocardial infarction.
\newblock \emph{J Appl Physiol}, 96:\penalty0 1306--1311, 2004.

\bibitem[Magnusson et~al.(2004)Magnusson, Melander, Israelsson, Grubb, Groop,
  and Jovinge]{Magnusson2004}
M~Magnusson, O~Melander, B~Israelsson, A~Grubb, L~Groop, and S~Jovinge.
\newblock Elevated plasma levels of nt-probnp in patients with type 2 diabetes
  without overt cardiovascular disease.
\newblock \emph{Diabetes Care}, 27:\penalty0 1929--35, 2004.

\bibitem[Maisel(2001)]{bib3255}
Maisel.
\newblock B-type natriuretic peptide (bnp) levels: diagnostic and therapeutic
  potential.
\newblock \emph{(Review) Rev Cardiovasc Med 2(suppl 2):S13-18}, 2001.

\bibitem[Maisel et~al.(2001)Maisel, J, and et~al]{bib3124}
Maisel, Koon J, and Krishnaswamy~P et~al.
\newblock Utility of b-natriuretic peptide as a rapid, pointof-care test for
  screening patients undergoing echocardiography to determine left ventricular
  dysfunction. am heart j.
\newblock 141:\penalty0 367--374, 2001.

\bibitem[Maisel et~al.(2002{\natexlab{a}})Maisel, P, and et~al]{bib3111}
Maisel, Krishnaswamy P, and Nowak~RM et~al.
\newblock Rapid measurement of b-type natriuretic peptide in the emergency
  diagnosis of heart failure.
\newblock \emph{N Engl J Med}, 347:\penalty0 161--167, 2002{\natexlab{a}}.

\bibitem[Maisel et~al.(2003)Maisel, J, and et~al]{bib3112}
Maisel, McCord J, and Nowak~RM et~al.
\newblock Bedside b-type natriuretic peptide in the emergency diagnosis of
  heart failure with reduced or preserved ejection fraction. results from the
  breathing not properly multinational study.
\newblock \emph{J Am Coll Cardiol}, 41:\penalty0 2010--2017, 2003.

\bibitem[Maisel et~al.(2004)Maisel, JE, and et~al]{bib3262}
Maisel, Hollander JE, and Guss~D et~al.
\newblock Rapid emergency department heart failure outpatient trial
  investigators. primary results of the rapid emergency department heart
  failure outpatient trial (redhot). a multicenter study of b-type natriuretic
  peptide levels, emergency department decision making, and outcomes in
  patients presenting with shortness of breath.
\newblock \emph{J Am Coll Cardiol}, 44:\penalty0 1328--1333, 2004.

\bibitem[Maisel and Wettersten(2018)]{Maisel2018}
Alan~S Maisel and Nicholas Wettersten.
\newblock Natriuretic peptides in heart failure. atrial and b-type natriuretic
  peptides.
\newblock \emph{Heart Failure Clin}, 14:\penalty0 13--25, 2018.

\bibitem[Maisel et~al.(2002{\natexlab{b}})Maisel, Krishnaswamy, Nowak, McCord,
  Hollander, Duc, Omland, Storrow, Abraham, Wu, Clopton, Steg, Westheim,
  Knudsen, Perez, Kazanegra, Herrmann, and Study]{Maisel2002}
AS~Maisel, P~Krishnaswamy, RM~Nowak, J~McCord, JE~Hollander, P~Duc, T~Omland,
  AB~Storrow, WT~Abraham, AH~Wu, P~Clopton, PG~Steg, A~Westheim, CW~Knudsen,
  A~Perez, R~Kazanegra, HC~Herrmann, and Investigators McCullough PA; Breathing
  Not Properly~Multinational Study.
\newblock Rapid measurement of b-type natriuretic peptide in the emergency
  diagnosis of heart failure.
\newblock \emph{N Engl J Med}, 347:\penalty0 161--7, 2002{\natexlab{b}}.

\bibitem[Mak et~al.(2004)Mak, A, P, and AS]{bib3180}
Mak, DeMaria A, Clopton P, and Maisel AS.
\newblock Utility of b-natriuretic peptide in the evaluation of left
  ventricular diastolic function: comparison with tissue doppler imaging
  recordings.
\newblock \emph{Am Heart J}, 148:\penalty0 895--902, 2004.

\bibitem[Marchioli and SL(1997)]{155}
Marchioli and Graziano SL.
\newblock Paraneoplastic syndromes associated with small cell lung cancer.
\newblock \emph{Chest Surg Clin N Am}, 7:\penalty0 65--80, 1997.

\bibitem[Marumoto et~al.(1995)Marumoto, M, and K]{bib3246}
Marumoto, Hamada M, and Hiwada K.
\newblock Increased secretion of atrial and brain natriuretic peptides during
  acute myocardial ischaemia induced by dynamic exercise in patients with
  angina pectoris.
\newblock \emph{Clin Sci}, 88:\penalty0 551--556, 1995.

\bibitem[MB(2005)]{190}
Anand-Srivastava MB.
\newblock Natriuretic peptide receptor-c signaling and regulation.
\newblock \emph{Peptides}, 26:\penalty0 1044--1059, 2005.

\bibitem[McCullough et~al.(2004{\natexlab{a}})McCullough, J, and VS]{bib385}
McCullough, Kuncheria J, and Mathur VS.
\newblock Diagnostic and therapeutic utility of b-type natriuretic peptide in
  patients with renal insufficiency and decompensated heart failure.
\newblock \emph{(Review) Rev Cardiovasc Med}, 5:\penalty0 16--25,
  2004{\natexlab{a}}.

\bibitem[McCullough et~al.(2004{\natexlab{b}})McCullough, Kuncheria, and
  VS]{145}
McCullough, Kuncheria, and Mathur VS.
\newblock Diagnostic and therapeutic utility of b-type natriuretic peptide in
  patients with renal insufficiency and decompensated heart failure.
\newblock \emph{Rev Cardiovasc Med}, 5:\penalty0 16--25, 2004{\natexlab{b}}.

\bibitem[McCullough et~al.(2002)McCullough, Nowak, McCord, Hollander, Herrmann,
  Steg, Duc, Westheim, Omland, Knudsen, Storrow, Abraham, Lamba, Wu, Perez,
  Clopton, Krishnaswamy, Kazanegra, and Maisel]{McCullough2002}
PA~McCullough, RM~Nowak, J~McCord, JE~Hollander, HC~Herrmann, PG~Steg, P~Duc,
  A~Westheim, T~Omland, CW~Knudsen, AB~Storrow, WT~Abraham, S~Lamba, AH~Wu,
  A~Perez, P~Clopton, P~Krishnaswamy, R~Kazanegra, and AS~Maisel.
\newblock B-type natriuretic peptide and clinical judgment in emergency
  diagnosis of heart failure: analysis from breathing not properly (bnp)
  multinational study.
\newblock \emph{Circulation}, 106:\penalty0 416--22, 2002.

\bibitem[McDonagh et~al.(2001)McDonagh, AD, and et~al]{bib3227}
McDonagh, Cunningham AD, and Morrison~CE et~al.
\newblock Left ventricular dysfunction, natriuretic peptides, and mortality in
  an urban population.
\newblock \emph{Heart}, 86:\penalty0 21--26, 2001.

\bibitem[McGeoch et~al.(2002)McGeoch, J, and et~al]{bib3258}
McGeoch, Lainchbury J, and Town~GI et~al.
\newblock Plasma brain natriuretic peptide after longterm treatment for heart
  failure in general practice.
\newblock \emph{Eur J Heart Fail}, 4:\penalty0 479--483, 2002.

\bibitem[McGirt et~al.(2004)McGirt, Blessing, and SM]{150}
McGirt, Blessing, and Nimjee SM.
\newblock Correlation of serum brain natriuretic peptide with hyponatremia and
  delayed ischemic neurological deficits after subarachnoid hemorrhage.
\newblock \emph{Neurosurgery}, 54:\penalty0 1369--1373, 2004.

\bibitem[McGrath and de~Bold~AJ(2005)]{13}
McGrath and de~Bold~AJ.
\newblock Determinants of natriuretic peptide gene expression.
\newblock \emph{Peptides}, 26:\penalty0 933--943, 2005.

\bibitem[McGregor et~al.(1990)McGregor, Richards, Espiner, Yandle, and
  Ikram]{McGregor1990}
A~McGregor, M~Richards, E~Espiner, T~Yandle, and H~Ikram.
\newblock Brain natriuretic peptide administered to man: actions and
  metabolism.
\newblock \emph{J Clin Endocrinol Metab}, 70:\penalty0 1103--1107, 1990.

\bibitem[McLean et~al.(2003)McLean, B, and et~al]{bib3116}
McLean, Tang B, and Nalos~M et~al.
\newblock Increased b-type natriuretic peptide (bnp) level is a strong
  predictor for cardiac dysfunction in intensive care unit patients.
\newblock \emph{Anaesth Intensive Care}, 31:\penalty0 21--27, 2003.

\bibitem[McNairy et~al.(2002)McNairy, Gardetto, Clopton, Garcia, Krishnaswamy,
  Kazanegra, Ziegler, and Maisel]{McNairy2002}
M~McNairy, N~Gardetto, P~Clopton, A~Garcia, P~Krishnaswamy, R~Kazanegra,
  M~Ziegler, and AS~Maisel.
\newblock Stability of b-type natriuretic peptide levels during exercise in
  patients with congestive heart failure: implications for outpatient
  monitoring with b-type natriuretic peptide.
\newblock \emph{Am Heart J}, 143:\penalty0 406--11, 2002.

\bibitem[Mehra et~al.(2004{\natexlab{a}})Mehra, PA, and et~al]{bib353}
Mehra, Uber PA, and Park~MH et~al.
\newblock Obesity and suppressed b-type natriuretic peptide levels in heart
  failure.
\newblock \emph{J Am Coll Cardiol}, 43:\penalty0 1590--1595,
  2004{\natexlab{a}}.

\bibitem[Mehra et~al.(2004{\natexlab{b}})Mehra, Uber, Park, Scott, Ventura,
  Harris, and Frohlich]{Mehra2004}
MR~Mehra, PA~Uber, MH~Park, RL~Scott, HO~Ventura, BC~Harris, and ED~Frohlich.
\newblock Obesity and suppressed b-type natriuretic peptide levels in heart
  failure.
\newblock \emph{J Am Coll Cardiol}, 43:\penalty0 1590--5, 2004{\natexlab{b}}.

\bibitem[Michaels et~al.(2005)Michaels, Chatterjee, and De-Marco]{Michaels2005}
AD~Michaels, K~Chatterjee, and T~De-Marco.
\newblock Effects of intravenous nesiritide on pulmonary vascular hemodynamics
  in pulmonary hypertension.
\newblock \emph{J Card Fail}, 11:\penalty0 425--431, 2005.

\bibitem[Mills et~al.(1999)Mills, LeJemtel, Horton, Liang, Lang, Silver, Lui,
  and Chatterjee]{Mills1999}
RM~Mills, TH~LeJemtel, DP~Horton, C~Liang, R~Lang, MA~Silver, C~Lui, and
  K~Chatterjee.
\newblock Sustained hemodynamic effects of an infusion of nesiritide (human
  b-type natriuretic peptide) in heart failure: a randomized, double-blind,
  placebo-controlled clinical trial; natrecor study group.
\newblock \emph{J Am Coll Cardiol}, 34:\penalty0 155--162, 1999.

\bibitem[Mimura et~al.(1996)Mimura, Kanauchi, Ogawa, and Oohara]{154}
Mimura, Kanauchi, Ogawa, and Oohara.
\newblock Resistance to natriuresis in patients with peritonitis carcinomatosa.
\newblock \emph{Horm Metab Res}, 28:\penalty0 183--186, 1996.

\bibitem[Missouris et~al.(1998)Missouris, E, and et~al]{bib3273}
Missouris, Grouzmann E, and Buckley~MG et~al.
\newblock How does treatment influence endocrine mechanisms in acute severe
  heart failure? effects on cardiac natriuretic peptides, the renin system,
  neuropeptide y and catecholamines.
\newblock \emph{Clin Sci}, 94:\penalty0 591--599, 1998.

\bibitem[Mizuno et~al.(2001)Mizuno, Yoshimura, and Yasue]{209}
Mizuno, Yoshimura, and Yasue.
\newblock Aldosterone production is activated in failing ventricle in humans.
\newblock \emph{Circulation}, 103:\penalty0 72--77, 2001.

\bibitem[Moffatt et~al.(2007)Moffatt, Thomas, Sellin, Bessette, Lafreniere,
  Akhouayri, St-Arnaud, and Lanctot]{Moffatt2007}
P~Moffatt, G~Thomas, K~Sellin, MC~Bessette, F~Lafreniere, O~Akhouayri,
  R~St-Arnaud, and C~Lanctot.
\newblock Osteocrin is a specific ligand of the natriuretic peptide clearance
  receptor that modulates bone growth.
\newblock \emph{J Biol Chem}, 282:\penalty0 36454--36462, 2007.

\bibitem[Morimoto et~al.(2004)Morimoto, Y, and et~al]{bib3263}
Morimoto, Hayashino Y, and Shimbo~T et~al.
\newblock Is b-type natriuretic peptide-guided heart failure management
  cost-effective?
\newblock \emph{Int J Cardiol}, 96:\penalty0 177--181, 2004.

\bibitem[Morishige et~al.(2000)Morishige, Shimokawa, and Yamawaki]{85}
Morishige, Shimokawa, and Yamawaki.
\newblock Local adenovirus-mediated transfer of c-type natriuretic peptide
  suppresses vascular remodeling in porcine coronary arteries in vivo.
\newblock \emph{J Am Coll Cardiol}, 35:\penalty0 1040--1047, 2000.

\bibitem[Morita et~al.(1993{\natexlab{a}})Morita, H, and et~al]{bib3135}
Morita, Yasue H, and Yoshimura~M et~al.
\newblock Increased plasma levels of brain natriuretic peptide in patients with
  acute myocardial infarction.
\newblock \emph{Circulation}, 88:\penalty0 82--91, 1993{\natexlab{a}}.

\bibitem[Morita et~al.(1993{\natexlab{b}})Morita, Yasue, and Yoshimura]{163}
Morita, Yasue, and Yoshimura.
\newblock Increased plasma levels of brain natriuretic peptide in patients with
  acute myocardial infarction.
\newblock \emph{Circulation}, 88:\penalty0 82--91, 1993{\natexlab{b}}.

\bibitem[Mueller and P(2002)]{bib3259}
Mueller and Buser P.
\newblock B-type natriuretic peptide (bnp): can it improve our management of
  patients with congestive heart failure?
\newblock \emph{(Review) Swiss Med Wkly}, 132:\penalty0 618--622, 2002.

\bibitem[Mueller et~al.(2004)Mueller, A, and et~al]{bib3265}
Mueller, Scholer A, and Laule-Kilian~K et~al.
\newblock Use of b-type natriuretic peptide in the evaluation and management of
  acute dyspnea.
\newblock \emph{N Engl J Med}, 350:\penalty0 647--654, 2004.

\bibitem[Mukkaddam-Daher et~al.(1996)Mukkaddam-Daher, J, and et~al]{bib346}
Mukkaddam-Daher, Tremblay J, and Fujio~N et~al.
\newblock Alteration of lung atrial natriuretic peptide receptors in genetic
  cardiomyopathy.
\newblock \emph{Am J Physiol}, 271:\penalty0 138--145, 1996.

\bibitem[Mukoyama et~al.(1991{\natexlab{a}})Mukoyama, Nakao, and Hosoda]{208}
Mukoyama, Nakao, and Hosoda.
\newblock Brain natriuretic peptide as a novel cardiac hormone in humans.
  evidence for an exquisite dual natriuretic peptide system, atrial natriuretic
  peptide and brain natriuretic peptide.
\newblock \emph{J Clin Invest}, 87:\penalty0 1402--1412, 1991{\natexlab{a}}.

\bibitem[Mukoyama et~al.(1991{\natexlab{b}})Mukoyama, Nakao, and Obata]{162}
Mukoyama, Nakao, and Obata.
\newblock Augmented secretion of brain natriuretic peptide in acute myocardial
  infarction.
\newblock \emph{Biochem Biophys Res Commun volume = 15}, 1991{\natexlab{b}}.

\bibitem[Mukoyama et~al.(1990)Mukoyama, Nakao, Saito, Ogawa, Hosoda, Suga,
  Shirakami, Jougasaki, and Imura]{Mukoyama1990}
M~Mukoyama, K~Nakao, Y~Saito, Y~Ogawa, K~Hosoda, S~Suga, G~Shirakami,
  M~Jougasaki, and H~Imura.
\newblock Increased human brain natriuretic peptide in congestive heart
  failure.
\newblock \emph{N Engl J Med}, 323:\penalty0 757--758, 1990.

\bibitem[Mukoyama et~al.(1991{\natexlab{c}})Mukoyama, Nakao, Hosoda, Suga,
  Saito, Ogawa, Shirakami, Jougasaki, Obata, and Yasue]{Mukoyama1991}
M~Mukoyama, K~Nakao, K~Hosoda, S~Suga, Y~Saito, Y~Ogawa, G~Shirakami,
  M~Jougasaki, K~Obata, and H~Yasue.
\newblock Brain natriuretic peptide as a novel cardiac hormone in humans;
  evidence for an exquisite dual natriuretic peptide system, atrial natriuretic
  peptide and brain natriuretic peptide.
\newblock \emph{J Clin Invest}, 87:\penalty0 1402--1412, 1991{\natexlab{c}}.

\bibitem[Murdoch et~al.(1999)Murdoch, TA, and et~al]{bib3252}
Murdoch, McDonagh TA, and Byrne~J et~al.
\newblock Titration of vasodilator therapy in chronic heart failure according
  to plasma brain natriuretic peptide concentration: randomized comparison of
  the hemodynamic and neuroendocrine effects of tailored versus empirical
  therapy.
\newblock \emph{Am Heart J}, 138:\penalty0 1126--1132, 1999.

\bibitem[Nagaya et~al.(1998)Nagaya, Nishikimi, and Goto]{80}
Nagaya, Nishikimi, and Goto.
\newblock Plasma brain natriuretic peptide is a biochemical marker for the
  prediction of progressive ventricular remodeling after acute myocardial
  infarction.
\newblock \emph{Am Heart J}, 135:\penalty0 21--28, 1998.

\bibitem[Nagaya et~al.(2000{\natexlab{a}})Nagaya, Nishikimi, and Uematsu]{127}
Nagaya, Nishikimi, and Uematsu.
\newblock Plasma brain natriuretic peptide as a prognostic indicator in
  patients with primary pulmonary hypertension.
\newblock \emph{Circulation}, 102:\penalty0 865--870, 2000{\natexlab{a}}.

\bibitem[Nagaya et~al.(2000{\natexlab{b}})Nagaya, T, and et~al]{bib383}
Nagaya, Nishikimi T, and Uematsu~M et~al.
\newblock Plasma brain natriuretic peptide as a prognostic indicator in
  patients with primary pulmonary hypertension.
\newblock \emph{Circulation}, 102:\penalty0 865--870, 2000{\natexlab{b}}.

\bibitem[Nakagawa et~al.(1995)Nakagawa, Y, and et~al]{bib3119}
Nakagawa, Ogawa Y, and Itoh~H et~al.
\newblock Rapid transcriptional activation and early mrna turnover of brain
  natriuretic peptide in cardiocyte hypertrophy. evidence for brain natriuretic
  peptide as an “emergency” cardiac hormone against ventricular overload.
\newblock \emph{J Clin Invest}, 96:\penalty0 1280--1287, 1995.

\bibitem[Nakamura et~al.(2002)Nakamura, H, and et~al]{bib366}
Nakamura, Endo H, and Nasu~M et~al.
\newblock Value of plasma b type natriuretic peptide measurement for heart
  disease screening in a japanese population.
\newblock \emph{Heart}, 87:\penalty0 131--135, 2002.

\bibitem[Nakamura et~al.(2005)Nakamura, T, and et~al]{bib3174}
Nakamura, Sakai T, and Osawa~M et~al.
\newblock Comparison of positive cases for b-type natriuretic peptide and ecg
  testing for identification of precursor forms of heart failure in an elderly
  population.
\newblock \emph{Int Heart J}, 46:\penalty0 477--487, 2005.

\bibitem[Nakanishi et~al.(2005)Nakanishi, Saito, and Kishimoto]{89}
Nakanishi, Saito, and Kishimoto.
\newblock Role of natriuretic peptide receptor guanylyl cyclase-a in myocardial
  infarction evaluated using genetically engineered mice.
\newblock \emph{Hypertension}, 46:\penalty0 1--7, 2005.

\bibitem[Nakayama(2005)]{251}
Nakayama.
\newblock The genetic contribution of the natriuretic peptide system to
  cardiovascular diseases.
\newblock \emph{Endocr J}, 52:\penalty0 11--21, 2005.

\bibitem[Nakayama et~al.(2000{\natexlab{a}})Nakayama, Soma, and Takahashi]{265}
Nakayama, Soma, and Takahashi.
\newblock \emph{title = {Functional deletion mutation of the}, 5’-flanking
  region of type A natriuretic peptide receptor gene and its association with
  essential hypertension and left ventricular hypertrophy in the Japanese.},
  86:\penalty0 841--845, 2000{\natexlab{a}}.

\bibitem[Nakayama et~al.(2000{\natexlab{b}})Nakayama, Soma, Takahashi,
  Rehemudula, Kanmatsuse, and Furuya]{Nakayama2000}
T~Nakayama, M~Soma, Y~Takahashi, D~Rehemudula, K~Kanmatsuse, and K~Furuya.
\newblock Functional deletion mutation of the 5-flanking region of type a human
  natriuretic peptide receptor gene and its association with essential
  hypertension and left ventricular hypertrophy in the japanese.
\newblock \emph{Circ Res}, 86:\penalty0 841--845, 2000{\natexlab{b}}.

\bibitem[Nazario et~al.(1995)Nazario, Hu, and Pedram]{273}
Nazario, Hu, and Pedram.
\newblock Atrial and brain natriuretic peptides stimulate the production and
  secretion of c-type natriuretic peptide from bovine aortic endothelial cells.
\newblock \emph{J Clin Invest}, 95:\penalty0 1151--1157, 1995.

\bibitem[Ng et~al.(2003)Ng, I, and et~al]{bib3171}
Ng, Loke I, and Davies~JE et~al.
\newblock Identification of previously undiagnosed left ventricular systolic
  dysfunction: community screening using natriuretic peptides and
  electrocardiography.
\newblock \emph{Eur J Heart Fail}, 5:\penalty0 775--782, 2003.

\bibitem[Ng et~al.(2004)Ng, Geeranavor, and SC]{203}
Ng, Geeranavor, and Jennings SC.
\newblock Diagnosis of heart failure using urinary natriuretic peptides.
\newblock \emph{Clin Sci}, 106:\penalty0 129--133, 2004.

\bibitem[Nicholls et~al.(2001)Nicholls, JG, and et~al]{bib3256}
Nicholls, Lainchbury JG, and Richards~AM et~al.
\newblock Brain natriuretic peptide-guided therapy for heart failure.
\newblock \emph{Ann Med}, 33:\penalty0 422--427, 2001.

\bibitem[Nielsen et~al.(2003)Nielsen, TA, SD, and HJ]{bib392}
Nielsen, McDonagh TA, Robb SD, and Dargie HJ.
\newblock Retrospective analysis of the costeffectiveness of using plasma brain
  natriuretic peptide in screening for left ventricular systolic dysfunction in
  the general population.
\newblock \emph{J Am Coll Cardiol}, 41:\penalty0 113--120, 2003.

\bibitem[Nishikimi et~al.(1996)Nishikimi, H, and et~al]{bib3272}
Nishikimi, Matsuoka H, and Ishikawa~K et~al.
\newblock Antihypertensive therapy reduces increased plasma levels of
  adrenomedullin and brain natriuretic peptide concomitant with regression of
  left ventricular hypertrophy in a patient with malignant hypertension.
\newblock \emph{Hypertens Res}, 19:\penalty0 97--101, 1996.

\bibitem[Nousiainen et~al.(1998{\natexlab{a}})Nousiainen, E, and
  et~al]{bib3149}
Nousiainen, Jantunen E, and Vanninen~E et~al.
\newblock Acute neurohumoral and cardiovascular effects of idarubicin in
  leukemia patients.
\newblock \emph{Eur J Haematol}, 61:\penalty0 347--353, 1998{\natexlab{a}}.

\bibitem[Nousiainen et~al.(1998{\natexlab{b}})Nousiainen, Jantunen, and
  Vanninen]{159}
Nousiainen, Jantunen, and Vanninen.
\newblock Acute neurohumoral and cardiovascular effects of idarubicin in
  leukemia patients.
\newblock \emph{Eur J Haematol}, 61:\penalty0 347--353, 1998{\natexlab{b}}.

\bibitem[Nousiainen et~al.(1999{\natexlab{a}})Nousiainen, E, and
  et~al]{bib3150}
Nousiainen, Jantunen E, and Vanninen~E et~al.
\newblock Natriuretic peptides as markers of cardiotoxicity during doxorubicin
  treatment for non-hodgkin’s lymphoma.
\newblock \emph{Eur J Haematol}, 62:\penalty0 135--141, 1999{\natexlab{a}}.

\bibitem[Nousiainen et~al.(1999{\natexlab{b}})Nousiainen, Jantunen, and
  Vanninen]{160}
Nousiainen, Jantunen, and Vanninen.
\newblock Natriuretic peptides as markers of cardiotoxicity during doxorubicin
  treatment for non-hodgkin’s lymphoma.
\newblock \emph{Eur J Haematol}, 62:\penalty0 135--141, 1999{\natexlab{b}}.

\bibitem[Nugent et~al.(1994)Nugent, Onuoha, and DJ]{195}
Nugent, Onuoha, and McEneaney DJ.
\newblock Variable patterns of atrial natriuretic peptide secretion in man.
\newblock \emph{Eur J Clin Invest}, 24:\penalty0 267--274, 1994.

\bibitem[Nussenzveig et~al.(1990)Nussenzveig, Lewicki, and
  Maack]{Nussenzveig1990}
DR~Nussenzveig, JA~Lewicki, and T~Maack.
\newblock Cellular mechanisms of the clearance function of type c receptors of
  atrial natriuretic factor.
\newblock \emph{J Biol Chem}, 265:\penalty0 20952--20958, 1990.

\bibitem[Ogawa et~al.(1994{\natexlab{a}})Ogawa, Itoh, and Tamura]{254}
Ogawa, Itoh, and Tamura.
\newblock Molecular cloning of the complementary dna and gene that encode mouse
  brain natriuretic peptide and generation of transgenic mice that overexpress
  tha brain natriuretic peptide gene.
\newblock \emph{J Clin Invest}, 93:\penalty0 1911--1921, 1994{\natexlab{a}}.

\bibitem[Ogawa et~al.(2002)Ogawa, A, and et~al]{bib3170}
Ogawa, Oida A, and Sugimura~H et~al.
\newblock Clinical significance of blood brain natriuretic peptide level
  measurement in the detection of heart disease in untreated outpatients:
  comparison of electrocardiography, chest radiography and echocardiography.
\newblock \emph{Circ J}, 66:\penalty0 122--126, 2002.

\bibitem[Ogawa et~al.(2004)Ogawa, Qiu, Ogata, and KS]{177}
Ogawa, Qiu, Ogata, and Risono KS.
\newblock Crystal structure of hormone-bound atrial natriuretic peptide
  receptor extracellular domain rotation mechanism for transmembrane signal
  transduction.
\newblock \emph{J Biol Chem}, 279:\penalty0 28625--28631, 2004.

\bibitem[Ogawa et~al.(1994{\natexlab{b}})Ogawa, Itoh, Tamura, Suga, Yoshimasa,
  Uehira, Matsuda, Shiono, Nishimoto, and Nakao]{Ogawa1994a}
Y~Ogawa, H~Itoh, N~Tamura, S~Suga, T~Yoshimasa, M~Uehira, S~Matsuda, S~Shiono,
  H~Nishimoto, and K~Nakao.
\newblock Molecular cloning of the complementary dna and gene that encode mouse
  brain natriuretic peptide and generation of transgenic mice that overexpress
  the brain natriuretic peptide gene.
\newblock \emph{J Clin Invest}, 93:\penalty0 1911--1921, 1994{\natexlab{b}}.

\bibitem[Ogawa et~al.(1994{\natexlab{c}})Ogawa, Itoh, Yoshitake, Inoue,
  Yoshimasa, Serikawa, and Nakao]{Ogawa1994b}
Y~Ogawa, H~Itoh, Y~Yoshitake, M~Inoue, T~Yoshimasa, T~Serikawa, and K~Nakao.
\newblock Molecular cloning and chromosomal assignment of the mouse c-type
  natriuretic peptide (cnp) gene (nppc): comparison with the human cnp gene
  (nppc).
\newblock \emph{Genomics}, 24:\penalty0 383--387, 1994{\natexlab{c}}.

\bibitem[Ohno et~al.(2002)Ohno, Itoh, and Ikeda]{281}
Ohno, Itoh, and Ikeda.
\newblock Accelerated reendothelialization with suppressed thrombogenic
  property and neointimal hyperplasia of rabbit jugular vein grafts by
  adenovirusmediated gene transfer of c-type natriuretic peptide.
\newblock \emph{Circulation}, 105:\penalty0 1623--1626, 2002.

\bibitem[Ohta et~al.(2000)Ohta, K, and et~al]{bib3293}
Ohta, Watanabe K, and Nakazawa~M et~al.
\newblock Carvedilol enhances atrial and brain natriuretic peptide mrna
  expression and release in rat heart.
\newblock \emph{J Cardiovasc Pharmacol 36(suppl 2):S19-23}, 2000.

\bibitem[Oikawa et~al.(1984)Oikawa, Imai, Ueno, Tanaka, Noguchi, Nakazato,
  Kangawa, Fukuda, and Matsuo]{Oikawa1984}
S~Oikawa, M~Imai, A~Ueno, S~Tanaka, T~Noguchi, H~Nakazato, K~Kangawa, A~Fukuda,
  and H~Matsuo.
\newblock Cloning and sequence analysis of cdna encoding a precursor for human
  atrial natriuretic polypeptide.
\newblock \emph{Nature}, 309:\penalty0 724--726, 1984.

\bibitem[Okumura and andYoshida T~et al(2000)]{bib3151}
Okumura and Iuchi~K andYoshida T~et al.
\newblock Brain natriuretic peptide is a predictor of anthracycline-induced
  cardiotoxicity.
\newblock \emph{Acta Haematol}, 104:\penalty0 158--163, 2000.

\bibitem[Okumura et~al.(2000)Okumura, Iuchi, and Yoshida]{161}
Okumura, Iuchi, and Yoshida.
\newblock Brain natriuretic peptide is a predictor of anthracycline-induced
  cardiotoxicity.
\newblock \emph{Acta Haematol}, 104:\penalty0 158--163, 2000.

\bibitem[Oliver et~al.(1997)Oliver, Fox, Kim, Rockman, Kim, Reddick, Pandey,
  Milgram, Smithies, and Maeda]{Oliver1997}
PM~Oliver, JE~Fox, R~Kim, HA~Rockman, HS~Kim, RL~Reddick, KN~Pandey,
  SL~Milgram, O~Smithies, and N~Maeda.
\newblock Hypertension, cardiac hypertrophy, and sudden death in mice lacking
  natriuretic peptide receptor a.
\newblock \emph{Proc Natl Acad Sci U S A}, 94:\penalty0 14730--14735, 1997.

\bibitem[Oliver et~al.(1998)Oliver, John, Purdy, Kim, Maeda, Goy, and
  Smithies]{Oliver1998}
PM~Oliver, SW~John, KE~Purdy, R~Kim, N~Maeda, MF~Goy, and O~Smithies.
\newblock Natriuretic peptide receptor 1 expression influences blood pressures
  of mice in a dose-dependent manner.
\newblock \emph{Proc Natl Acad Sci U S A}, 95:\penalty0 2547--2551, 1998.

\bibitem[Olney et~al.(2006)Olney, Bukulmez, Bartels, Prickett, Espiner, Potter,
  and Warman]{Olney2006}
RC~Olney, H~Bukulmez, CF~Bartels, TC~Prickett, EA~Espiner, LR~Potter, and
  ML~Warman.
\newblock Heterozygous mutations in natriuretic peptide receptor-b (npr2) are
  associated with short stature.
\newblock \emph{J Clin Endocrinol Metab}, 91:\penalty0 1229--1232, 2006.

\bibitem[Omland et~al.(1996{\natexlab{a}})Omland, A, and et~al]{bib3138}
Omland, Aakvaag A, and Bonarjee~VV et~al.
\newblock Plasma brain natriuretic peptide as an indicator of left ventricular
  systolic function and long-term survival after acute myocardial infarction.
  comparison with plasma atrial natriuretic peptide and n-terminal proatrial
  natriuretic peptide.
\newblock \emph{Circulation}, 93:\penalty0 1963--1969, 1996{\natexlab{a}}.

\bibitem[Omland et~al.(1996{\natexlab{b}})Omland, A, and H]{bib3108}
Omland, Aakvaag A, and Vik-Mo H.
\newblock Plasma cardiac natriuretic peptide determination as a screening test
  for the detection of patients with mild left ventricular impairment.
\newblock \emph{Heart}, 76:\penalty0 232--237, 1996{\natexlab{b}}.

\bibitem[Omland et~al.(2002)Omland, A, and et~al]{bib3223}
Omland, Persson A, and Ng~L et~al.
\newblock N-terminal pro-b-type natriuretic peptide and longterm mortality in
  acute coronary syndromes.
\newblock \emph{Circulation}, 106:\penalty0 2913--2918, 2002.

\bibitem[Omland et~al.(2005)Omland, AM, and andVik Mo~H]{bib3241}
Omland, Richards AM, and Wergeland~R andVik Mo~H.
\newblock B-type natriuretic peptide and longterm survival in patients with
  stable coronary artery disease.
\newblock \emph{Am J Cardiol}, 95:\penalty0 24--28, 2005.

\bibitem[Ono et~al.(2001)Ono, K, and et~al]{bib3128}
Ono, Tanabe K, and Asanuma~T et~al.
\newblock Doppler echocardiography-derived index of myocardial performance (tei
  index): comparison with brain natriuretic peptide levels in various heart
  diseases.
\newblock \emph{Jpn Circ J}, 65:\penalty0 637--642, 2001.

\bibitem[Opocher et~al.(1990)Opocher, Rocco, and Carpene]{137}
Opocher, Rocco, and Carpene.
\newblock Atrial natriuretic peptide in cushing’s disease.
\newblock \emph{J Endocrinol Invest}, 13:\penalty0 133--137, 1990.

\bibitem[O’Neill et~al.(2005)O’Neill, CE, and 3rd~et al]{bib3183}
O’Neill, Bott-Silverman CE, and McRae~AT 3rd~et al.
\newblock B-type natriuretic peptide levels are not a surrogate marker for
  invasive hemodynamics during management of patients with severe heart
  failure.
\newblock \emph{Am Heart J}, 149:\penalty0 363--369, 2005.

\bibitem[Packer(1992)]{bib358}
Packer.
\newblock The neurohormonal hypothesis: a theory to explain the mechanisms of
  disease progression in heart failure.
\newblock \emph{(Review) J Am Coll Cardiol}, 20:\penalty0 248--254, 1992.

\bibitem[Pagani et~al.(2003)Pagani, F, and M]{bib397}
Pagani, Stefini F, and Panteghini M.
\newblock Biological variation in serum concentrations of nterminal pro-brain
  natriuretic peptide (nt-probnp).
\newblock \emph{(Abstract) Clin Chem}, 49:\penalty0 A34, 2003.

\bibitem[Palladini et~al.(2003{\natexlab{a}})Palladini, C, and et~al]{bib387}
Palladini, Campana C, and Klersy~C et~al.
\newblock Serum n-terminal pro-brain natriuretic peptide is a sensitive marker
  of myocardial dysfunction in al amyloidosis.
\newblock \emph{Circulation}, 107:\penalty0 2440--2445, 2003{\natexlab{a}}.

\bibitem[Palladini et~al.(2003{\natexlab{b}})Palladini, Campana, and
  Klersy]{149}
Palladini, Campana, and Klersy.
\newblock Serum n-terminal pro-brain natriuretic peptide is a sensitive marker
  of myocardial dysfunction in al amyloidosis.
\newblock \emph{Circulation}, 107:\penalty0 2440--2445, 2003{\natexlab{b}}.

\bibitem[Pandey(1993)]{185}
Pandey.
\newblock Stoichiometric analysis of internalization, recycling and
  redistribution of photoaffinity-labeled guanylate cyclase/atrial natriuretic
  factor receptors in cultured murine leydig tumor cells.
\newblock \emph{J Biol Chem}, 268:\penalty0 4382--4390, 1993.

\bibitem[Pandey(2001)]{187}
Pandey.
\newblock Dynamics of internalization and sequestration of guanylyl
  cyclase/atrial natriuretic peptide receptor-a.
\newblock \emph{Can J Physiol Pharmacol}, 79:\penalty0 631--639, 2001.

\bibitem[Pandey(2005)]{112}
Pandey.
\newblock Biology of natriuretic peptides and their receptors.
\newblock \emph{Peptides}, 26:\penalty0 901--932, 2005.

\bibitem[Pandey et~al.(1986)Pandey, Inagami, and KS]{184}
Pandey, Inagami, and Misono KS.
\newblock Atrial natriuretic factor receptor on cultured leydig tumor cells
  ligand binding and photoaffinity labeling.
\newblock \emph{Biochemistry}, 25:\penalty0 8467--8472, 1986.

\bibitem[Pandey et~al.(2000)Pandey, Kumar, Li, and Nguyen]{186}
Pandey, Kumar, Li, and Nguyen.
\newblock Functional domains and expression of truncated atrial natriuretic
  peptide receptor-a the carboxyl-terminal regions direct the receptor
  internalization and sequestration in cos-/ cells.
\newblock \emph{Mol Pharmacol}, 57:\penalty0 259--267, 2000.

\bibitem[Pandey(2002)]{Pandey2002}
KN~Pandey.
\newblock Intracellular trafficking and metabolic turnover of ligand-bound
  guanylyl cyclase/atrial natriuretic peptide receptor-a into subcellular
  compartments.
\newblock \emph{Mol Cell Biochem}, 230:\penalty0 6172, 2002.

\bibitem[Pankow et~al.(2007)Pankow, Wang, Gembardt, Krause, Sun, Krause,
  Schultheiss, Siems, and Walther]{Pankow2007}
K~Pankow, Y~Wang, F~Gembardt, E~Krause, X~Sun, G~Krause, HP~Schultheiss,
  WE~Siems, and T~Walther.
\newblock Successive action of meprin a and neprilysin catabolizes b-type
  natriuretic peptide.
\newblock \emph{Circ Res}, 101:\penalty0 875--882, 2007.

\bibitem[Panteghini and A(2004)]{bib335}
Panteghini and Clerico A.
\newblock Understanding the clinical biochemistry of n-terminal pro-b-type
  natriuretic peptide: the prerequisite for its optimal clinical use.
\newblock \emph{(Review) Clin Lab}, 2004.

\bibitem[Panteghini et~al.(2003)Panteghini, C, and et~al]{bib3139}
Panteghini, Cuccia C, and Bonetti~G et~al.
\newblock Rapid determination of brain natriuretic peptide in patients with
  acute myocardial infarction.
\newblock \emph{Clin Chem Lab Med}, 41:\penalty0 164--168, 2003.

\bibitem[Parlapiano et~al.(1998)Parlapiano, Campana, and Alessandri]{132}
Parlapiano, Campana, and Alessandri.
\newblock Plasma atrial natriuretic hormone in hyperthyroidism.
\newblock \emph{Endocr Res}, 24:\penalty0 105--112, 1998.

\bibitem[Parsonage et~al.(2005)Parsonage, AJ, GL, and JM]{bib3184}
Parsonage, Galbraith AJ, Koerbin GL, and Potter JM.
\newblock Value of b-type natriuretic peptide for identifying significantly
  elevated pulmonary artery wedge pressure in patients treated for established
  chronic heart failure secondary to ischemic or idiopathic dilated
  cardiomyopathy.
\newblock \emph{Am J Cardiol}, 95:\penalty0 883--885, 2005.

\bibitem[Patel et~al.(2005)Patel, Valencik, Pritchett, Burnett, McDonald, and
  Redfield]{Patel2005}
JB~Patel, ML~Valencik, AM~Pritchett, JC~Burnett, JA~McDonald, and MM~Redfield.
\newblock Cardiac-specific attenuation of natriuretic peptide a receptor
  activity accentuates adverse cardiac remodeling and mortality in response to
  pressure overload.
\newblock \emph{Am J Physiol Heart Circ Physiol}, 289:\penalty0 H777H784, 2005.

\bibitem[Pedersen et~al.(1999)Pedersen, Pedersen, and KT]{196}
Pedersen, Pedersen, and Jensen KT.
\newblock Pulsatile secretion of atrial natriuretic peptide and brain
  natriuretic peptide in healthy humans.
\newblock \emph{Clin Sci}, 97:\penalty0 201--206, 1999.

\bibitem[Perras et~al.(2004)Perras, Schultes, and Behn]{103}
Perras, Schultes, and Behn.
\newblock Intranasal atrial natriuretic peptide acts as central nervous
  inhibitor of the hypothalamo-pituitary-adrenal stress system in humans.
\newblock \emph{J Clin Endocrinol Metab}, 89:\penalty0 4642--4648, 2004.

\bibitem[Pfeifer et~al.(1999)Pfeifer, Ruth, and Dostmann]{167}
Pfeifer, Ruth, and Dostmann.
\newblock Structure and function of cgmp-dependent protein kinases.
\newblock \emph{Rev Physiol Biochem Pharmacol}, 135:\penalty0 105--149, 1999.

\bibitem[Pfeifer et~al.(1996)Pfeifer, Aszodi, Seidler, Ruth, Hofmann, and
  Fassler]{Pfeifer1996}
A~Pfeifer, A~Aszodi, U~Seidler, P~Ruth, F~Hofmann, and R~Fassler.
\newblock Intestinal secretory defects and dwarfism in mice lacking
  cgmpdependent protein kinase ii.
\newblock \emph{Science}, 274:\penalty0 2082--2086, 1996.

\bibitem[Pfister and Schneider(2004)]{Pfister2004}
R~Pfister and CA~Schneider.
\newblock Natriuretic peptides bnp and nt-pro-bnp: established laboratory
  markers in clinical practice or just perspectives?
\newblock \emph{Clin Chim Acta}, 349:\penalty0 25--38, 2004.

\bibitem[Pichon et~al.(2005)Pichon, F, and et~al]{bib3161}
Pichon, Cvitkovic F, and Hacene~K et~al.
\newblock Drug-induced cardiotoxicity studied by longitudinal b-type
  natriuretic peptide assays and radionuclide ventriculography.
\newblock \emph{In vivo}, 19:\penalty0 567--576, 2005.

\bibitem[Pilo et~al.(1998)Pilo, Iervasi, and Clerico]{198}
Pilo, Iervasi, and Clerico.
\newblock The circulatory model in metabolic studies of rapidly renewed
  hormones application to anp kinetics.
\newblock \emph{Am J Physiol}, 274, 1998.

\bibitem[Porter et~al.(1990)Porter, Arfsten, Fuller, Miller, Gregory, and
  Lewicki]{Porter1990}
JG~Porter, A~Arfsten, F~Fuller, JA~Miller, LC~Gregory, and JA~Lewicki.
\newblock Isolation and functional expression of the human atrial natriuretic
  peptide clearance receptor cdna.
\newblock \emph{Biochem Biophys Res Commun}, 171:\penalty0 796--803, 1990.

\bibitem[Potter(1998)]{171}
Potter.
\newblock Phosphorylation-dependent regulation of the guanylyl cyclase-linked
  natriuretic peptide receptor b dephosphorylation is a mechanism of
  desensitization.
\newblock \emph{Biochemistry}, 37:\penalty0 2422--2429, 1998.

\bibitem[Potter and DL(1992)]{179}
Potter and Garber DL.
\newblock Dephosphorylation of the guanyl cyclase-a receptor causes
  desensitization.
\newblock \emph{J Biol Chem}, 267:\penalty0 14531--14534, 1992.

\bibitem[Potter and DL(1994)]{180}
Potter and Garber DL.
\newblock Protein kinase c-dependent desensitization of the atrial natriuretic
  peptide receptor is mediated by dephosphorylation.
\newblock \emph{J Biol Chem}, 269:\penalty0 14636--14642, 1994.

\bibitem[Potter and Hunter(1998{\natexlab{a}})]{169}
Potter and Hunter.
\newblock Identification and characterization of the major phosphorylation
  sites of the b-type natriuretic peptide receptor.
\newblock \emph{J Biol Chem}, 273:\penalty0 15533--15539, 1998{\natexlab{a}}.

\bibitem[Potter and Hunter(1998{\natexlab{b}})]{170}
Potter and Hunter.
\newblock Phosphorylation of the kinase homology domain is essential for
  activation of the a-type natriuretic peptide receptor.
\newblock \emph{Mol Cell Biol}, 18:\penalty0 2164--2172, 1998{\natexlab{b}}.

\bibitem[Potter and T(1998)]{bib350}
Potter and Hunter T.
\newblock Phosphorylation of the kinase homology domain is essential for
  activation of the a-type natriuretic peptide receptor.
\newblock \emph{Mol Cell Biol}, 18:\penalty0 2164--2172, 1998.

\bibitem[Potter and Garbers(1992)]{Potter1992}
LR~Potter and DL~Garbers.
\newblock Dephosphorylation of the guanylyl cyclase-a receptor causes
  desensitization.
\newblock \emph{J Biol Chem}, 267:\penalty0 14531--14534, 1992.

\bibitem[Potter and Garbers(1994)]{Potter1994}
LR~Potter and DL~Garbers.
\newblock Protein kinase c-dependent desensitization of the atrial natriuretic
  peptide receptor is mediated by dephosphorylation.
\newblock \emph{J Biol Chem}, 269:\penalty0 14636--14642, 1994.

\bibitem[Potter and Hunter(2000)]{Potter2000}
LR~Potter and T~Hunter.
\newblock Activation of pkc stimulates the dephosphorylation of natriuretic
  peptide receptor-b at a single serine residue: a possible mechanism of
  heterologous desensitization.
\newblock \emph{J Biol Chem}, 275:\penalty0 31099--31106, 2000.

\bibitem[Potthast et~al.(2004)Potthast, Abbey-Hosch, Antos, Marchant, Kuhn, and
  Potter]{Potthast2004}
R~Potthast, SE~Abbey-Hosch, LK~Antos, JS~Marchant, M~Kuhn, and LR~Potter.
\newblock Calcium-dependent dephosphorylation mediates the hyperosmotic and
  lysophosphatidic acid-dependent inhibition of natriuretic peptide
  receptor-b/guanylyl cyclase-b.
\newblock \emph{J Biol Chem}, 279:\penalty0 48513--48519, 2004.

\bibitem[Prontera et~al.(2003)Prontera, Emdin, and et~al]{bib320}
Prontera, Emdin, and Zucchelli~GC et~al.
\newblock Fully-automated nt-probnp and irma methods for bnp and anp in heart
  failure and healthy subjects.
\newblock \emph{Clin Chem}, 49:\penalty0 1552--1554, 2003.

\bibitem[Pruszczyk et~al.(2003)Pruszczyk, Kostrubiec, and Bochowicz]{122}
Pruszczyk, Kostrubiec, and Bochowicz.
\newblock N-terminal pro-brain natriuretic peptide in patients with acute
  pulmonary embolism.
\newblock \emph{Eur Respir J}, 22:\penalty0 649--653, 2003.

\bibitem[Pyle and Solaro(2004)]{Pyle2004}
WG~Pyle and RJ~Solaro.
\newblock At the crossroads of myocardial signaling: the role of z-discs in
  intracellular signaling and cardiac function.
\newblock \emph{Circ Res}, 94:\penalty0 296--305, 2004.

\bibitem[Qian et~al.(2002)Qian, Haruno, and Asada]{88}
Qian, Haruno, and Asada.
\newblock Local expression of c-type natriuretic peptide suppresses
  inflammation, eliminates shear stress-induced thrombosis, and prevents
  neointima formation through enhanced nitric oxide production in rabbit
  injured carotid arteries.
\newblock \emph{Circ Res}, 91:\penalty0 1063--1069, 2002.

\bibitem[Rahman et~al.(1994)Rahman, Kim, Mathew, Goldberg, Allgren, Schrier,
  and Conger]{Rahman1994}
SN~Rahman, GE~Kim, AS~Mathew, CA~Goldberg, R~Allgren, RW~Schrier, and
  JD~Conger.
\newblock Effects of atrial natriuretic peptide in clinical acute renal
  failure.
\newblock \emph{Kidney Int}, 45:\penalty0 1731--1738, 1994.

\bibitem[Rahmutula et~al.(2001)Rahmutula, Nakayama, and Soma]{262}
Rahmutula, Nakayama, and Soma.
\newblock Association study between the variants of the human anp gene and
  essential hypertension.
\newblock \emph{Hypertens Res}, 24:\penalty0 291--294, 2001.

\bibitem[Ramasawmy et~al.(1993)Ramasawmy, Kotea, and Lu]{258}
Ramasawmy, Kotea, and Lu.
\newblock A new polymorphic restriction site at the human atrial natriuretic
  peptide (hanp) gene locus.
\newblock \emph{Hum Genet}, 91:\penalty0 509--510, 1993.

\bibitem[Ray et~al.(2004)Ray, M, and et~al]{bib3146}
Ray, Arthaud M, and Lefort~Y et~al.
\newblock Usefulness of b-type natriuretic peptide in elderly patients with
  acute dyspnea.
\newblock \emph{Intensive Care Med}, 30:\penalty0 2230--2236, 2004.

\bibitem[Raymond et~al.(2003)Raymond, Groenning, Hildebrandt, Nilsson, Baumann,
  Trawinski, and Pedersen]{Raymond2003}
I~Raymond, BA~Groenning, PR~Hildebrandt, JC~Nilsson, M~Baumann, J~Trawinski,
  and F~Pedersen.
\newblock The influence of age, sex and other variables on the plasma level of
  nterminal pro brain natriuretic peptide in a large sample of the general
  population.
\newblock \emph{Heart}, 89:\penalty0 745--751, 2003.

\bibitem[Redfield et~al.(2002)Redfield, RJ, and et~al]{bib38}
Redfield, Rodeheffer RJ, and Jacobsen~SJ et~al.
\newblock Plasma brain natriuretic peptide concentration: impact of age and
  gender.
\newblock \emph{J Am Coll Cardiol}, 40:\penalty0 976--982, 2002.

\bibitem[Remes et~al.(1991)Remes, H, A, and K]{bib3104}
Remes, Miettinen H, Reunanen A, and Pyorala K.
\newblock Validity of clinical diagnosis of heart failure in primary health
  care.
\newblock \emph{Eur Heart J}, 12:\penalty0 315--321, 1991.

\bibitem[Remme and K(2001)]{bib369}
Remme and Swedberg K.
\newblock Task force report. guidelines for the diagnosis and treatment of
  chronic heart failure.
\newblock \emph{Eur Heart J}, 22:\penalty0 1527--1560, 2001.

\bibitem[Richards(2003)]{bib3261}
Richards.
\newblock Outpatient management of heart failure.
\newblock \emph{(Review) Heart Fail Rev}, 8:\penalty0 345--348, 2003.

\bibitem[Richards and RW(2004)]{bib363}
Richards and Troughton RW.
\newblock Nt-probnp in heart failure: therapy decisions and monitoring.
\newblock \emph{(Review) Eur J Heart Fail}, 6:\penalty0 351--354, 2004.

\bibitem[Richards et~al.(1998)Richards, MG, and et~al]{bib3117}
Richards, Nicholls MG, and Yandle~TG et~al.
\newblock Plasma n-terminal pro-brain natriuretic peptide and adrenomedullin:
  new neurohormonal predictors of left ventricular function and prognosis after
  myocardial infarction.
\newblock \emph{Circulation}, 97:\penalty0 1921--1929, 1998.

\bibitem[Richards et~al.(2001)Richards, R, and et~al]{bib3228}
Richards, Doughty R, and Nicholls~MG et~al.
\newblock Plasma n-terminal pro-brain natriuretic peptide and adrenomedullin:
  prognostic utility and prediction of benefit from carvedilol in chronic
  ischemic left ventricular dysfunction. australia-new zealand heart failure
  group.
\newblock \emph{J Am Coll Cardiol}, 37:\penalty0 1781--1787, 2001.

\bibitem[Richards et~al.(2002)Richards, JG, and et~al]{bib361}
Richards, Lainchbury JG, and Nicholls~MG et~al.
\newblock Bnp in hormone-guided treatment of heart failure.
\newblock \emph{(Review) Trends Endocrinol Metab}, 13:\penalty0 151--155, 2002.

\bibitem[Richards et~al.(1988)Richards, Tonolo, Montorsi, Finlayson, Fraser,
  Inglis, Towrie, and Morton]{Richards1988}
AM~Richards, G~Tonolo, P~Montorsi, J~Finlayson, R~Fraser, G~Inglis, A~Towrie,
  and JJ~Morton.
\newblock Low dose infusions of 26and 28-amino acid human atrial natriuretic
  peptides in normal man.
\newblock \emph{J Clin Endocrinol Metab}, 66:\penalty0 465--472, 1988.

\bibitem[Richards et~al.(1999)Richards, Doughty, Nicholls, Macmahon, Ikram,
  Sharpe, Espiner, Frampton, and Yandle]{Richards1999}
AM~Richards, R~Doughty, MG~Nicholls, S~Macmahon, H~Ikram, N~Sharpe, EA~Espiner,
  C~Frampton, and TG~Yandle.
\newblock Neurohumoral prediction of benefit from carvedilol in ischemic left
  ventricular dysfunction, australia-new zealand heart failure group.
\newblock \emph{Circulation}, 99:\penalty0 786--92, 1999.

\bibitem[Rocca et~al.(2001)Rocca, DM, and RL]{94}
Brunner-La Rocca, Kaye DM, and Woods RL.
\newblock Effects of intravenous brain natriuretic peptide on regional
  sympathetic activity in patients with chronic heart failure as compared with
  healthy control subjects.
\newblock \emph{J Am Coll Cardiol}, 37:\penalty0 1221--1227, 2001.

\bibitem[Rodeheffer(2004)]{bib3185}
Rodeheffer.
\newblock Measuring plasma b-type natriuretic peptide in heart failure: good to
  go in 2004?
\newblock \emph{(Review) J Am Coll Cardiol}, 44:\penalty0 740--749, 2004.

\bibitem[Rollin et~al.(2004)Rollin, Mediero, and Roldan-Pallares]{286}
Rollin, Mediero, and Roldan-Pallares.
\newblock Natriuretic peptide system in the human retina.
\newblock \emph{Mol Vis}, 10:\penalty0 15--22, 2004.

\bibitem[Rose and Giles(2008)]{Rose2008}
RA~Rose and WR~Giles.
\newblock Natriuretic peptide c receptor signalling in the heart and
  vasculature.
\newblock \emph{J Physiol}, 586:\penalty0 353--366, 2008.

\bibitem[Ruskoaho(2003{\natexlab{a}})]{78}
Ruskoaho.
\newblock Cardiac hormones as diagnostic tools in heart failure.
\newblock \emph{Endocr Rev}, 24:\penalty0 341--356, 2003{\natexlab{a}}.

\bibitem[Ruskoaho(2003{\natexlab{b}})]{bib33}
Ruskoaho.
\newblock Cardiac hormones as diagnostic tools in heart failure.
\newblock \emph{(Review) Endocr Rev}, 24:\penalty0 341--356,
  2003{\natexlab{b}}.

\bibitem[Ruskoaho et~al.(1997)Ruskoaho, Leskinen, and Magga]{117}
Ruskoaho, Leskinen, and Magga.
\newblock Mechanisms of mechanical load-induced atrial natriuretic peptide
  secretion role of endothelin, nitric oxide, and angiotensin ii.
\newblock \emph{J Mol Med}, 75:\penalty0 876--885, 1997.

\bibitem[Ruskoaho(2003{\natexlab{c}})]{Ruskoaho2003}
H~Ruskoaho.
\newblock Cardiac hormones as diagnostic tools in heart failure.
\newblock \emph{Endocr Rev}, 24:\penalty0 341--356, 2003{\natexlab{c}}.

\bibitem[Rutledge et~al.(1995)Rutledge, Sun, and EA]{257}
Rutledge, Sun, and Ross EA.
\newblock Polymorphisms within the atrial natriuretic peptide gene in essential
  hypertension.
\newblock \emph{J Hypertens}, 13:\penalty0 953--955, 1995.

\bibitem[Sabatine et~al.(2002)Sabatine, DA, and de~Lemos JA~et al]{bib3230}
Sabatine, Morrow DA, and de~Lemos JA~et al.
\newblock Multimarker approach to risk stratification in non-st elevation acute
  coronary syndromes: simultaneous assessment of troponin i, c-reactive
  protein, and b-type natriuretic peptide.
\newblock \emph{Circulation}, 105:\penalty0 1760--1763, 2002.

\bibitem[Sabatine et~al.(2004)Sabatine, DA, and de~Lemos JA~et al]{bib3164}
Sabatine, Morrow DA, and de~Lemos JA~et al.
\newblock Timi study group. acute changes in circulating natriuretic peptide
  levels in relation to myocardial ischemia.
\newblock \emph{J Am Coll Cardiol}, 44:\penalty0 1988--1995, 2004.

\bibitem[Sabrane et~al.(2005)Sabrane, Kruse, Fabritz, Zetsche, Mitko, Skryabin,
  Zwiener, Baba, Yanagisawa, and Kuhn]{Sabrane2005}
K~Sabrane, MN~Kruse, L~Fabritz, B~Zetsche, D~Mitko, BV~Skryabin, M~Zwiener,
  HA~Baba, M~Yanagisawa, and M~Kuhn.
\newblock Vascular endothelium is critically involved in the hypotensive and
  hypovolemic actions of atrial natriuretic peptide.
\newblock \emph{J Clin Invest}, 115:\penalty0 1666--1674, 2005.

\bibitem[Sackett and RB(2002)]{bib391}
Sackett and Haynes RB.
\newblock The architecture of diagnostic research.
\newblock \emph{Br Med J}, 324:\penalty0 539--541, 2002.

\bibitem[Sackner-Bernstein et~al.(2005{\natexlab{a}})Sackner-Bernstein,
  Kowalski, Fox, and Aaronson]{Sackner-Bernstein2005a}
JD~Sackner-Bernstein, M~Kowalski, M~Fox, and K~Aaronson.
\newblock Short-term risk of death after treatment with nesiritide for
  decompensated heart failure: a pooled analysis of randomized controlled
  trials.
\newblock \emph{Jama}, 293:\penalty0 1900--1905, 2005{\natexlab{a}}.

\bibitem[Sackner-Bernstein et~al.(2005{\natexlab{b}})Sackner-Bernstein,
  Skopicki, and Aaronson]{Sackner-Bernstein2005b}
JD~Sackner-Bernstein, HA~Skopicki, and KD~Aaronson.
\newblock Risk of worsening renal function with nesiritide in patients with
  acutely decompensated heart failure.
\newblock \emph{Circulation}, 111:\penalty0 1487--1491, 2005{\natexlab{b}}.

\bibitem[Sagnella(2002)]{bib340}
Sagnella.
\newblock Vasopeptidase inhibitors.
\newblock \emph{(Review) J Renin Angiotensin Aldosterone Syst}, 3:\penalty0
  90--95, 2002.

\bibitem[Saito et~al.(1987{\natexlab{a}})Saito, K, and et~al]{bib329}
Saito, Nakao K, and Nishimura~K et~al.
\newblock Clinical application of atrial natriuretic polypeptide in patients
  with congestive heart failure: beneficial effects on left ventricular
  function.
\newblock \emph{Circulation}, 76:\penalty0 115--124, 1987{\natexlab{a}}.

\bibitem[Saito et~al.(1987{\natexlab{b}})Saito, Nakao, Nishimura, Sugawara,
  Okumura, Obata, Sonoda, Ban, Yasue, and Imura]{Saito1987}
Y~Saito, K~Nakao, K~Nishimura, A~Sugawara, K~Okumura, K~Obata, R~Sonoda, T~Ban,
  H~Yasue, and H~Imura.
\newblock Clinical application of atrial natriuretic polypeptide in patients
  with congestive heart failure: beneficial effects on left ventricular
  function.
\newblock \emph{Circulation}, 76:\penalty0 115--124, 1987{\natexlab{b}}.

\bibitem[Salo et~al.(1996)Salo, Jimenez, and Kuhn]{143}
Salo, Jimenez, and Kuhn.
\newblock Urinary excretion of urodilatin in patients with cirrhosis.
\newblock \emph{Hepatology}, 24:\penalty0 1428--1432, 1996.

\bibitem[Sanderson et~al.(1995)Sanderson, WW, and et~al]{bib3281}
Sanderson, Chan WW, and Hung~YT et~al.
\newblock Effect of low dose beta blockers on atrial and ventricular (b type)
  natriuretic factor in heart failure: a double blind, randomised comparison of
  metoprolol and a third generation vasodilating beta blocker.
\newblock \emph{Br Heart J}, 74:\penalty0 502--507, 1995.

\bibitem[Sandri et~al.(2005)Sandri, M, and et~al]{bib3162}
Sandri, Salvatici M, and Cardinale~D et~al.
\newblock N-terminal pro-b-type natriuretic peptide after high-dose
  chemotherapy: a marker predictive of cardiac dysfunction?
\newblock \emph{Clin Chem}, 51:\penalty0 1405--1410, 2005.

\bibitem[Sarzani et~al.(1999)Sarzani, Dessi-Fulgheri, and Salvi]{264}
Sarzani, Dessi-Fulgheri, and Salvi.
\newblock A novel promoter variant of the natriuretic peptide clearance
  receptor gene is associated with lower atrial natriuretic peptide and higher
  blood pressure in obese hypertensives.
\newblock \emph{J Hypertens}, 17:\penalty0 1301--1305, 1999.

\bibitem[Sarzani et~al.(2004)Sarzani, P, and et~al]{bib352}
Sarzani, Strazzullo P, and Salvi~F et~al.
\newblock Natriuretic peptide clearance receptor alleles and susceptibility to
  abdominal adiposity.
\newblock \emph{Obes Res}, 12:\penalty0 351--356, 2004.

\bibitem[Sayama et~al.(1999)Sayama, Y, N, and M]{bib315}
Sayama, Nakamura Y, Saito N, and Kinoshita M.
\newblock Why is the concentration of plasma brain natriuretic peptide in
  elderly inpatients greater than normal?
\newblock \emph{Coron Artery Dis}, 10:\penalty0 537--540, 1999.

\bibitem[Schorr et~al.(1997)Schorr, Beige, and Ringel]{259}
Schorr, Beige, and Ringel.
\newblock Hpaii polymorphism of the atrial natriuretic peptide gene and blood
  pressure response to salt intake in normotensive men.
\newblock \emph{J Hypertens}, 15:\penalty0 715--718, 1997.

\bibitem[Schrier and Abraham(1999)]{Schrier1999}
RW~Schrier and WT~Abraham.
\newblock Hormones and hemodynamics in heart failure.
\newblock \emph{New England Journal of Medicine}, 341:\penalty0 577--85, 1999.

\bibitem[Schultz et~al.(2004)Schultz, Faber, and Kistorp]{133}
Schultz, Faber, and Kistorp.
\newblock 2004.

\bibitem[Schulz et~al.(1989)Schulz, Singh, Bellet, Singh, Tubb, Chin, and
  Garbers]{Schulz1989}
S~Schulz, S~Singh, RA~Bellet, G~Singh, DJ~Tubb, H~Chin, and DL~Garbers.
\newblock The primary structure of a plasma membrane guanylate cyclase
  demonstrates diversity within this new receptor family.
\newblock \emph{Cell}, 58:\penalty0 1155--1162, 1989.

\bibitem[Scotland et~al.(2005)Scotland, Ahluwalia, and AJ]{271}
Scotland, Ahluwalia, and Hobbs AJ.
\newblock C-type natriuretic peptide in vascular physiology and disease.
\newblock \emph{Pharmacol Ther}, 105:\penalty0 85--89, 2005.

\bibitem[Segawa et~al.(2005)Segawa, M, and et~al]{bib3198}
Segawa, Nakamura M, and Itai~K et~al.
\newblock Plasma b-type natriuretic peptide levels and risk factors for
  congestive heart failure in a japanese general population.
\newblock \emph{Int Heart J}, 46:\penalty0 465--475, 2005.

\bibitem[Shimizu et~al.(2002)Shimizu, K, and et~al]{bib337}
Shimizu, Masuta K, and Aono~K et~al.
\newblock Molecular forms of human brain natriuretic peptide in plasma.
\newblock \emph{Clin Chim Acta}, 316:\penalty0 129--135, 2002.

\bibitem[Shimizu et~al.(2003{\natexlab{a}})Shimizu, K, and et~al]{bib338}
Shimizu, Masuta K, and Asada~H et~al.
\newblock Characterization of molecular forms of probrain natriuretic peptide
  in human plasma.
\newblock \emph{Clin Chim Acta}, 334:\penalty0 233--239, 2003{\natexlab{a}}.

\bibitem[Shimizu et~al.(2003{\natexlab{b}})Shimizu, Masuta, and Asada]{204}
Shimizu, Masuta, and Asada.
\newblock Characterization of molecular forms of probrain natriuretic peptide
  in human plasma.
\newblock \emph{Clin Chim Acta}, 334:\penalty0 233--239, 2003{\natexlab{b}}.

\bibitem[Sim et~al.(2003)Sim, D, and et~al]{bib393}
Sim, Hampton D, and Phillips~C et~al.
\newblock The use of brain natriuretic peptide as a screening test for left
  ventricular systolic dysfunction cost-effectiveness in relation to open
  access echocardiography.
\newblock \emph{Fam Pract}, 20:\penalty0 570--574, 2003.

\bibitem[Squire et~al.(2005)Squire, S, and et~al]{bib3240}
Squire, Orn S, and Ng~LL et~al.
\newblock Plasma natriuretic peptides up to 2 years after acute myocardial
  infarction and relation to orognosis: an optimaal substudy.
\newblock \emph{J Card Fail}, 11:\penalty0 492--497, 2005.

\bibitem[Stanek et~al.(2001)Stanek, B, and et~al]{bib3190}
Stanek, Frey B, and Hulsmann~M et~al.
\newblock Prognostic evaluation of neurohumoral plasma levels before and during
  beta-blocker therapy in advanced left ventricular dysfunction.
\newblock \emph{J Am Coll Cardiol}, 38:\penalty0 436--442, 2001.

\bibitem[Stanton and andWijeysundera HC~et al(2005)]{bib3199}
Stanton and Hansen~M andWijeysundera HC~et al.
\newblock A direct comparison of the natriuretic peptides and their
  relationship to survival in chronic heart failure of a presumed non-ischaemic
  origin.
\newblock \emph{Eur J Heart Fail}, 7:\penalty0 557--565, 2005.

\bibitem[Steg et~al.(2005)Steg, L, and et~al]{bib3181}
Steg, Joubin L, and McCord~J et~al.
\newblock B-type natriuretic peptide and echocardiographic determination of
  ejection fraction in the diagnosis of congestive heart failure in patients
  with acute dyspnea.
\newblock \emph{Chest}, 128:\penalty0 21--29, 2005.

\bibitem[Steinhelper et~al.(1990{\natexlab{a}})Steinhelper, Cochrane, and
  LJ]{253}
Steinhelper, Cochrane, and Field LJ.
\newblock Hypotension in transgenic mice expressing atrial natriuretic factor
  fusion genes.
\newblock \emph{Hypertension}, 16:\penalty0 301--307, 1990{\natexlab{a}}.

\bibitem[Steinhelper et~al.(1990{\natexlab{b}})Steinhelper, Cochrane, and
  Field]{Steinhelper1990}
ME~Steinhelper, KL~Cochrane, and LJ~Field.
\newblock Hypotension in transgenic mice expressing atrial natriuretic factor
  fusion genes.
\newblock \emph{Hypertension}, 16:\penalty0 301--307, 1990{\natexlab{b}}.

\bibitem[Straub et~al.(1996)Straub, Hall, and BK]{140}
Straub, Hall, and Kramer BK.
\newblock Atrial natriuretic factor and digoxin-like immunoreactive factor in
  diabetic patients their interrelation and the influence of the autonomic
  nervous system.
\newblock \emph{J Clin Endocrinol Metab}, 81:\penalty0 3385--3389, 1996.

\bibitem[Struthers(1993)]{bib3175}
Struthers.
\newblock Plasma concentrations of brain natriuretic peptide: will this new
  test reduce the need for cardiac investigations?
\newblock \emph{(Editorial) Br Heart J}, 70:\penalty0 397--398, 1993.

\bibitem[Sudoh et~al.(1988)Sudoh, Kangawa, Minamino, and Matsuo]{Sudoh1988}
T~Sudoh, K~Kangawa, N~Minamino, and H~Matsuo.
\newblock A new natriuretic peptide in porcine brain.
\newblock \emph{Nature}, 332:\penalty0 78--81, 1988.

\bibitem[Sudoh et~al.(1990)Sudoh, Minamino, Kangawa, and Matsuo]{Sudoh1990}
T~Sudoh, N~Minamino, K~Kangawa, and H~Matsuo.
\newblock C-type natriuretic peptide (cnp): a new member of natriuretic peptide
  family identified in porcine brain.
\newblock \emph{Biochem Biophys Res Commun}, 168:\penalty0 863--870, 1990.

\bibitem[Suga et~al.(1993{\natexlab{a}})Suga, Itoh, and Komatsu]{280}
Suga, Itoh, and Komatsu.
\newblock Cytokine-induced c-type natriuretic peptide (cnp) secretion from
  vascular endothelial cells evidence for cnp as a novel autocrine/paracrine
  regulator from endothelial cells.
\newblock \emph{Endocrinology}, 133:\penalty0 3038--3041, 1993{\natexlab{a}}.

\bibitem[Suga et~al.(1992{\natexlab{a}})Suga, Nakao, Hosoda, Mukoyama, Ogawa,
  Shirakami, Arai, Saito, Kambayashi, Inouye, and Imura]{Suga1992a}
S~Suga, K~Nakao, K~Hosoda, M~Mukoyama, Y~Ogawa, G~Shirakami, H~Arai, Y~Saito,
  Y~Kambayashi, K~Inouye, and H~Imura.
\newblock Receptor selectivity of natriuretic peptide family, atrial
  natriuretic peptide, brain natriuretic peptide, and c-type natriuretic
  peptide.
\newblock \emph{Endocrinology}, 130:\penalty0 229--239, 1992{\natexlab{a}}.

\bibitem[Suga et~al.(1992{\natexlab{b}})Suga, Nakao, Itoh, Komatsu, Ogawa,
  Hama, and Imura]{Suga1992b}
S~Suga, K~Nakao, H~Itoh, Y~Komatsu, Y~Ogawa, N~Hama, and H~Imura.
\newblock Endothelial production of c-type natriuretic peptide and its marked
  augmentation by transforming growth factor-beta; possible existence of
  vascular natriuretic peptide system.
\newblock \emph{J Clin Invest}, 90:\penalty0 1145--1149, 1992{\natexlab{b}}.

\bibitem[Suga et~al.(1993{\natexlab{b}})Suga, Itoh, Komatsu, Ogawa, Hama,
  Yoshimasa, and Nakao]{Suga1993}
S~Suga, H~Itoh, Y~Komatsu, Y~Ogawa, N~Hama, T~Yoshimasa, and K~Nakao.
\newblock Cytokine-induced c-type natriuretic peptide (cnp) secretion from
  vascular endothelial cells-evidence for cnp as a novel autocrine/paracrine
  regulator from endothelial cells.
\newblock \emph{Endocrinology}, 133:\penalty0 3038--3041, 1993{\natexlab{b}}.

\bibitem[Sugawara et~al.(1988)Sugawara, Nakao, and Itoh]{135}
Sugawara, Nakao, and Itoh.
\newblock Cosecretion of peptides derived from gamma human atrial natriuretic
  polypeptide in normal volunteers and patients with essential hypertension and
  adrenal disorders.
\newblock \emph{J Hypertens}, 6(Suppl. 4):\penalty0 S327--329, 1988.

\bibitem[Suzuki and andYamazaki T~et al(1998)]{bib3148}
Suzuki and Hayashi~D andYamazaki T~et al.
\newblock Elevated b-type natriuretic peptide levels after anthracycline
  administration.
\newblock \emph{Am Heart J}, 136:\penalty0 362--363, 1998.

\bibitem[Suzuki et~al.(1998)Suzuki, Hayashi, and Yamazaki]{158}
Suzuki, Hayashi, and Yamazaki.
\newblock Elevated b-type natriuretic peptide levels after anthracycline
  administration.
\newblock \emph{Am Heart J}, 136:\penalty0 362--363, 1998.

\bibitem[Suzuki et~al.(2000)Suzuki, K, and et~al]{bib3123}
Suzuki, Yamaoki K, and Nakajima~O et~al.
\newblock Screening for cardiac dysfunction in asymptomatic patients by
  measuring b-type natriuretic peptide levels.
\newblock \emph{Jpn Heart J}, 41:\penalty0 205--214, 2000.

\bibitem[Suzuki et~al.(2001)Suzuki, Yamazaki, and Yazaki]{Suzuki2001}
Toru Suzuki, Tsutomu Yamazaki, and Yoshio Yazaki.
\newblock The role of natriuretic peptides in the cardiovascular system.
\newblock \emph{Cardiovascular Research}, 51:\penalty0 489--494, 2001.

\bibitem[Sward et~al.(2005)Sward, Valsson, Sellgren, and Ricksten]{Sward2005}
K~Sward, F~Valsson, J~Sellgren, and SE~Ricksten.
\newblock Differential effects of human atrial natriuretic peptide and
  furosemide on glomerular filtration rate and renal oxygen consumption in
  humans.
\newblock \emph{Intensive Care Med}, 31:\penalty0 79--85, 2005.

\bibitem[Swedberg et~al.(2005)Swedberg, Cleland, Dargie, Drexler, Follath,
  Komajda, Tavazzi, Smiseth, Gavazzi, Haverich, Hoes, Jaarsma, Korewicki, Levy,
  Linde, Lopez-Sendon, Nieminen, Pierard, and Remme]{Swedberg2005}
K~Swedberg, J~Cleland, H~Dargie, H~Drexler, F~Follath, M~Komajda, L~Tavazzi,
  OA~Smiseth, A~Gavazzi, A~Haverich, A~Hoes, T~Jaarsma, J~Korewicki, S~Levy,
  C~Linde, JL~Lopez-Sendon, MS~Nieminen, L~Pierard, and WJ~Remme.
\newblock Guidelines for the diagnosis and treatment of chronic heart failure:
  executive summary (update 2005).
\newblock \emph{Eur Heart J}, 26:\penalty0 1115--40, 2005.

\bibitem[Takeda et~al.(2004)Takeda, T, and et~al]{bib390}
Takeda, Fukutomi T, and Suzuki~S et~al.
\newblock Effects of carvedilol on plasma b-type natriuretic peptide
  concentration and symptoms in patients with heart failure and preserved
  ejection fraction.
\newblock \emph{Am J Cardiol}, 94:\penalty0 448--453, 2004.

\bibitem[Takemura et~al.(1998)Takemura, Takatsu, and Doyama]{148}
Takemura, Takatsu, and Doyama.
\newblock Expression of atrial and brain natriuretic peptides and their genes
  in hearts of patients with cardiac amyloidosis.
\newblock \emph{J Am Coll Cardiol}, 31:\penalty0 254--265, 1998.

\bibitem[Takeuchi et~al.(2003)Takeuchi, Ohmori, and Kondo]{86}
Takeuchi, Ohmori, and Kondo.
\newblock Potentiation of c-type natriuretic peptide with ultrasound and
  microbubbles to prevent neointimal formation after vascular injury in rats.
\newblock \emph{Cardiovasc Res}, 58:\penalty0 231--238, 2003.

\bibitem[Talwar et~al.(1999)Talwar, IB, and et~al]{bib3173}
Talwar, Squire IB, and Davies~JE et~al.
\newblock Plasma n-terminal pro-brain natriuretic peptide and the ecg in the
  assessment of left-ventricular systolic dysfunction in a high risk
  population.
\newblock \emph{Eur Heart J}, 20:\penalty0 1736--1744, 1999.

\bibitem[Talwar et~al.(2000)Talwar, Squire, Downie, Mccullough, Campton,
  Davies, Barnett, and Ng]{Talwar2000}
S~Talwar, IB~Squire, PF~Downie, AM~Mccullough, MC~Campton, JE~Davies,
  DB~Barnett, and LL~Ng.
\newblock Profile of plasma n-terminal probnp following acute myocardial
  infarction; correlation with left ventricular systolic dysfunction.
\newblock \emph{Eur Heart J}, 21:\penalty0 1514--21, 2000.

\bibitem[Tamura et~al.(2000)Tamura, Ogawa, Chusho, Nakamura, Nakao, Suda,
  Kasahara, Hashimoto, Katsuura, Mukoyama, Itoh, Saito, Tanaka, Otani, and
  Katsuki]{Tamura2000}
N~Tamura, Y~Ogawa, H~Chusho, K~Nakamura, K~Nakao, M~Suda, M~Kasahara,
  R~Hashimoto, G~Katsuura, M~Mukoyama, H~Itoh, Y~Saito, I~Tanaka, H~Otani, and
  M~Katsuki.
\newblock Cardiac fibrosis in mice lacking brain natriuretic peptide.
\newblock \emph{Proc Natl Acad Sci U S A}, 97:\penalty0 4239--4244, 2000.

\bibitem[Tamura et~al.(2001)Tamura, Chrisman, and Garbers]{Tamura2001}
N~Tamura, TD~Chrisman, and DL~Garbers.
\newblock The regulation and physiological roles of the guanylyl cyclase
  receptors.
\newblock \emph{Endocr J}, 48:\penalty0 611--634, 2001.

\bibitem[Tamura et~al.(2004)Tamura, Doolittle, Hammer, Shelton, Richardson, and
  Garbers]{Tamura2004}
N~Tamura, LK~Doolittle, RE~Hammer, JM~Shelton, JA~Richardson, and DL~Garbers.
\newblock Critical roles of the guanylyl cyclase b receptor in endochondral
  ossification and development of female reproductive organs.
\newblock \emph{Proc Natl Acad Sci U S A}, 101:\penalty0 17300--17305, 2004.

\bibitem[Tanaka et~al.(2005)Tanaka, Nagai, and Date]{119}
Tanaka, Nagai, and Date.
\newblock Effects of bradykinin on cardiovascular remodeling in renovascular
  hypertensive rats.
\newblock \emph{Hypertens Res}, 27:\penalty0 865--875, 2005.

\bibitem[ten Wolde et~al.(2003{\natexlab{a}})ten Wolde, II, and et~al]{bib382}
ten Wolde, Tulevski II, and Mulder~JW et~al.
\newblock Brain natriuretic peptide as a predictor of adverse outcome in
  patients with pulmonary embolism.
\newblock \emph{Circulation}, 107:\penalty0 2082--2084, 2003{\natexlab{a}}.

\bibitem[ten Wolde et~al.(2003{\natexlab{b}})ten Wolde, Tulevski, and JW]{124}
ten Wolde, Tulevski, and Mulder JW.
\newblock Brain natriuretic peptide as a predictor of adverse outcome in
  patients with pulmonary embolism.
\newblock \emph{Circulation}, 107:\penalty0 2082--2084, 2003{\natexlab{b}}.

\bibitem[Tenhunen et~al.(2005)Tenhunen, Szokodi, and Ruskoaho]{32}
Tenhunen, Szokodi, and Ruskoaho.
\newblock Posttranscriptional activation of bnp gene expression in response to
  increased left ventricular wall stress role of calcineurin and pkc.
\newblock \emph{Regul Pept}, 128:\penalty0 187--196, 2005.

\bibitem[Thomas et~al.(2004)Thomas, KF, AJ, and GC]{bib3176}
Thomas, Fox KF, Coats AJ, and Sutton GC.
\newblock The epidemiological enigma of heart failure with preserved systolic
  function.
\newblock \emph{Eur J Heart Fail}, 6:\penalty0 125--136, 2004.

\bibitem[Thompson et~al.(2005)Thompson, CA, and et~al]{bib3268}
Thompson, Skrabal CA, and Loebe~M et~al.
\newblock Plasma neurohormone levels correlate with left ventricular functional
  and morphological improvement in lvad patients.
\newblock \emph{J Surg Res}, 123:\penalty0 25--32, 2005.

\bibitem[Thuerauf et~al.(1994)Thuerauf, Hanford, and Glembotski]{Thuerauf1994}
DJ~Thuerauf, DS~Hanford, and CC~Glembotski.
\newblock Regulation of rat brain natriuretic peptide transcription; a
  potential role for gata-related transcription factors in myocardial cell gene
  expression.
\newblock \emph{J Biol Chem}, 269:\penalty0 17772--17775, 1994.

\bibitem[Toth et~al.(1994)Toth, KH, and et~al]{bib3244}
Toth, Vuorinen KH, and Vuolteenaho~O et~al.
\newblock Hypoxia stimulates release of anp and bnp from perfused rat
  ventricular myocardium.
\newblock \emph{Am J Physiol 266(4 Pt 2):H1572-1580}, 1994.

\bibitem[Totsune et~al.(1996)Totsune, Takahashi, and Satoh]{202}
Totsune, Takahashi, and Satoh.
\newblock Urinary immunoreactive brain natriuretic peptide in patients with
  renal disease.
\newblock \emph{Regul Pept}, 63:\penalty0 141--146, 1996.

\bibitem[Trindade and JL(2001)]{bib339}
Trindade and Rouleau JL.
\newblock Vasopeptidase inhibitors: potential role in the treatment of heart
  failure.
\newblock \emph{(Review) Heart Fail Monit}, 2:\penalty0 2--7, 2001.

\bibitem[Troughton and andYandle TG~et al(2000)]{bib3253}
Troughton and Frampton~CM andYandle TG~et al.
\newblock Treatment of heart failure guided by plasma aminoterminal brain
  natriuretic peptide (n-bnp) concentrations.
\newblock \emph{Lancet}, 355:\penalty0 1126--1130, 2000.

\bibitem[Troughton et~al.(2001)Troughton, AM, and MG]{bib3257}
Troughton, Richards AM, and Nicholls MG.
\newblock Individualized treatment of heart failure.
\newblock \emph{Intern Med J}, 31:\penalty0 138--141, 2001.

\bibitem[Troughton et~al.(2000)Troughton, Frampton, Yandle, Espiner, Nicholls,
  and Richards]{Troughton2000}
RW~Troughton, CM~Frampton, TG~Yandle, EA~Espiner, MG~Nicholls, and AM~Richards.
\newblock Treatment of heart failure guided by plasma aminoterminal brain
  natriuretic peptide (n-bnp) concentrations.
\newblock \emph{Lancet}, 355:\penalty0 1126--30, 2000.

\bibitem[Tsuji et~al.(2004)Tsuji, Nishino, Kimura, Yamada, Nukui, Yamamoto,
  Iwasaka, and Takahashi]{Tsuji2004}
H~Tsuji, N~Nishino, Y~Kimura, K~Yamada, M~Nukui, S~Yamamoto, T~Iwasaka, and
  H~Takahashi.
\newblock Haemoglobin level influences plasma brain natriuretic peptide
  concentration.
\newblock \emph{Acta Cardiol}, 59:\penalty0 527--31, 2004.

\bibitem[Tsuji and Kunieda(2005)]{Tsuji2005}
T~Tsuji and T~Kunieda.
\newblock A loss-of-function mutation in natriuretic peptide receptor 2 (npr2)
  gene is responsible for disproportionate dwarfism in cn/cn mouse.
\newblock \emph{J Biol Chem}, 280:\penalty0 1428814292, 2005.

\bibitem[Tsukagoshi et~al.(2001)Tsukagoshi, Shimizu, and Kawata]{95}
Tsukagoshi, Shimizu, and Kawata.
\newblock Atrial natriuretic peptide inhibits tumor necrosis factor-alpha
  production by interferon-gamma-activated macrophages via suppression of p38
  mitogen-activated protein kinase and nuclear factor-kappa b activation.
\newblock \emph{Reg Pept}, 99:\penalty0 21--29, 2001.

\bibitem[Tsunoda et~al.(1988)Tsunoda, FAO, and et~al]{bib344}
Tsunoda, Mendelsoohn FAO, and Sexton~PM et~al.
\newblock Decreased atrial natriuretic peptide binding in renal medulla in rats
  with chronic heart failure.
\newblock \emph{Circ Res}, 62:\penalty0 155--161, 1988.

\bibitem[Tsutamoto et~al.(1993)Tsutamoto, T, and et~al]{bib345}
Tsutamoto, Kanamory T, and Morigami~N et~al.
\newblock Possibility of downregulation of atrial natriuretic peptide receptor
  coupled to guanylate cyclase in peripheral vascular beds of patients with
  chronic severe heart failure.
\newblock \emph{Circulation}, 87:\penalty0 70--75, 1993.

\bibitem[Tsutamoto et~al.(1999)Tsutamoto, A, and et~al]{bib3189}
Tsutamoto, Wada A, and Maeda~K et~al.
\newblock Plasma brain natriuretic peptide level as a biochemical marker of
  morbidity and mortality in patients with asymptomatic or minimally
  symptomatic left ventricular dysfunction. comparison with plasma angiotensin
  ii and endothelin-1.
\newblock \emph{Eur Heart J}, 20:\penalty0 1799--1807, 1999.

\bibitem[Tsutamoto et~al.(2001)Tsutamoto, A, and et~al]{bib3275}
Tsutamoto, Wada A, and Maeda~K et~al.
\newblock Effect of spironolactone on plasma brain natriuretic peptide and left
  ventricular remodeling in patients with congestive heart failure.
\newblock \emph{J Am Coll Cardiol}, 37:\penalty0 1228--1233, 2001.

\bibitem[Tsutamoto et~al.(1997)Tsutamoto, Wada, Maeda, Hisanaga, Maeda, Fukai,
  Ohnishi, Sugimoto, and Kinoshita]{Tsutamoto1997}
T~Tsutamoto, A~Wada, K~Maeda, T~Hisanaga, Y~Maeda, D~Fukai, M~Ohnishi,
  Y~Sugimoto, and M~Kinoshita.
\newblock Attenuation of compensation of endogenous cardiac natriuretic peptide
  system in chronic heart failure: prognostic role of plasma brain natriuretic
  peptide concentration in patients with chronic symptomatic left ventricular
  dysfunction.
\newblock \emph{Circulation}, 96:\penalty0 509--16, 1997.

\bibitem[Tsutamoto et~al.(2004)Tsutamoto, Sakai, Wada, Ishikawa, Ohno, Fujii,
  Yamamoto, Takayama, Dohke, and Horie]{Tsutamoto2004}
T~Tsutamoto, H~Sakai, Wada, C~Ishikawa, K~Ohno, M~Fujii, T~Yamamoto,
  T~Takayama, T~Dohke, and M~Horie.
\newblock Torasemide inhibits transcardiac extraction of aldosterone in
  patients with congestive heart failure.
\newblock \emph{J Am Coll Cardiol}, 44:\penalty0 2252--3, 2004.

\bibitem[Tulevski et~al.(2002)Tulevski, Mulder, and van
  Veldhuisen]{Tulevski2002}
II~Tulevski, BJ~Mulder, and DJ~van Veldhuisen.
\newblock Utility of a bnp as a marker for rv dysfunction in acute pulmonary
  embolism.
\newblock \emph{J Am Coll Cardiol}, 39:\penalty0 2080, 2002.

\bibitem[Ueda et~al.(2003)Ueda, M, and et~al]{bib316}
Ueda, Yokouchi M, and Suzuki~T et~al.
\newblock Prognostic value of high plasma brain natriuretic peptide
  concentrations in very elderly persons.
\newblock \emph{Am J Med}, 114:\penalty0 266--270, 2003.

\bibitem[Uusimaa et~al.(1999)Uusimaa, H, and et~al]{bib3137}
Uusimaa, Ruskoaho H, and Vuolteenaho~O et~al.
\newblock Plasma vasoactive peptides after acute myocardial infarction in
  relation to left ventricular dysfunction.
\newblock \emph{Int J Cardiol}, 69:\penalty0 5--14, 1999.

\bibitem[Valle et~al.(2005)Valle, N, and et~al]{bib3147}
Valle, Aspromonte N, and Barro~S et~al.
\newblock The nt-probnp assay identifies very elderly nursing home residents
  suffering from pre-clinical heart failure.
\newblock \emph{Eur J Heart Fail}, 7:\penalty0 542--551, 2005.

\bibitem[van~den Meiracker et~al.(2003)van~den Meiracker, TW, van~de Ven~LL,
  and F]{bib3291}
van~den Meiracker, Lameris TW, van~de Ven~LL, and Boomsma F.
\newblock Increased plasma concentration of natriuretic peptides by selective
  beta1-blocker bisoprolol.
\newblock \emph{J Cardiovasc Pharmacol}, 42:\penalty0 462--468, 2003.

\bibitem[Vanderheyden and andVerstreken S~et al(2004)]{bib3126}
Vanderheyden and Goethals~M andVerstreken S~et al.
\newblock Wall stress modulates brain natriuretic peptide production in
  pressure overload cardiomyopathy.
\newblock \emph{J Am Coll Cardiol}, 44:\penalty0 2349--2354, 2004.

\bibitem[Vanderheyden et~al.(2004)Vanderheyden, J, and M]{bib3102}
Vanderheyden, Bartunek J, and Goethals M.
\newblock Brain and other natriuretic peptides: molecular aspects.
\newblock \emph{Eur J Heart Fail}, 6:\penalty0 261--268, 2004.

\bibitem[Vasan et~al.(1995)Vasan, EJ, and D]{bib3120}
Vasan, Benjamin EJ, and Levy D.
\newblock Prevalence, clinical features and prognosis of diastolic heart
  failure: an epidemiologic perspective.
\newblock \emph{J Am Coll Cardiol}, 26:\penalty0 1565--1574, 1995.

\bibitem[Vasan et~al.(2002)Vasan, EJ, and et~al]{bib39}
Vasan, Benjamin EJ, and Larson~MG et~al.
\newblock Plasma natriuretic peptides for community screening for left
  ventricular hypertrophy and systolic dysfunction.
\newblock \emph{JAMA}, 288:\penalty0 1252--1259, 2002.

\bibitem[Vatta et~al.(1996)Vatta, Presas, and LG]{91}
Vatta, Presas, and Bianciotti LG.
\newblock B and c types natriuretic peptides modulate norepinephrine uptake and
  release in the rat hypothalamus.
\newblock \emph{Regul Pept}, 16:\penalty0 175--184, 1996.

\bibitem[Vatta et~al.(1997)Vatta, Presas, and LG]{92}
Vatta, Presas, and Bianciotti LG.
\newblock B and c types natriuretic peptides modify norepinephrine uptake and
  release in the rat adrenal medulla.
\newblock \emph{Peptides}, 18:\penalty0 1483--1489, 1997.

\bibitem[Ventura et~al.(2002)Ventura, Gomes, and WL]{90}
Ventura, Gomes, and Reis WL.
\newblock Nitrergic modulation of vasopressin, oxytocin and atrial natriuretic
  peptide secretion in response to sodium intake and hypertonic blood volume
  expansion.
\newblock \emph{Braz J Med Biol Res}, 35:\penalty0 1101--1109, 2002.

\bibitem[Vesely(2003)]{100}
Vesely.
\newblock Natriuretic peptides and acute renal failure.
\newblock \emph{Am J Physiol Renal Physiol}, 285:\penalty0 F167--177, 2003.

\bibitem[Vieira et~al.(2001{\natexlab{a}})Vieira, Gao, Nikonova, and
  Maack]{189}
Vieira, Gao, Nikonova, and Maack.
\newblock Molecular and cellular physiology of the dissociation of atrial
  natriuretic peptide from guanylyl cyclase a receptors.
\newblock \emph{J Biol Chem}, 276:\penalty0 36438--36445, 2001{\natexlab{a}}.

\bibitem[Vieira et~al.(2001{\natexlab{b}})Vieira, Gao, Nikonova, and
  Maack]{Vieira2001}
MA~Vieira, M~Gao, LN~Nikonova, and T~Maack.
\newblock Molecular and cellular physiology of the dissociation of atrial
  natriuretic peptide from guanylyl cyclase a receptors.
\newblock \emph{J Biol Chem}, 276:\penalty0 3643836445, 2001{\natexlab{b}}.

\bibitem[Villa et~al.(1995)Villa, Riccardi, and Lazzeri]{142}
La~Villa, Riccardi, and Lazzeri.
\newblock Blunted natriuretic response to low-dose brain natriuretic peptide
  infusion in non azotemic cirrhotic patients with ascites and avid sodium
  retention.
\newblock \emph{Hepatology}, 22:\penalty0 1745--1750, 1995.

\bibitem[Vollmar(2005)]{99}
Vollmar.
\newblock The role of atrial natriuretic peptide in the immune system.
\newblock \emph{Peptides}, 26:\penalty0 1086--1094, 2005.

\bibitem[Vollmar and AK(2001)]{106}
Vollmar and Kiemer AK.
\newblock Immunomodulatory and cytoprotective function of atrial natriuretic
  peptide.
\newblock \emph{Crit Rev Immunol}, 21:\penalty0 473--485, 2001.

\bibitem[Vollmar and Schultz(1995)]{105}
Vollmar and Schultz.
\newblock Expression and differential regulation of natriuretic peptides in
  mouse macrophages.
\newblock \emph{J Clin Invest}, 95:\penalty0 2442--2450, 1995.

\bibitem[Vollmar et~al.(1995)Vollmar, Wolf, and Schulz]{104}
Vollmar, Wolf, and Schulz.
\newblock Co-expression of the natriuretic peptides (anp, bnp, cnp) and their
  receptors in normal and acutely involuted rat thymus.
\newblock \emph{J Neuroimmunol}, 57:\penalty0 117--127, 1995.

\bibitem[Vollmer et~al.(1988)Vollmer, Mytzka, Arendt, and Schulz]{114}
Vollmer, Mytzka, Arendt, and Schulz.
\newblock Atrial natriuretic peptide in bovine corpus luteum.
\newblock \emph{Endocrinology}, 123:\penalty0 762--767, 1988.

\bibitem[Wallen et~al.(1997)Wallen, S, and et~al]{bib3188}
Wallen, Landahl S, and Hedner~T et~al.
\newblock Brain natriuretic peptide predicts mortality in the elderly.
\newblock \emph{Heart}, 77:\penalty0 264--267, 1997.

\bibitem[Walther et~al.(2003)Walther, Klostermann, and Hering-Walther]{35}
Walther, Klostermann, and Hering-Walther.
\newblock Fibrosis rather than blood pressure determines cardiac bnp expression
  in mice.
\newblock \emph{Regul Pept}, 116:\penalty0 95--100, 2003.

\bibitem[Wang et~al.(2002)Wang, MG, and et~al]{bib310}
Wang, Larson MG, and Levy~D et~al.
\newblock Impact of age and sex on plasma natriuretic peptide levels in healthy
  adults.
\newblock \emph{Am J Cardiol}, 90:\penalty0 254--258, 2002.

\bibitem[Wang et~al.(2004{\natexlab{a}})Wang, MG, and et~al]{bib354}
Wang, Larson MG, and Levy~D et~al.
\newblock Impact of obesity on plasma natriuretic peptide levels.
\newblock \emph{Circulation}, 109:\penalty0 594--600, 2004{\natexlab{a}}.

\bibitem[Wang et~al.(2004{\natexlab{b}})Wang, Dowling, Meadows, Ayala,
  Marshall, Minshall, Greenberg, Thattassery, Fisher, Rao, and
  Gottlieb]{Wang2004a}
DJ~Wang, TC~Dowling, D~Meadows, T~Ayala, J~Marshall, S~Minshall, N~Greenberg,
  E~Thattassery, ML~Fisher, K~Rao, and SS~Gottlieb.
\newblock Nesiritide does not improve renal function in patients with chronic
  heart failure and worsening serum creatinine.
\newblock \emph{Circulation}, 110:\penalty0 1620--1625, 2004{\natexlab{b}}.

\bibitem[Wang et~al.(2004{\natexlab{c}})Wang, Larson, Levy, Benjamin, Leip,
  Wilson, and Vasan]{Wang2004b}
TJ~Wang, MG~Larson, D~Levy, EJ~Benjamin, EP~Leip, PW~Wilson, and RS~Vasan.
\newblock Impact of obesity on plasma natriuretic peptide levels.
\newblock \emph{Circulation}, 109:\penalty0 594--600, 2004{\natexlab{c}}.

\bibitem[Wang et~al.(2007)Wang, deWaard, Sterner-Kock, Stepan, Schultheiss,
  Duncker, and Walther]{Wang2007}
Y~Wang, MC~deWaard, A~Sterner-Kock, H~Stepan, HP~Schultheiss, DJ~Duncker, and
  T~Walther.
\newblock Cardiomyocyte-restricted over-expression of c-type natriuretic
  peptide prevents cardiac hypertrophy induced by myocardial infarction in
  mice.
\newblock \emph{Eur J Heart Fail}, 9:\penalty0 548--557, 2007.

\bibitem[Waschek(2004)]{107}
Waschek.
\newblock Developmental actions of natriuretic peptides in the brain and
  skeleton.
\newblock \emph{Cell Mol Life Sci}, 61:\penalty0 2332--2342, 2004.

\bibitem[Weber et~al.(2003)Weber, Blumenthal, and Hartung]{97}
Weber, Blumenthal, and Hartung.
\newblock Anp inhibits tnf-alpha-induced endothelial mcp-1 expression
  involvement of p38 mapk and mkp-1.
\newblock \emph{J Leukoc Biol}, 74:\penalty0 932--941, 2003.

\bibitem[Widecka et~al.(1998)Widecka, Ciechanowicz, and Adler]{260}
Widecka, Ciechanowicz, and Adler.
\newblock Analysis of polymorphisms sma (hpa ii) and sca i gene precursors of
  atrial natriuretic peptide (anp) in patients with essential hypertension.
\newblock \emph{Pol Arch Med Wewn}, 100:\penalty0 27--34, 1998.

\bibitem[Widmaier et~al.(2008)Widmaier, Raff, and Strang]{Widmaier2008}
EP~Widmaier, H~Raff, and KT~Strang.
\newblock \emph{Vander's Human Physiology}.
\newblock 11 edition, 2008.

\bibitem[Williams et~al.(2004)Williams, LL, and et~al]{bib375}
Williams, Ng~LL, and O’Brien~RJ et~al.
\newblock Comparison of plasma n-brain natriuretic peptide, peak oxygen
  consumption, and left ventricular ejection fraction for severity of chronic
  heart failure.
\newblock \emph{Am J Cardiol}, 93:\penalty0 1560--1561, 2004.

\bibitem[Willis et~al.(2005)Willis, Lee, and Grenache]{Willis2005}
MS~Willis, ES~Lee, and DG~Grenache.
\newblock Effect of anemia on plasma concentrations of nt-probnp.
\newblock \emph{Clin Chim Acta}, 358:\penalty0 175--81, 2005.

\bibitem[Witteles et~al.(2007)Witteles, Kao, Christopherson, Matsuda, Vagelos,
  Schreiber, and Fowler]{Witteles2007}
RM~Witteles, D~Kao, D~Christopherson, K~Matsuda, RH~Vagelos, D~Schreiber, and
  MB~Fowler.
\newblock Impact of nesiritide on renal function in patients with acute
  decompensated heart failure and pre-existing renal dysfunction a randomized,
  double-blind, placebo-controlled clinical trial.
\newblock \emph{J Am Coll Cardiol}, 50:\penalty0 1835--1840, 2007.

\bibitem[Witthaut et~al.(2003)Witthaut, Busch, and Fraunberger]{61}
Witthaut, Busch, and Fraunberger.
\newblock Plasma atrial natriuretic peptide and brain natriuretic peptide are
  increased in septic shock impact of interleukin-6 and sepsis-associated left
  ventricular dysfunction.
\newblock \emph{Intensive Care Med}, 29:\penalty0 1696--1702, 2003.

\bibitem[Wiviott et~al.(2004)Wiviott, de~Lemos~JA, and DA]{bib378}
Wiviott, de~Lemos~JA, and Morrow DA.
\newblock Pathophysiology, prognostic significance and clinical utility of
  b-type natriuretic peptide in acute coronary syndromes.
\newblock \emph{(Review) Clin Chim Acta}, 346:\penalty0 119--128, 2004.

\bibitem[Wold et~al.(2005)Wold, Vik-Mo, and Omland]{Wold2005}
KC~Wold, H~Vik-Mo, and T~Omland.
\newblock Blood haemoglobin is an independent predictor of b-type natriuretic
  peptide (bnp).
\newblock \emph{Clin Sci (Lond)}, 109:\penalty0 69--74, 2005.

\bibitem[Woodard et~al.(2002)Woodard, Rosado, and Brown]{57}
Woodard, Rosado, and Brown.
\newblock Expression and control of c-type natriuretic peptide in rat vascular
  smooth muscle cells.
\newblock \emph{Am J Physiol Reg Int Comp Physiol}, 282:\penalty0 R156--165,
  2002.

\bibitem[Wright et~al.(2003)Wright, RN, and et~al]{bib3133}
Wright, Doughty RN, and Pearl~A et~al.
\newblock Plasma amino-terminal pro-brain natriuretic peptide and accuracy of
  heart-failure diagnosis in primary care: a randomized, controlled trial.
\newblock \emph{J Am Coll Cardiol}, 42:\penalty0 1793--1800, 2003.

\bibitem[Wu and A(2004)]{bib3100}
Wu and Smith A.
\newblock Biological variation of the natriuretic peptides and their role in
  monitoring patients with heart failure.
\newblock \emph{Eur J Heart Fail}, 6:\penalty0 355--358, 2004.

\bibitem[Wu et~al.(2003{\natexlab{a}})Wu, A, and et~al]{bib399}
Wu, Smith A, and Wieczorek~S et~al.
\newblock Biological variation for n-terminal proand btype natriuretic peptides
  and implications for therapeutic monitoring of patients with congestive heart
  failure.
\newblock \emph{Am J Cardiol}, 92:\penalty0 628--631, 2003{\natexlab{a}}.

\bibitem[Wu et~al.(2004{\natexlab{a}})Wu, A, and AS]{bib3264}
Wu, Harrison A, and Maisel AS.
\newblock Reduced readmission rate for alternating diagnoses of heart failure
  and pulmonary disease after implementation of b-type natriuretic peptide
  testing.
\newblock \emph{Eur J Heart Fail}, 6:\penalty0 309--312, 2004{\natexlab{a}}.

\bibitem[Wu et~al.(2004{\natexlab{b}})Wu, Omland, Duc, McCord, Nowak, and
  Hollander]{Wu2004}
AH~Wu, T~Omland, P~Duc, J~McCord, RM~Nowak, and JE~Hollander.
\newblock The effect of diabetes on b-type natriuretic peptide concentrations
  in patients with acute dyspnea: an analysis from the breathing not properly
  multinational study.
\newblock \emph{Diabetes Care}, 27:\penalty0 2398--404, 2004{\natexlab{b}}.

\bibitem[Wu et~al.(2005)Wu, Omland, Knudsen, McCord, Nowak, and
  Hollander]{Wu2005}
AH~Wu, T~Omland, C~Wold Knudsen, J~McCord, RM~Nowak, and JE~Hollander.
\newblock Relationship of b-type natriuretic peptide and anemia in patients
  with and without heart failure: A substudy from the breathing not properly
  (bnp) multinational study.
\newblock \emph{Am J Hematol}, 80:\penalty0 174--80, 2005.

\bibitem[Wu et~al.(2003{\natexlab{b}})Wu, Smith, Wieczorek, Mather, Duncan,
  White, McGill, Katten, and Heller]{Wu2003b}
AHB Wu, A~Smith, S~Wieczorek, JF~Mather, B~Duncan, CM~White, C~McGill,
  D~Katten, and G~Heller.
\newblock Biological variation for n-terminal proand b-type natriuretic
  peptides and implications for therapeutic monitoring of patients with
  congestive heart failure.
\newblock \emph{Am J Cardiol}, 92:\penalty0 628--31, 2003{\natexlab{b}}.

\bibitem[Wu et~al.(2003{\natexlab{c}})Wu, Wu, Pan, Morser, and Wu]{Wu2003a}
C~Wu, F~Wu, J~Pan, J~Morser, and Q~Wu.
\newblock Furin-mediated processing of pro-c-type natriuretic peptide.
\newblock \emph{J Biol Chem}, 278:\penalty0 25847--25852, 2003{\natexlab{c}}.

\bibitem[Wylie et~al.(2004)Wylie, SA, and et~al]{bib3239}
Wylie, Murphy SA, and Morrow~DA et~al.
\newblock Validated risk score predicts the development of congestive heart
  failure after presentation with unstable angina or non-st-elevation
  myocardial infarction: results from opus-timi 16 and tactics-timi 18.
\newblock \emph{Am Heart J}, 148:\penalty0 173--180, 2004.

\bibitem[Yan et~al.(2000)Yan, Wu, Morser, and Wu]{Yan2000}
W~Yan, F~Wu, J~Morser, and Q~Wu.
\newblock Corin, a transmembrane cardiac serine protease, acts as a pro-atrial
  natriuretic peptide-converting enzyme.
\newblock \emph{Proc Natl Acad Sci U S A}, 97:\penalty0 8525--8529, 2000.

\bibitem[Yasoda et~al.(2004)Yasoda, Komatsu, Chusho, Miyazawa, Ozasa, Miura,
  Kurihara, Rogi, Tanaka, Suda, Tamura, Ogawa, and Nakao]{Yasoda2004}
A~Yasoda, Y~Komatsu, H~Chusho, T~Miyazawa, A~Ozasa, M~Miura, T~Kurihara,
  T~Rogi, S~Tanaka, M~Suda, N~Tamura, Y~Ogawa, and K~Nakao.
\newblock Overexpression of cnp in chondrocytes rescues achondroplasia through
  a mapk-dependent pathway.
\newblock \emph{Nat Med}, 10:\penalty0 80--86, 2004.

\bibitem[Yasuda et~al.(2002)Yasuda, Kanna, and Sakuragi]{87}
Yasuda, Kanna, and Sakuragi.
\newblock Local delivery of single low-dose of c-type natriuretic peptide, an
  endogenous vascular modulator, inhibits neointimal hyperplasia in a
  balloon-injured rabbit iliac artery model.
\newblock \emph{J Cardiovasc Pharmacol}, 39:\penalty0 784--788, 2002.

\bibitem[Yasutake et~al.(2005)Yasutake, Y, and et~al]{bib388}
Yasutake, Seino Y, and Kashiwagi~M et~al.
\newblock Detection of cardiac sarcoidosis using cardiac markers and myocardial
  integrated backscatter.
\newblock \emph{Int J Cardiol}, 102:\penalty0 259--268, 2005.

\bibitem[Yeung et~al.(1996)Yeung, Ho, Nicholls, and Cockram]{Yeung1996}
VT~Yeung, SK~Ho, MG~Nicholls, and CS~Cockram.
\newblock Binding of cnp-22 and cnp-53 to cultured mouse astrocytes and effects
  on cyclic gmp.
\newblock \emph{Peptides}, 17:\penalty0 101--106, 1996.

\bibitem[Yoshimura et~al.(1994)Yoshimura, H, and et~al]{bib3280}
Yoshimura, Yasue H, and Tanaka~H et~al.
\newblock Responses of plasma concentrations of a type natriuretic peptide and
  b type natriuretic peptide to alacepril, an angiotensin-converting enzyme
  inhibitor, in patients with congestive heart failure.
\newblock \emph{Br Heart J}, 72:\penalty0 528--533, 1994.

\bibitem[Yoshimura et~al.(1991)Yoshimura, Yasue, Morita, Sakaino, Jougasaki,
  Kurose, Mukoyama, Saito, Nakao, and Imura]{Yoshimura1991}
M~Yoshimura, H~Yasue, E~Morita, N~Sakaino, M~Jougasaki, M~Kurose, M~Mukoyama,
  Y~Saito, K~Nakao, and H~Imura.
\newblock Hemodynamic, renal, and hormonal responses to brain natriuretic
  peptide infusion in patients with congestive heart failure.
\newblock \emph{Circulation}, 84:\penalty0 1581--1588, 1991.

\bibitem[Zeidel(2000)]{bib331}
Zeidel.
\newblock Physiological responses to natriuretic hormones. in: Fray jcs,
  goodman hm (eds) handbook of physiology, section 7, the endocrine system,
  volume iii: Endocrine regulation of water and electrolyte balance.
\newblock 2000.

\bibitem[Zhang et~al.(2005)Zhang, Moalem, and Tse]{79}
Zhang, Moalem, and Tse.
\newblock Effects of natriuretic peptides on ventricular myocyte contraction
  and role of cyclic gmp signaling.
\newblock \emph{Eur J Pharmacol}, 510:\penalty0 209--215, 2005.

\end{thebibliography}
